id	sid	tid	token	lemma	pos
easat-2032	1	1	edelweiss	edelweiss	PROPN
easat-2032	1	2	applied	apply	VERB
easat-2032	1	3	science	science	NOUN
easat-2032	1	4	and	and	CCONJ
easat-2032	1	5	technology	technology	NOUN
easat-2032	1	6	issn	issn	PROPN
easat-2032	1	7	:	:	PUNCT
easat-2032	1	8	2576	2576	NUM
easat-2032	1	9	-	-	SYM
easat-2032	1	10	8484	8484	NUM
easat-2032	1	11	vol	vol	NOUN
easat-2032	1	12	.	.	PROPN
easat-2032	1	13	8	8	NUM
easat-2032	1	14	,	,	PUNCT
easat-2032	1	15	no	no	INTJ
easat-2032	1	16	.	.	NOUN
easat-2032	1	17	6	6	NUM
easat-2032	1	18	,	,	PUNCT
easat-2032	1	19	163	163	NUM
easat-2032	1	20	-	-	SYM
easat-2032	1	21	168	168	NUM
easat-2032	1	22	2024	2024	NUM
easat-2032	1	23	publisher	publisher	NOUN
easat-2032	1	24	:	:	PUNCT
easat-2032	1	25	learning	learn	VERB
easat-2032	1	26	gate	gate	NOUN
easat-2032	1	27	doi	doi	PROPN
easat-2032	1	28	:	:	PUNCT
easat-2032	1	29	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	1	30	©	©	PROPN
easat-2032	1	31	2024	2024	NUM
easat-2032	1	32	by	by	ADP
easat-2032	1	33	the	the	DET
easat-2032	1	34	author	author	NOUN
easat-2032	1	35	;	;	PUNCT
easat-2032	1	36	licensee	licensee	PROPN
easat-2032	1	37	learning	learning	NOUN
easat-2032	1	38	gate	gate	NOUN
easat-2032	1	39	©	©	PROPN
easat-2032	1	40	2024	2024	NUM
easat-2032	1	41	by	by	ADP
easat-2032	1	42	the	the	DET
easat-2032	1	43	author	author	NOUN
easat-2032	1	44	;	;	PUNCT
easat-2032	1	45	licensee	licensee	PROPN
easat-2032	1	46	learning	learn	VERB
easat-2032	1	47	gate	gate	NOUN
easat-2032	1	48	*	*	PUNCT
easat-2032	1	49	correspondence	correspondence	NOUN
easat-2032	1	50	:	:	PUNCT
easat-2032	1	51	tarigeltoum@nu.edu.om	tarigeltoum@nu.edu.om	NOUN
easat-2032	1	52	diagnosis	diagnosis	NOUN
easat-2032	1	53	and	and	CCONJ
easat-2032	1	54	treatment	treatment	NOUN
easat-2032	1	55	of	of	ADP
easat-2032	1	56	pneumocystis	pneumocystis	ADJ
easat-2032	1	57	pneumonia	pneumonia	NOUN
easat-2032	1	58	a	a	DET
easat-2032	1	59	review	review	NOUN
easat-2032	1	60	article	article	NOUN
easat-2032	1	61	tarig	tarig	NOUN
easat-2032	1	62	eltoum	eltoum	PROPN
easat-2032	1	63	yagoub	yagoub	PROPN
easat-2032	1	64	fadelelmoula1	fadelelmoula1	PROPN
easat-2032	2	1	*	*	PROPN
easat-2032	3	1	1department	1department	NUM
easat-2032	3	2	of	of	ADP
easat-2032	3	3	medicine	medicine	NOUN
easat-2032	3	4	,	,	PUNCT
easat-2032	3	5	college	college	NOUN
easat-2032	3	6	of	of	ADP
easat-2032	3	7	medicine	medicine	NOUN
easat-2032	3	8	and	and	CCONJ
easat-2032	3	9	health	health	NOUN
easat-2032	3	10	sciences	sciences	PROPN
easat-2032	3	11	,	,	PUNCT
easat-2032	3	12	national	national	ADJ
easat-2032	3	13	university	university	PROPN
easat-2032	3	14	of	of	ADP
easat-2032	3	15	science	science	NOUN
easat-2032	3	16	and	and	CCONJ
easat-2032	3	17	technology	technology	NOUN
easat-2032	3	18	,	,	PUNCT
easat-2032	3	19	sohar	sohar	PROPN
easat-2032	3	20	,	,	PUNCT
easat-2032	3	21	oman	oman	PROPN
easat-2032	3	22	;	;	PUNCT
easat-2032	3	23	tarigeltoum@nu.edu.om	tarigeltoum@nu.edu.om	PROPN
easat-2032	3	24	(	(	PUNCT
easat-2032	3	25	t.e.ylf	t.e.ylf	PROPN
easat-2032	3	26	.	.	PUNCT
easat-2032	3	27	)	)	PUNCT
easat-2032	3	28	.	.	PUNCT
easat-2032	4	1	abstract	abstract	ADV
easat-2032	4	2	:	:	PUNCT
easat-2032	4	3	this	this	DET
easat-2032	4	4	study	study	NOUN
easat-2032	4	5	aims	aim	VERB
easat-2032	4	6	to	to	PART
easat-2032	4	7	comprehensively	comprehensively	ADV
easat-2032	4	8	evaluate	evaluate	VERB
easat-2032	4	9	the	the	DET
easat-2032	4	10	literature	literature	NOUN
easat-2032	4	11	on	on	ADP
easat-2032	4	12	recent	recent	ADJ
easat-2032	4	13	advances	advance	NOUN
easat-2032	4	14	in	in	ADP
easat-2032	4	15	the	the	DET
easat-2032	4	16	diagnosis	diagnosis	NOUN
easat-2032	4	17	and	and	CCONJ
easat-2032	4	18	treatment	treatment	NOUN
easat-2032	4	19	of	of	ADP
easat-2032	4	20	pneumocystis	pneumocystis	ADJ
easat-2032	4	21	pneumonia	pneumonia	NOUN
easat-2032	4	22	(	(	PUNCT
easat-2032	4	23	pcp	pcp	PROPN
easat-2032	4	24	)	)	PUNCT
easat-2032	4	25	.	.	PUNCT
easat-2032	5	1	a	a	DET
easat-2032	5	2	thorough	thorough	ADJ
easat-2032	5	3	review	review	NOUN
easat-2032	5	4	of	of	ADP
easat-2032	5	5	relevant	relevant	ADJ
easat-2032	5	6	literature	literature	NOUN
easat-2032	5	7	was	be	AUX
easat-2032	5	8	conducted	conduct	VERB
easat-2032	5	9	.	.	PUNCT
easat-2032	6	1	data	datum	NOUN
easat-2032	6	2	were	be	AUX
easat-2032	6	3	sourced	source	VERB
easat-2032	6	4	from	from	ADP
easat-2032	6	5	electronic	electronic	ADJ
easat-2032	6	6	databases	database	NOUN
easat-2032	6	7	such	such	ADJ
easat-2032	6	8	as	as	ADP
easat-2032	6	9	pubmed	pubmed	PROPN
easat-2032	6	10	,	,	PUNCT
easat-2032	6	11	scopus	scopus	PROPN
easat-2032	6	12	,	,	PUNCT
easat-2032	6	13	google	google	NOUN
easat-2032	6	14	scholar	scholar	NOUN
easat-2032	6	15	,	,	PUNCT
easat-2032	6	16	and	and	CCONJ
easat-2032	6	17	medline	medline	NOUN
easat-2032	6	18	,	,	PUNCT
easat-2032	6	19	focusing	focus	VERB
easat-2032	6	20	on	on	ADP
easat-2032	6	21	articles	article	NOUN
easat-2032	6	22	published	publish	VERB
easat-2032	6	23	within	within	ADP
easat-2032	6	24	the	the	DET
easat-2032	6	25	last	last	ADJ
easat-2032	6	26	ten	ten	NUM
easat-2032	6	27	years	year	NOUN
easat-2032	6	28	.	.	PUNCT
easat-2032	7	1	the	the	DET
easat-2032	7	2	review	review	NOUN
easat-2032	7	3	included	include	VERB
easat-2032	7	4	41	41	NUM
easat-2032	7	5	articles	article	NOUN
easat-2032	7	6	.	.	PUNCT
easat-2032	8	1	the	the	DET
easat-2032	8	2	diagnosis	diagnosis	NOUN
easat-2032	8	3	of	of	ADP
easat-2032	8	4	pcp	pcp	PROPN
easat-2032	8	5	has	have	AUX
easat-2032	8	6	evolved	evolve	VERB
easat-2032	8	7	with	with	ADP
easat-2032	8	8	the	the	DET
easat-2032	8	9	development	development	NOUN
easat-2032	8	10	of	of	ADP
easat-2032	8	11	molecular	molecular	ADJ
easat-2032	8	12	techniques	technique	NOUN
easat-2032	8	13	,	,	PUNCT
easat-2032	8	14	advanced	advanced	ADJ
easat-2032	8	15	imaging	imaging	NOUN
easat-2032	8	16	modalities	modality	NOUN
easat-2032	8	17	,	,	PUNCT
easat-2032	8	18	and	and	CCONJ
easat-2032	8	19	artificial	artificial	ADJ
easat-2032	8	20	intelligence	intelligence	NOUN
easat-2032	8	21	models	model	NOUN
easat-2032	8	22	.	.	PUNCT
easat-2032	9	1	trimethoprim	trimethoprim	ADJ
easat-2032	9	2	-	-	PUNCT
easat-2032	9	3	sulfamethoxazole	sulfamethoxazole	NOUN
easat-2032	9	4	(	(	PUNCT
easat-2032	9	5	tmp	tmp	NOUN
easat-2032	9	6	-	-	PUNCT
easat-2032	9	7	smx	smx	NOUN
easat-2032	9	8	)	)	PUNCT
easat-2032	9	9	remains	remain	VERB
easat-2032	9	10	the	the	DET
easat-2032	9	11	mainstay	mainstay	NOUN
easat-2032	9	12	of	of	ADP
easat-2032	9	13	treatment	treatment	NOUN
easat-2032	9	14	.	.	PUNCT
easat-2032	10	1	corticosteroid	corticosteroid	ADJ
easat-2032	10	2	adjunctive	adjunctive	ADJ
easat-2032	10	3	therapy	therapy	NOUN
easat-2032	10	4	(	(	PUNCT
easat-2032	10	5	cat	cat	NOUN
easat-2032	10	6	)	)	PUNCT
easat-2032	10	7	has	have	AUX
easat-2032	10	8	demonstrated	demonstrate	VERB
easat-2032	10	9	efficacy	efficacy	NOUN
easat-2032	10	10	in	in	ADP
easat-2032	10	11	improving	improve	VERB
easat-2032	10	12	outcomes	outcome	NOUN
easat-2032	10	13	,	,	PUNCT
easat-2032	10	14	while	while	SCONJ
easat-2032	10	15	emerging	emerge	VERB
easat-2032	10	16	research	research	NOUN
easat-2032	10	17	suggests	suggest	VERB
easat-2032	10	18	a	a	DET
easat-2032	10	19	potential	potential	ADJ
easat-2032	10	20	role	role	NOUN
easat-2032	10	21	for	for	ADP
easat-2032	10	22	immunomodulatory	immunomodulatory	ADJ
easat-2032	10	23	agents	agent	NOUN
easat-2032	10	24	.	.	PUNCT
easat-2032	11	1	chemoprophylaxis	chemoprophylaxis	VERB
easat-2032	11	2	with	with	ADP
easat-2032	11	3	tmp	tmp	NOUN
easat-2032	11	4	-	-	PUNCT
easat-2032	11	5	smx	smx	NOUN
easat-2032	11	6	remains	remain	VERB
easat-2032	11	7	the	the	DET
easat-2032	11	8	main	main	ADJ
easat-2032	11	9	stay	stay	NOUN
easat-2032	11	10	of	of	ADP
easat-2032	11	11	prevention	prevention	NOUN
easat-2032	11	12	in	in	ADP
easat-2032	11	13	populations	population	NOUN
easat-2032	11	14	at	at	ADP
easat-2032	11	15	risk	risk	NOUN
easat-2032	11	16	.	.	PUNCT
easat-2032	12	1	despite	despite	SCONJ
easat-2032	12	2	advances	advance	NOUN
easat-2032	12	3	in	in	ADP
easat-2032	12	4	diagnostic	diagnostic	ADJ
easat-2032	12	5	technologies	technology	NOUN
easat-2032	12	6	,	,	PUNCT
easat-2032	12	7	treatment	treatment	NOUN
easat-2032	12	8	options	option	NOUN
easat-2032	12	9	for	for	ADP
easat-2032	12	10	pcp	pcp	PROPN
easat-2032	12	11	have	have	AUX
easat-2032	12	12	largely	largely	ADV
easat-2032	12	13	remained	remain	VERB
easat-2032	12	14	unchanged	unchanged	ADJ
easat-2032	12	15	.	.	PUNCT
easat-2032	13	1	there	there	PRON
easat-2032	13	2	are	be	VERB
easat-2032	13	3	currently	currently	ADV
easat-2032	13	4	no	no	DET
easat-2032	13	5	vaccines	vaccine	NOUN
easat-2032	13	6	,	,	PUNCT
easat-2032	13	7	and	and	CCONJ
easat-2032	13	8	chemoprophylaxis	chemoprophylaxis	ADJ
easat-2032	13	9	remains	remain	VERB
easat-2032	13	10	the	the	DET
easat-2032	13	11	mainstay	mainstay	NOUN
easat-2032	13	12	of	of	ADP
easat-2032	13	13	prevention	prevention	NOUN
easat-2032	13	14	.	.	PUNCT
easat-2032	14	1	practical	practical	ADJ
easat-2032	14	2	immediate	immediate	ADJ
easat-2032	14	3	treatment	treatment	NOUN
easat-2032	14	4	is	be	AUX
easat-2032	14	5	essential	essential	ADJ
easat-2032	14	6	.	.	PUNCT
easat-2032	15	1	new	new	ADJ
easat-2032	15	2	elisa	elisa	PROPN
easat-2032	15	3	techniques	technique	NOUN
easat-2032	15	4	are	be	AUX
easat-2032	15	5	viable	viable	ADJ
easat-2032	15	6	,	,	PUNCT
easat-2032	15	7	while	while	SCONJ
easat-2032	15	8	real	real	ADJ
easat-2032	15	9	-	-	PUNCT
easat-2032	15	10	time	time	NOUN
easat-2032	15	11	pcr	pcr	PROPN
easat-2032	15	12	proves	prove	VERB
easat-2032	15	13	superior	superior	ADJ
easat-2032	15	14	to	to	PART
easat-2032	15	15	nested	nested	ADJ
easat-2032	15	16	pcr	pcr	PROPN
easat-2032	15	17	.	.	PUNCT
easat-2032	16	1	clinical	clinical	ADJ
easat-2032	16	2	judgment	judgment	NOUN
easat-2032	16	3	plays	play	VERB
easat-2032	16	4	a	a	DET
easat-2032	16	5	critical	critical	ADJ
easat-2032	16	6	role	role	NOUN
easat-2032	16	7	in	in	ADP
easat-2032	16	8	supporting	support	VERB
easat-2032	16	9	laboratory	laboratory	NOUN
easat-2032	16	10	diagnoses	diagnosis	NOUN
easat-2032	16	11	.	.	PUNCT
easat-2032	17	1	high	high	ADJ
easat-2032	17	2	-	-	PUNCT
easat-2032	17	3	resolution	resolution	NOUN
easat-2032	17	4	ct	ct	NUM
easat-2032	17	5	scans	scan	NOUN
easat-2032	17	6	may	may	AUX
easat-2032	17	7	be	be	AUX
easat-2032	17	8	warranted	warrant	VERB
easat-2032	17	9	for	for	ADP
easat-2032	17	10	evaluating	evaluate	VERB
easat-2032	17	11	immunosuppressed	immunosuppressed	ADJ
easat-2032	17	12	patients	patient	NOUN
easat-2032	17	13	with	with	ADP
easat-2032	17	14	suspected	suspect	VERB
easat-2032	17	15	pneumonia	pneumonia	NOUN
easat-2032	17	16	when	when	SCONJ
easat-2032	17	17	chest	chest	NOUN
easat-2032	17	18	x	x	NOUN
easat-2032	17	19	-	-	NOUN
easat-2032	17	20	rays	ray	NOUN
easat-2032	17	21	appear	appear	VERB
easat-2032	17	22	normal	normal	ADJ
easat-2032	17	23	.	.	PUNCT
easat-2032	18	1	radiomics	radiomic	NOUN
easat-2032	18	2	can	can	AUX
easat-2032	18	3	assist	assist	VERB
easat-2032	18	4	in	in	ADP
easat-2032	18	5	distinguishing	distinguish	VERB
easat-2032	18	6	pcp	pcp	NOUN
easat-2032	18	7	from	from	ADP
easat-2032	18	8	other	other	ADJ
easat-2032	18	9	types	type	NOUN
easat-2032	18	10	of	of	ADP
easat-2032	18	11	pneumonia	pneumonia	NOUN
easat-2032	18	12	in	in	ADP
easat-2032	18	13	non	non	ADJ
easat-2032	18	14	-	-	ADJ
easat-2032	18	15	hiv	hiv	ADJ
easat-2032	18	16	patients	patient	NOUN
easat-2032	18	17	.	.	PUNCT
easat-2032	19	1	trimethoprim	trimethoprim	ADJ
easat-2032	19	2	-	-	PUNCT
easat-2032	19	3	sulfamethoxazole	sulfamethoxazole	NOUN
easat-2032	19	4	remains	remain	VERB
easat-2032	19	5	the	the	DET
easat-2032	19	6	preferred	preferred	ADJ
easat-2032	19	7	treatment	treatment	NOUN
easat-2032	19	8	,	,	PUNCT
easat-2032	19	9	with	with	ADP
easat-2032	19	10	alternative	alternative	ADJ
easat-2032	19	11	options	option	NOUN
easat-2032	19	12	including	include	VERB
easat-2032	19	13	dapsone	dapsone	PROPN
easat-2032	19	14	with	with	ADP
easat-2032	19	15	trimethoprim	trimethoprim	NOUN
easat-2032	19	16	,	,	PUNCT
easat-2032	19	17	clindamycin	clindamycin	NOUN
easat-2032	19	18	with	with	ADP
easat-2032	19	19	primaquine	primaquine	NOUN
easat-2032	19	20	,	,	PUNCT
easat-2032	19	21	atovaquone	atovaquone	NOUN
easat-2032	19	22	,	,	PUNCT
easat-2032	19	23	or	or	CCONJ
easat-2032	19	24	pentamidine	pentamidine	VERB
easat-2032	19	25	.	.	PUNCT
easat-2032	20	1	corticosteroid	corticosteroid	ADJ
easat-2032	20	2	adjunct	adjunct	ADJ
easat-2032	20	3	therapy	therapy	NOUN
easat-2032	20	4	(	(	PUNCT
easat-2032	20	5	cat	cat	NOUN
easat-2032	20	6	)	)	PUNCT
easat-2032	20	7	is	be	AUX
easat-2032	20	8	beneficial	beneficial	ADJ
easat-2032	20	9	in	in	ADP
easat-2032	20	10	treating	treat	VERB
easat-2032	20	11	pcp	pcp	NOUN
easat-2032	20	12	,	,	PUNCT
easat-2032	20	13	and	and	CCONJ
easat-2032	20	14	chemoprophylaxis	chemoprophylaxis	NOUN
easat-2032	20	15	is	be	AUX
easat-2032	20	16	essential	essential	ADJ
easat-2032	20	17	for	for	ADP
easat-2032	20	18	high	high	ADJ
easat-2032	20	19	-	-	PUNCT
easat-2032	20	20	risk	risk	NOUN
easat-2032	20	21	populations	population	NOUN
easat-2032	20	22	.	.	PUNCT
easat-2032	21	1	keywords	keyword	NOUN
easat-2032	21	2	:	:	PUNCT
easat-2032	21	3	aids	aid	NOUN
easat-2032	21	4	,	,	PUNCT
easat-2032	21	5	immunocompromised	immunocompromise	VERB
easat-2032	21	6	,	,	PUNCT
easat-2032	21	7	pneumocystis	pneumocystis	NOUN
easat-2032	21	8	jirovecii	jirovecii	NOUN
easat-2032	21	9	,	,	PUNCT
easat-2032	21	10	pneumocystis	pneumocystis	ADJ
easat-2032	21	11	pneumonia	pneumonia	NOUN
easat-2032	21	12	.	.	PUNCT
easat-2032	22	1	1	1	X
easat-2032	22	2	.	.	X
easat-2032	22	3	introduction	introduction	NOUN
easat-2032	22	4	pneumocystis	pneumocystis	PROPN
easat-2032	22	5	jirovecii	jirovecii	NOUN
easat-2032	22	6	,	,	PUNCT
easat-2032	22	7	often	often	ADV
easat-2032	22	8	abbreviated	abbreviate	VERB
easat-2032	22	9	as	as	ADP
easat-2032	22	10	p.	p.	PROPN
easat-2032	22	11	jirovecii	jirovecii	PROPN
easat-2032	22	12	,	,	PUNCT
easat-2032	22	13	is	be	AUX
easat-2032	22	14	an	an	DET
easat-2032	22	15	opportunistic	opportunistic	ADJ
easat-2032	22	16	fungus	fungus	NOUN
easat-2032	22	17	that	that	PRON
easat-2032	22	18	leads	lead	VERB
easat-2032	22	19	to	to	ADP
easat-2032	22	20	a	a	DET
easat-2032	22	21	severe	severe	ADJ
easat-2032	22	22	lung	lung	NOUN
easat-2032	22	23	condition	condition	NOUN
easat-2032	22	24	known	know	VERB
easat-2032	22	25	as	as	ADP
easat-2032	22	26	pneumocystis	pneumocystis	ADJ
easat-2032	22	27	pneumonia	pneumonia	NOUN
easat-2032	22	28	(	(	PUNCT
easat-2032	22	29	pcp	pcp	PROPN
easat-2032	22	30	)	)	PUNCT
easat-2032	23	1	[	[	X
easat-2032	23	2	1	1	NUM
easat-2032	23	3	]	]	PUNCT
easat-2032	23	4	.	.	PUNCT
easat-2032	24	1	pcp	pcp	PROPN
easat-2032	24	2	,	,	PUNCT
easat-2032	24	3	attributed	attribute	VERB
easat-2032	24	4	to	to	ADP
easat-2032	24	5	p.	p.	PROPN
easat-2032	24	6	jirovecii	jirovecii	PROPN
easat-2032	24	7	,	,	PUNCT
easat-2032	24	8	predominantly	predominantly	ADV
easat-2032	24	9	affects	affect	VERB
easat-2032	24	10	immunocompromised	immunocompromised	ADJ
easat-2032	24	11	individuals	individual	NOUN
easat-2032	24	12	,	,	PUNCT
easat-2032	24	13	including	include	VERB
easat-2032	24	14	those	those	PRON
easat-2032	24	15	with	with	ADP
easat-2032	24	16	hiv	hiv	PROPN
easat-2032	24	17	/	/	SYM
easat-2032	24	18	aids	aids	PROPN
easat-2032	24	19	,	,	PUNCT
easat-2032	24	20	hematologic	hematologic	NOUN
easat-2032	24	21	malignancies	malignancy	NOUN
easat-2032	24	22	,	,	PUNCT
easat-2032	24	23	solid	solid	ADJ
easat-2032	24	24	organ	organ	NOUN
easat-2032	24	25	transplant	transplant	NOUN
easat-2032	24	26	recipients	recipient	NOUN
easat-2032	24	27	,	,	PUNCT
easat-2032	24	28	and	and	CCONJ
easat-2032	24	29	those	those	PRON
easat-2032	24	30	receiving	receive	VERB
easat-2032	24	31	immunosuppressive	immunosuppressive	ADJ
easat-2032	24	32	therapy	therapy	NOUN
easat-2032	24	33	[	[	X
easat-2032	24	34	2	2	NUM
easat-2032	24	35	,	,	PUNCT
easat-2032	24	36	3	3	NUM
easat-2032	24	37	]	]	PUNCT
easat-2032	24	38	.	.	PUNCT
easat-2032	25	1	pcp	pcp	PROPN
easat-2032	25	2	poses	pose	VERB
easat-2032	25	3	a	a	DET
easat-2032	25	4	significant	significant	ADJ
easat-2032	25	5	threat	threat	NOUN
easat-2032	25	6	to	to	ADP
easat-2032	25	7	the	the	DET
easat-2032	25	8	health	health	NOUN
easat-2032	25	9	and	and	CCONJ
easat-2032	25	10	survival	survival	NOUN
easat-2032	25	11	of	of	ADP
easat-2032	25	12	immunocompromised	immunocompromise	VERB
easat-2032	25	13	patients	patient	NOUN
easat-2032	25	14	[	[	X
easat-2032	25	15	4	4	NUM
easat-2032	25	16	,	,	PUNCT
easat-2032	25	17	5	5	NUM
easat-2032	25	18	]	]	PUNCT
easat-2032	25	19	.	.	PUNCT
easat-2032	26	1	those	those	PRON
easat-2032	26	2	with	with	ADP
easat-2032	26	3	malignancies	malignancy	NOUN
easat-2032	26	4	,	,	PUNCT
easat-2032	26	5	recipients	recipient	NOUN
easat-2032	26	6	of	of	ADP
easat-2032	26	7	solid	solid	ADJ
easat-2032	26	8	organ	organ	NOUN
easat-2032	26	9	transplants	transplant	NOUN
easat-2032	26	10	,	,	PUNCT
easat-2032	26	11	and	and	CCONJ
easat-2032	26	12	individuals	individual	NOUN
easat-2032	26	13	undergoing	undergo	VERB
easat-2032	26	14	treatment	treatment	NOUN
easat-2032	26	15	with	with	ADP
easat-2032	26	16	immunosuppressive	immunosuppressive	ADJ
easat-2032	26	17	drugs	drug	NOUN
easat-2032	26	18	are	be	AUX
easat-2032	26	19	particularly	particularly	ADV
easat-2032	26	20	vulnerable	vulnerable	ADJ
easat-2032	26	21	to	to	ADP
easat-2032	26	22	this	this	DET
easat-2032	26	23	fungal	fungal	ADJ
easat-2032	26	24	infection	infection	NOUN
easat-2032	26	25	[	[	X
easat-2032	26	26	6,7	6,7	NUM
easat-2032	26	27	,	,	PUNCT
easat-2032	26	28	8	8	NUM
easat-2032	26	29	]	]	PUNCT
easat-2032	26	30	.	.	PUNCT
easat-2032	27	1	furthermore	furthermore	ADV
easat-2032	27	2	,	,	PUNCT
easat-2032	27	3	certain	certain	ADJ
easat-2032	27	4	health	health	NOUN
easat-2032	27	5	conditions	condition	NOUN
easat-2032	27	6	such	such	ADJ
easat-2032	27	7	as	as	ADP
easat-2032	27	8	diabetes	diabetes	NOUN
easat-2032	27	9	and	and	CCONJ
easat-2032	27	10	severe	severe	ADJ
easat-2032	27	11	malnutrition	malnutrition	NOUN
easat-2032	27	12	heighten	heighten	VERB
easat-2032	27	13	the	the	DET
easat-2032	27	14	susceptibility	susceptibility	NOUN
easat-2032	27	15	to	to	PART
easat-2032	27	16	pcp	pcp	VERB
easat-2032	28	1	[	[	X
easat-2032	28	2	9	9	NUM
easat-2032	28	3	,	,	PUNCT
easat-2032	28	4	10	10	NUM
easat-2032	28	5	]	]	PUNCT
easat-2032	28	6	.	.	PUNCT
easat-2032	29	1	dyspnoea	dyspnoea	NOUN
easat-2032	29	2	on	on	ADP
easat-2032	29	3	exertion	exertion	NOUN
easat-2032	29	4	is	be	AUX
easat-2032	29	5	a	a	DET
easat-2032	29	6	hallmark	hallmark	ADJ
easat-2032	29	7	symptom	symptom	NOUN
easat-2032	29	8	of	of	ADP
easat-2032	29	9	pcp	pcp	PROPN
easat-2032	29	10	,	,	PUNCT
easat-2032	29	11	often	often	ADV
easat-2032	29	12	progressing	progress	VERB
easat-2032	29	13	rapidly	rapidly	ADV
easat-2032	29	14	to	to	ADP
easat-2032	29	15	respiratory	respiratory	ADJ
easat-2032	29	16	distress	distress	NOUN
easat-2032	29	17	,	,	PUNCT
easat-2032	29	18	reflecting	reflect	VERB
easat-2032	29	19	the	the	DET
easat-2032	29	20	severity	severity	NOUN
easat-2032	29	21	of	of	ADP
easat-2032	29	22	lung	lung	NOUN
easat-2032	29	23	involvement	involvement	NOUN
easat-2032	29	24	[	[	X
easat-2032	29	25	11	11	NUM
easat-2032	29	26	]	]	PUNCT
easat-2032	29	27	.	.	PUNCT
easat-2032	30	1	patients	patient	NOUN
easat-2032	30	2	commonly	commonly	ADV
easat-2032	30	3	present	present	VERB
easat-2032	30	4	with	with	ADP
easat-2032	30	5	a	a	DET
easat-2032	30	6	nonproductive	nonproductive	ADJ
easat-2032	30	7	cough	cough	NOUN
easat-2032	30	8	,	,	PUNCT
easat-2032	30	9	which	which	PRON
easat-2032	30	10	may	may	AUX
easat-2032	30	11	be	be	AUX
easat-2032	30	12	associated	associate	VERB
easat-2032	30	13	with	with	ADP
easat-2032	30	14	low	low	ADJ
easat-2032	30	15	-	-	PUNCT
easat-2032	30	16	grade	grade	NOUN
easat-2032	30	17	fever	fever	NOUN
easat-2032	30	18	and	and	CCONJ
easat-2032	30	19	malaise	malaise	NOUN
easat-2032	30	20	[	[	X
easat-2032	30	21	12	12	NUM
easat-2032	30	22	]	]	PUNCT
easat-2032	30	23	.	.	PUNCT
easat-2032	31	1	hypoxemia	hypoxemia	PROPN
easat-2032	31	2	is	be	AUX
easat-2032	31	3	a	a	DET
easat-2032	31	4	frequent	frequent	ADJ
easat-2032	31	5	finding	finding	NOUN
easat-2032	31	6	in	in	ADP
easat-2032	31	7	pcp	pcp	PROPN
easat-2032	31	8	and	and	CCONJ
easat-2032	31	9	may	may	AUX
easat-2032	31	10	present	present	VERB
easat-2032	31	11	as	as	ADP
easat-2032	31	12	refractory	refractory	NOUN
easat-2032	31	13	hypoxemia	hypoxemia	NOUN
easat-2032	31	14	,	,	PUNCT
easat-2032	31	15	necessitating	necessitate	VERB
easat-2032	31	16	supplemental	supplemental	ADJ
easat-2032	31	17	oxygen	oxygen	NOUN
easat-2032	31	18	therapy	therapy	NOUN
easat-2032	31	19	or	or	CCONJ
easat-2032	31	20	mechanical	mechanical	ADJ
easat-2032	31	21	ventilation	ventilation	NOUN
easat-2032	31	22	in	in	ADP
easat-2032	31	23	severe	severe	ADJ
easat-2032	31	24	cases	case	NOUN
easat-2032	31	25	[	[	X
easat-2032	31	26	13	13	NUM
easat-2032	31	27	]	]	PUNCT
easat-2032	31	28	.	.	PUNCT
easat-2032	32	1	pcp	pcp	PROPN
easat-2032	32	2	can	can	AUX
easat-2032	32	3	occasionally	occasionally	ADV
easat-2032	32	4	involve	involve	VERB
easat-2032	32	5	extrapulmonary	extrapulmonary	ADJ
easat-2032	32	6	sites	site	NOUN
easat-2032	32	7	,	,	PUNCT
easat-2032	32	8	such	such	ADJ
easat-2032	32	9	as	as	ADP
easat-2032	32	10	the	the	DET
easat-2032	32	11	central	central	ADJ
easat-2032	32	12	nervous	nervous	ADJ
easat-2032	32	13	system	system	NOUN
easat-2032	32	14	,	,	PUNCT
easat-2032	32	15	leading	lead	VERB
easat-2032	32	16	to	to	ADP
easat-2032	32	17	symptoms	symptom	NOUN
easat-2032	32	18	like	like	ADP
easat-2032	32	19	headache	headache	NOUN
easat-2032	32	20	,	,	PUNCT
easat-2032	32	21	altered	alter	VERB
easat-2032	32	22	mental	mental	ADJ
easat-2032	32	23	status	status	NOUN
easat-2032	32	24	,	,	PUNCT
easat-2032	32	25	and	and	CCONJ
easat-2032	32	26	164	164	NUM
easat-2032	32	27	edelweiss	edelweiss	PROPN
easat-2032	32	28	applied	apply	VERB
easat-2032	32	29	science	science	NOUN
easat-2032	32	30	and	and	CCONJ
easat-2032	32	31	technology	technology	NOUN
easat-2032	32	32	issn	issn	PROPN
easat-2032	32	33	:	:	PUNCT
easat-2032	32	34	2576	2576	NUM
easat-2032	32	35	-	-	SYM
easat-2032	32	36	8484	8484	NUM
easat-2032	32	37	vol	vol	NOUN
easat-2032	32	38	.	.	PROPN
easat-2032	33	1	8	8	NUM
easat-2032	33	2	,	,	PUNCT
easat-2032	33	3	no	no	INTJ
easat-2032	33	4	.	.	NOUN
easat-2032	34	1	6	6	NUM
easat-2032	34	2	:	:	SYM
easat-2032	34	3	163	163	NUM
easat-2032	34	4	-	-	SYM
easat-2032	34	5	168	168	NUM
easat-2032	34	6	,	,	PUNCT
easat-2032	34	7	2024	2024	NUM
easat-2032	34	8	doi	doi	NOUN
easat-2032	34	9	:	:	PUNCT
easat-2032	34	10	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	34	11	©	©	PROPN
easat-2032	34	12	2024	2024	NUM
easat-2032	34	13	by	by	ADP
easat-2032	34	14	the	the	DET
easat-2032	34	15	author	author	NOUN
easat-2032	34	16	;	;	PUNCT
easat-2032	34	17	licensee	licensee	PROPN
easat-2032	34	18	learning	learn	VERB
easat-2032	34	19	gate	gate	VERB
easat-2032	34	20	focal	focal	ADJ
easat-2032	34	21	neurological	neurological	ADJ
easat-2032	34	22	deficits	deficit	NOUN
easat-2032	34	23	[	[	X
easat-2032	34	24	14	14	NUM
easat-2032	34	25	]	]	PUNCT
easat-2032	34	26	.	.	PUNCT
easat-2032	35	1	this	this	DET
easat-2032	35	2	study	study	NOUN
easat-2032	35	3	aims	aim	VERB
easat-2032	35	4	to	to	PART
easat-2032	35	5	thoroughly	thoroughly	ADV
easat-2032	35	6	evaluate	evaluate	VERB
easat-2032	35	7	the	the	DET
easat-2032	35	8	literature	literature	NOUN
easat-2032	35	9	on	on	ADP
easat-2032	35	10	the	the	DET
easat-2032	35	11	current	current	ADJ
easat-2032	35	12	advances	advance	NOUN
easat-2032	35	13	in	in	ADP
easat-2032	35	14	the	the	DET
easat-2032	35	15	diagnosis	diagnosis	NOUN
easat-2032	35	16	and	and	CCONJ
easat-2032	35	17	treatment	treatment	NOUN
easat-2032	35	18	of	of	ADP
easat-2032	35	19	pcp	pcp	PROPN
easat-2032	35	20	.	.	PUNCT
easat-2032	36	1	2	2	X
easat-2032	36	2	.	.	X
easat-2032	36	3	methodology	methodology	NOUN
easat-2032	36	4	this	this	DET
easat-2032	36	5	study	study	NOUN
easat-2032	36	6	was	be	AUX
easat-2032	36	7	carried	carry	VERB
easat-2032	36	8	out	out	ADP
easat-2032	36	9	after	after	ADP
easat-2032	36	10	a	a	DET
easat-2032	36	11	thorough	thorough	ADJ
easat-2032	36	12	evaluation	evaluation	NOUN
easat-2032	36	13	of	of	ADP
easat-2032	36	14	the	the	DET
easat-2032	36	15	pertinent	pertinent	ADJ
easat-2032	36	16	literature	literature	NOUN
easat-2032	36	17	.	.	PUNCT
easat-2032	37	1	the	the	DET
easat-2032	37	2	data	datum	NOUN
easat-2032	37	3	was	be	AUX
easat-2032	37	4	searched	search	VERB
easat-2032	37	5	through	through	ADP
easat-2032	37	6	electronic	electronic	ADJ
easat-2032	37	7	databases	database	NOUN
easat-2032	37	8	like	like	ADP
easat-2032	37	9	pubmed	pubmed	PROPN
easat-2032	37	10	,	,	PUNCT
easat-2032	37	11	scopus	scopus	PROPN
easat-2032	37	12	,	,	PUNCT
easat-2032	37	13	google	google	NOUN
easat-2032	37	14	scholar	scholar	NOUN
easat-2032	37	15	,	,	PUNCT
easat-2032	37	16	and	and	CCONJ
easat-2032	37	17	medline	medline	NOUN
easat-2032	37	18	to	to	PART
easat-2032	37	19	find	find	VERB
easat-2032	37	20	articles	article	NOUN
easat-2032	37	21	that	that	PRON
easat-2032	37	22	had	have	AUX
easat-2032	37	23	just	just	ADV
easat-2032	37	24	been	be	AUX
easat-2032	37	25	published	publish	VERB
easat-2032	37	26	in	in	ADP
easat-2032	37	27	the	the	DET
easat-2032	37	28	last	last	ADJ
easat-2032	37	29	ten	ten	NUM
easat-2032	37	30	years	year	NOUN
easat-2032	37	31	.	.	PUNCT
easat-2032	38	1	the	the	DET
easat-2032	38	2	search	search	NOUN
easat-2032	38	3	was	be	AUX
easat-2032	38	4	conducted	conduct	VERB
easat-2032	38	5	using	use	VERB
easat-2032	38	6	the	the	DET
easat-2032	38	7	terms	term	NOUN
easat-2032	38	8	"	"	PUNCT
easat-2032	38	9	pneumocystis	pneumocystis	NOUN
easat-2032	38	10	carinii	carinii	VERB
easat-2032	38	11	,	,	PUNCT
easat-2032	38	12	"	"	PUNCT
easat-2032	38	13	"	"	PUNCT
easat-2032	38	14	pneumocystis	pneumocystis	PROPN
easat-2032	38	15	jiroveci	jiroveci	NOUN
easat-2032	38	16	,	,	PUNCT
easat-2032	38	17	"	"	PUNCT
easat-2032	38	18	"	"	PUNCT
easat-2032	38	19	diagnosis	diagnosis	NOUN
easat-2032	38	20	,	,	PUNCT
easat-2032	38	21	"	"	PUNCT
easat-2032	38	22	and	and	CCONJ
easat-2032	38	23	"	"	PUNCT
easat-2032	38	24	treatment	treatment	NOUN
easat-2032	38	25	.	.	PUNCT
easat-2032	38	26	"	"	PUNCT
easat-2032	39	1	analysis	analysis	NOUN
easat-2032	39	2	has	have	AUX
easat-2032	39	3	been	be	AUX
easat-2032	39	4	done	do	VERB
easat-2032	39	5	through	through	ADP
easat-2032	39	6	only	only	ADJ
easat-2032	39	7	english	english	ADJ
easat-2032	39	8	-	-	PUNCT
easat-2032	39	9	language	language	NOUN
easat-2032	39	10	research	research	NOUN
easat-2032	39	11	that	that	PRON
easat-2032	39	12	focused	focus	VERB
easat-2032	39	13	on	on	ADP
easat-2032	39	14	diagnosis	diagnosis	NOUN
easat-2032	39	15	and	and	CCONJ
easat-2032	39	16	treatment	treatment	NOUN
easat-2032	39	17	of	of	ADP
easat-2032	39	18	pneumocystis	pneumocystis	ADJ
easat-2032	39	19	pneumonia	pneumonia	NOUN
easat-2032	39	20	.	.	PUNCT
easat-2032	40	1	3	3	X
easat-2032	40	2	.	.	X
easat-2032	40	3	results	result	NOUN
easat-2032	40	4	of	of	ADP
easat-2032	40	5	pcp	pcp	NOUN
easat-2032	40	6	diagnosis	diagnosis	NOUN
easat-2032	40	7	today	today	NOUN
easat-2032	40	8	,	,	PUNCT
easat-2032	40	9	pcp	pcp	PROPN
easat-2032	40	10	can	can	AUX
easat-2032	40	11	be	be	AUX
easat-2032	40	12	diagnosed	diagnose	VERB
easat-2032	40	13	via	via	ADP
easat-2032	40	14	different	different	ADJ
easat-2032	40	15	methods	method	NOUN
easat-2032	40	16	,	,	PUNCT
easat-2032	40	17	depending	depend	VERB
easat-2032	40	18	on	on	ADP
easat-2032	40	19	laboratory	laboratory	NOUN
easat-2032	40	20	conditions	condition	NOUN
easat-2032	40	21	,	,	PUNCT
easat-2032	40	22	available	available	ADJ
easat-2032	40	23	resources	resource	NOUN
easat-2032	40	24	,	,	PUNCT
easat-2032	40	25	and	and	CCONJ
easat-2032	40	26	type	type	NOUN
easat-2032	40	27	and	and	CCONJ
easat-2032	40	28	quality	quality	NOUN
easat-2032	40	29	of	of	ADP
easat-2032	40	30	samples	sample	NOUN
easat-2032	40	31	obtained	obtain	VERB
easat-2032	40	32	from	from	ADP
easat-2032	40	33	patients	patient	NOUN
easat-2032	40	34	[	[	X
easat-2032	40	35	15	15	NUM
easat-2032	40	36	,	,	PUNCT
easat-2032	40	37	17	17	NUM
easat-2032	40	38	]	]	PUNCT
easat-2032	40	39	.	.	PUNCT
easat-2032	41	1	in	in	ADP
easat-2032	41	2	a	a	DET
easat-2032	41	3	2	2	NUM
easat-2032	41	4	-	-	PUNCT
easat-2032	41	5	year	year	NOUN
easat-2032	41	6	australian	australian	ADJ
easat-2032	41	7	retrospective	retrospective	ADJ
easat-2032	41	8	cohort	cohort	NOUN
easat-2032	41	9	study	study	NOUN
easat-2032	41	10	of	of	ADP
easat-2032	41	11	patients	patient	NOUN
easat-2032	41	12	with	with	ADP
easat-2032	41	13	clinically	clinically	ADV
easat-2032	41	14	suspected	suspect	VERB
easat-2032	41	15	pjp	pjp	ADJ
easat-2032	41	16	,	,	PUNCT
easat-2032	41	17	p	p	PROPN
easat-2032	41	18	jirovecii	jirovecii	ADJ
easat-2032	41	19	pcr	pcr	NOUN
easat-2032	41	20	on	on	ADP
easat-2032	41	21	nasopharyngeal	nasopharyngeal	ADJ
easat-2032	41	22	swab	swab	NOUN
easat-2032	41	23	samples	sample	NOUN
easat-2032	41	24	showed	show	VERB
easat-2032	41	25	perfect	perfect	ADJ
easat-2032	41	26	specificity	specificity	NOUN
easat-2032	41	27	,	,	PUNCT
easat-2032	41	28	however	however	ADV
easat-2032	41	29	sensitivity	sensitivity	NOUN
easat-2032	41	30	was	be	AUX
easat-2032	41	31	low	low	ADJ
easat-2032	41	32	[	[	X
easat-2032	41	33	18	18	NUM
easat-2032	41	34	]	]	SYM
easat-2032	41	35	.	.	PUNCT
easat-2032	42	1	3.1	3.1	NUM
easat-2032	42	2	.	.	PUNCT
easat-2032	42	3	traditional	traditional	ADJ
easat-2032	42	4	tests	test	NOUN
easat-2032	42	5	traditional	traditional	ADJ
easat-2032	42	6	diagnostic	diagnostic	ADJ
easat-2032	42	7	methods	method	NOUN
easat-2032	42	8	like	like	ADP
easat-2032	42	9	staining	stain	VERB
easat-2032	42	10	techniques	technique	NOUN
easat-2032	42	11	have	have	VERB
easat-2032	42	12	limitations	limitation	NOUN
easat-2032	42	13	in	in	ADP
easat-2032	42	14	sensitivity	sensitivity	NOUN
easat-2032	42	15	and	and	CCONJ
easat-2032	42	16	specificity	specificity	NOUN
easat-2032	42	17	.	.	PUNCT
easat-2032	43	1	molecular	molecular	ADJ
easat-2032	43	2	techniques	technique	NOUN
easat-2032	43	3	such	such	ADJ
easat-2032	43	4	as	as	ADP
easat-2032	43	5	polymerase	polymerase	NOUN
easat-2032	43	6	chain	chain	NOUN
easat-2032	43	7	reaction	reaction	NOUN
easat-2032	43	8	(	(	PUNCT
easat-2032	43	9	pcr	pcr	PROPN
easat-2032	43	10	)	)	PUNCT
easat-2032	43	11	have	have	AUX
easat-2032	43	12	revolutionized	revolutionize	VERB
easat-2032	43	13	pcp	pcp	NOUN
easat-2032	43	14	diagnosis	diagnosis	NOUN
easat-2032	43	15	,	,	PUNCT
easat-2032	43	16	offering	offer	VERB
easat-2032	43	17	higher	high	ADJ
easat-2032	43	18	sensitivity	sensitivity	NOUN
easat-2032	43	19	and	and	CCONJ
easat-2032	43	20	specificity	specificity	NOUN
easat-2032	43	21	,	,	PUNCT
easat-2032	43	22	particularly	particularly	ADV
easat-2032	43	23	in	in	ADP
easat-2032	43	24	bronchoalveolar	bronchoalveolar	ADJ
easat-2032	43	25	lavage	lavage	NOUN
easat-2032	43	26	samples	sample	NOUN
easat-2032	43	27	[	[	X
easat-2032	43	28	19	19	NUM
easat-2032	43	29	]	]	PUNCT
easat-2032	43	30	.	.	PUNCT
easat-2032	44	1	3.2	3.2	NUM
easat-2032	44	2	.	.	PUNCT
easat-2032	44	3	serological	serological	ADJ
easat-2032	44	4	tests	test	NOUN
easat-2032	44	5	recently	recently	ADV
easat-2032	44	6	,	,	PUNCT
easat-2032	44	7	serological	serological	ADJ
easat-2032	44	8	assays	assay	NOUN
easat-2032	44	9	,	,	PUNCT
easat-2032	44	10	including	include	VERB
easat-2032	44	11	enzyme	enzyme	NOUN
easat-2032	44	12	-	-	PUNCT
easat-2032	44	13	linked	link	VERB
easat-2032	44	14	immunosorbent	immunosorbent	ADJ
easat-2032	44	15	assays	assay	NOUN
easat-2032	44	16	(	(	PUNCT
easat-2032	44	17	elisa	elisa	NOUN
easat-2032	44	18	)	)	PUNCT
easat-2032	44	19	,	,	PUNCT
easat-2032	44	20	have	have	AUX
easat-2032	44	21	shown	show	VERB
easat-2032	44	22	promise	promise	NOUN
easat-2032	44	23	in	in	ADP
easat-2032	44	24	detecting	detect	VERB
easat-2032	44	25	specific	specific	ADJ
easat-2032	44	26	antibodies	antibody	NOUN
easat-2032	44	27	against	against	ADP
easat-2032	44	28	pneumocystis	pneumocystis	NOUN
easat-2032	44	29	,	,	PUNCT
easat-2032	44	30	aiding	aid	VERB
easat-2032	44	31	in	in	ADP
easat-2032	44	32	diagnosis	diagnosis	NOUN
easat-2032	44	33	,	,	PUNCT
easat-2032	44	34	especially	especially	ADV
easat-2032	44	35	in	in	ADP
easat-2032	44	36	resource	resource	NOUN
easat-2032	44	37	-	-	PUNCT
easat-2032	44	38	limited	limit	VERB
easat-2032	44	39	settings	setting	NOUN
easat-2032	44	40	[	[	X
easat-2032	44	41	20	20	NUM
easat-2032	44	42	]	]	PUNCT
easat-2032	44	43	.	.	PUNCT
easat-2032	45	1	these	these	DET
easat-2032	45	2	new	new	ADJ
easat-2032	45	3	methods	method	NOUN
easat-2032	45	4	may	may	AUX
easat-2032	45	5	be	be	AUX
easat-2032	45	6	used	use	VERB
easat-2032	45	7	as	as	ADP
easat-2032	45	8	a	a	DET
easat-2032	45	9	screening	screening	NOUN
easat-2032	45	10	test	test	NOUN
easat-2032	45	11	for	for	ADP
easat-2032	45	12	pcp	pcp	PROPN
easat-2032	45	13	,	,	PUNCT
easat-2032	45	14	decreasing	decrease	VERB
easat-2032	45	15	the	the	DET
easat-2032	45	16	need	need	NOUN
easat-2032	45	17	for	for	ADP
easat-2032	45	18	biological	biological	ADJ
easat-2032	45	19	specimens	specimen	NOUN
easat-2032	45	20	obtained	obtain	VERB
easat-2032	45	21	by	by	ADP
easat-2032	45	22	invasive	invasive	ADJ
easat-2032	45	23	techniques	technique	NOUN
easat-2032	45	24	,	,	PUNCT
easat-2032	45	25	which	which	PRON
easat-2032	45	26	is	be	AUX
easat-2032	45	27	a	a	DET
easat-2032	45	28	major	major	ADJ
easat-2032	45	29	benefit	benefit	NOUN
easat-2032	45	30	to	to	ADP
easat-2032	45	31	the	the	DET
easat-2032	45	32	patient	patient	NOUN
easat-2032	45	33	’s	’s	PART
easat-2032	45	34	care	care	NOUN
easat-2032	45	35	and	and	CCONJ
easat-2032	45	36	an	an	DET
easat-2032	45	37	improvement	improvement	NOUN
easat-2032	45	38	in	in	ADP
easat-2032	45	39	the	the	DET
easat-2032	45	40	clinical	clinical	ADJ
easat-2032	45	41	management	management	NOUN
easat-2032	45	42	of	of	ADP
easat-2032	45	43	the	the	DET
easat-2032	45	44	disease	disease	NOUN
easat-2032	45	45	[	[	X
easat-2032	45	46	21	21	NUM
easat-2032	45	47	]	]	PUNCT
easat-2032	45	48	.	.	PUNCT
easat-2032	46	1	furthermore	furthermore	ADV
easat-2032	46	2	,	,	PUNCT
easat-2032	46	3	a	a	DET
easat-2032	46	4	multicenter	multicenter	NOUN
easat-2032	46	5	study	study	NOUN
easat-2032	46	6	evaluated	evaluate	VERB
easat-2032	46	7	the	the	DET
easat-2032	46	8	performance	performance	NOUN
easat-2032	46	9	of	of	ADP
easat-2032	46	10	a	a	DET
easat-2032	46	11	novel	novel	ADJ
easat-2032	46	12	elisa	elisa	NOUN
easat-2032	46	13	assay	assay	VERB
easat-2032	46	14	in	in	ADP
easat-2032	46	15	differentiating	differentiate	VERB
easat-2032	46	16	pcp	pcp	NOUN
easat-2032	46	17	from	from	ADP
easat-2032	46	18	other	other	ADJ
easat-2032	46	19	respiratory	respiratory	ADJ
easat-2032	46	20	infections	infection	NOUN
easat-2032	46	21	.	.	PUNCT
easat-2032	47	1	the	the	DET
easat-2032	47	2	assay	assay	NOUN
easat-2032	47	3	demonstrated	demonstrate	VERB
easat-2032	47	4	high	high	ADJ
easat-2032	47	5	specificity	specificity	NOUN
easat-2032	47	6	and	and	CCONJ
easat-2032	47	7	positive	positive	ADJ
easat-2032	47	8	predictive	predictive	ADJ
easat-2032	47	9	value	value	NOUN
easat-2032	47	10	,	,	PUNCT
easat-2032	47	11	indicating	indicate	VERB
easat-2032	47	12	its	its	PRON
easat-2032	47	13	potential	potential	NOUN
easat-2032	47	14	for	for	ADP
easat-2032	47	15	accurate	accurate	ADJ
easat-2032	47	16	pcp	pcp	NOUN
easat-2032	47	17	diagnosis	diagnosis	NOUN
easat-2032	47	18	in	in	ADP
easat-2032	47	19	clinical	clinical	ADJ
easat-2032	47	20	practice	practice	NOUN
easat-2032	47	21	[	[	X
easat-2032	47	22	22	22	NUM
easat-2032	47	23	]	]	PUNCT
easat-2032	47	24	.	.	PUNCT
easat-2032	48	1	3.3	3.3	NUM
easat-2032	48	2	.	.	PUNCT
easat-2032	49	1	molecular	molecular	ADJ
easat-2032	49	2	tests	test	NOUN
easat-2032	49	3	study	study	VERB
easat-2032	49	4	by	by	ADP
easat-2032	49	5	parian	parian	ADJ
easat-2032	49	6	et	et	PROPN
easat-2032	49	7	.	.	PUNCT
easat-2032	50	1	al	al	PROPN
easat-2032	50	2	,	,	PUNCT
easat-2032	50	3	evaluated	evaluate	VERB
easat-2032	50	4	the	the	DET
easat-2032	50	5	clinical	clinical	ADJ
easat-2032	50	6	utility	utility	NOUN
easat-2032	50	7	of	of	ADP
easat-2032	50	8	pcr	pcr	NOUN
easat-2032	50	9	in	in	ADP
easat-2032	50	10	guiding	guide	VERB
easat-2032	50	11	the	the	DET
easat-2032	50	12	initiation	initiation	NOUN
easat-2032	50	13	and	and	CCONJ
easat-2032	50	14	duration	duration	NOUN
easat-2032	50	15	of	of	ADP
easat-2032	50	16	antimicrobial	antimicrobial	ADJ
easat-2032	50	17	therapy	therapy	NOUN
easat-2032	50	18	for	for	ADP
easat-2032	50	19	pcp	pcp	PROPN
easat-2032	50	20	.	.	PUNCT
easat-2032	51	1	the	the	DET
easat-2032	51	2	study	study	NOUN
easat-2032	51	3	found	find	VERB
easat-2032	51	4	that	that	SCONJ
easat-2032	51	5	pcr	pcr	NOUN
easat-2032	51	6	-	-	PUNCT
easat-2032	51	7	guided	guide	VERB
easat-2032	51	8	therapy	therapy	NOUN
easat-2032	51	9	led	lead	VERB
easat-2032	51	10	to	to	ADP
easat-2032	51	11	more	more	ADV
easat-2032	51	12	timely	timely	ADJ
easat-2032	51	13	initiation	initiation	NOUN
easat-2032	51	14	of	of	ADP
easat-2032	51	15	treatment	treatment	NOUN
easat-2032	51	16	and	and	CCONJ
easat-2032	51	17	reduced	reduce	VERB
easat-2032	51	18	unnecessary	unnecessary	ADJ
easat-2032	51	19	antibiotic	antibiotic	ADJ
easat-2032	51	20	exposure	exposure	NOUN
easat-2032	51	21	,	,	PUNCT
easat-2032	51	22	highlighting	highlight	VERB
easat-2032	51	23	the	the	DET
easat-2032	51	24	potential	potential	ADJ
easat-2032	51	25	role	role	NOUN
easat-2032	51	26	of	of	ADP
easat-2032	51	27	pcr	pcr	NOUN
easat-2032	51	28	in	in	ADP
easat-2032	51	29	optimizing	optimize	VERB
easat-2032	51	30	patient	patient	ADJ
easat-2032	51	31	management	management	NOUN
easat-2032	51	32	[	[	X
easat-2032	51	33	23	23	NUM
easat-2032	51	34	]	]	PUNCT
easat-2032	51	35	.	.	PUNCT
easat-2032	52	1	in	in	ADP
easat-2032	52	2	a	a	DET
easat-2032	52	3	recent	recent	ADJ
easat-2032	52	4	study	study	NOUN
easat-2032	52	5	by	by	ADP
easat-2032	52	6	miriam	miriam	PROPN
easat-2032	52	7	et	et	PROPN
easat-2032	52	8	.	.	PUNCT
easat-2032	53	1	al	al	PROPN
easat-2032	53	2	,	,	PUNCT
easat-2032	53	3	nested	nested	ADJ
easat-2032	53	4	and	and	CCONJ
easat-2032	53	5	quantitative	quantitative	ADJ
easat-2032	53	6	realtime	realtime	ADJ
easat-2032	53	7	pcr	pcr	ADJ
easat-2032	53	8	methods	method	NOUN
easat-2032	53	9	for	for	ADP
easat-2032	53	10	the	the	DET
easat-2032	53	11	amplification	amplification	NOUN
easat-2032	53	12	of	of	ADP
easat-2032	53	13	the	the	DET
easat-2032	53	14	p.	p.	PROPN
easat-2032	53	15	jiroveci	jiroveci	PROPN
easat-2032	53	16	dhps	dhps	NOUN
easat-2032	53	17	(	(	PUNCT
easat-2032	53	18	dihydropteroate	dihydropteroate	VERB
easat-2032	53	19	synthase	synthase	NOUN
easat-2032	53	20	)	)	PUNCT
easat-2032	53	21	gene	gene	NOUN
easat-2032	53	22	were	be	AUX
easat-2032	53	23	evaluated	evaluate	VERB
easat-2032	53	24	in	in	ADP
easat-2032	53	25	a	a	DET
easat-2032	53	26	cohort	cohort	NOUN
easat-2032	53	27	of	of	ADP
easat-2032	53	28	71	71	NUM
easat-2032	53	29	microscopically	microscopically	ADV
easat-2032	53	30	confirmed	confirm	VERB
easat-2032	53	31	pcp	pcp	NOUN
easat-2032	53	32	cases	case	NOUN
easat-2032	53	33	and	and	CCONJ
easat-2032	53	34	70	70	NUM
easat-2032	53	35	negative	negative	ADJ
easat-2032	53	36	cases	case	NOUN
easat-2032	53	37	,	,	PUNCT
easat-2032	53	38	the	the	DET
easat-2032	53	39	sensitivities	sensitivity	NOUN
easat-2032	53	40	and	and	CCONJ
easat-2032	53	41	specificities	specificity	NOUN
easat-2032	53	42	were	be	AUX
easat-2032	53	43	94	94	NUM
easat-2032	53	44	%	%	NOUN
easat-2032	53	45	and	and	CCONJ
easat-2032	53	46	81	81	NUM
easat-2032	53	47	%	%	NOUN
easat-2032	53	48	for	for	ADP
easat-2032	53	49	nested	nested	ADJ
easat-2032	53	50	pcr	pcr	NOUN
easat-2032	53	51	and	and	CCONJ
easat-2032	53	52	94	94	NUM
easat-2032	53	53	%	%	NOUN
easat-2032	53	54	and	and	CCONJ
easat-2032	53	55	96	96	NUM
easat-2032	53	56	%	%	NOUN
easat-2032	53	57	for	for	ADP
easat-2032	53	58	real	real	ADJ
easat-2032	53	59	-	-	PUNCT
easat-2032	53	60	time	time	NOUN
easat-2032	53	61	pcr	pcr	NOUN
easat-2032	53	62	,	,	PUNCT
easat-2032	53	63	respectively	respectively	ADV
easat-2032	53	64	[	[	X
easat-2032	53	65	24	24	NUM
easat-2032	53	66	]	]	PUNCT
easat-2032	53	67	.	.	PUNCT
easat-2032	54	1	3.4	3.4	NUM
easat-2032	54	2	.	.	PUNCT
easat-2032	55	1	metagenomic	metagenomic	ADJ
easat-2032	55	2	next	next	ADJ
easat-2032	55	3	-	-	PUNCT
easat-2032	55	4	generation	generation	NOUN
easat-2032	55	5	sequencing	sequencing	NOUN
easat-2032	55	6	(	(	PUNCT
easat-2032	55	7	mngs	mng	NOUN
easat-2032	55	8	)	)	PUNCT
easat-2032	55	9	in	in	ADP
easat-2032	55	10	a	a	DET
easat-2032	55	11	study	study	NOUN
easat-2032	55	12	by	by	ADP
easat-2032	55	13	lu	lu	PROPN
easat-2032	55	14	et	et	PROPN
easat-2032	55	15	al	al	PROPN
easat-2032	55	16	,	,	PUNCT
easat-2032	55	17	metagenomic	metagenomic	ADJ
easat-2032	55	18	next	next	ADJ
easat-2032	55	19	-	-	PUNCT
easat-2032	55	20	generation	generation	NOUN
easat-2032	55	21	sequencing	sequencing	NOUN
easat-2032	55	22	(	(	PUNCT
easat-2032	55	23	mngs	mng	NOUN
easat-2032	55	24	)	)	PUNCT
easat-2032	55	25	was	be	AUX
easat-2032	55	26	compared	compare	VERB
easat-2032	55	27	with	with	ADP
easat-2032	55	28	routine	routine	ADJ
easat-2032	55	29	detection	detection	NOUN
easat-2032	55	30	assays	assay	NOUN
easat-2032	55	31	,	,	PUNCT
easat-2032	55	32	including	include	VERB
easat-2032	55	33	gomori	gomori	PROPN
easat-2032	55	34	methenamine	methenamine	PROPN
easat-2032	55	35	silver	silver	PROPN
easat-2032	55	36	(	(	PUNCT
easat-2032	55	37	gms	gms	NOUN
easat-2032	55	38	)	)	PUNCT
easat-2032	55	39	stain	stain	NOUN
easat-2032	55	40	and	and	CCONJ
easat-2032	55	41	polymerase	polymerase	NOUN
easat-2032	55	42	chain	chain	NOUN
easat-2032	55	43	reaction	reaction	NOUN
easat-2032	55	44	(	(	PUNCT
easat-2032	55	45	pcr	pcr	ADJ
easat-2032	55	46	)	)	PUNCT
easat-2032	55	47	technique	technique	NOUN
easat-2032	55	48	.	.	PUNCT
easat-2032	56	1	specimens	specimen	NOUN
easat-2032	56	2	of	of	ADP
easat-2032	56	3	4	4	NUM
easat-2032	56	4	bronchoalveolar	bronchoalveolar	ADJ
easat-2032	56	5	lavages	lavage	NOUN
easat-2032	56	6	(	(	PUNCT
easat-2032	56	7	bal	bal	ADJ
easat-2032	56	8	)	)	PUNCT
easat-2032	56	9	and	and	CCONJ
easat-2032	56	10	1	1	NUM
easat-2032	56	11	lung	lung	NOUN
easat-2032	56	12	tissue	tissue	NOUN
easat-2032	56	13	samples	sample	NOUN
easat-2032	56	14	were	be	AUX
easat-2032	56	15	obtained	obtain	VERB
easat-2032	56	16	from	from	ADP
easat-2032	56	17	4	4	NUM
easat-2032	56	18	non	non	ADJ
easat-2032	56	19	-	-	ADJ
easat-2032	56	20	hiv	hiv	ADJ
easat-2032	56	21	patients	patient	NOUN
easat-2032	56	22	from	from	ADP
easat-2032	56	23	our	our	PRON
easat-2032	56	24	hospitals	hospital	NOUN
easat-2032	56	25	.	.	PUNCT
easat-2032	57	1	although	although	SCONJ
easat-2032	57	2	both	both	DET
easat-2032	57	3	gms	gms	NOUN
easat-2032	57	4	and	and	CCONJ
easat-2032	57	5	mngs	mng	NOUN
easat-2032	57	6	were	be	AUX
easat-2032	57	7	positive	positive	ADJ
easat-2032	57	8	for	for	ADP
easat-2032	57	9	p.	p.	PROPN
easat-2032	57	10	jirovecii	jirovecii	PROPN
easat-2032	57	11	with	with	ADP
easat-2032	57	12	pcr	pcr	PROPN
easat-2032	57	13	as	as	ADP
easat-2032	57	14	positive	positive	ADJ
easat-2032	57	15	control	control	NOUN
easat-2032	57	16	,	,	PUNCT
easat-2032	57	17	the	the	DET
easat-2032	57	18	testing	testing	NOUN
easat-2032	57	19	time	time	NOUN
easat-2032	57	20	of	of	ADP
easat-2032	57	21	mngs	mng	NOUN
easat-2032	57	22	was	be	AUX
easat-2032	57	23	obviously	obviously	ADV
easat-2032	57	24	shorter	short	ADJ
easat-2032	57	25	than	than	ADP
easat-2032	57	26	gms	gms	NOUN
easat-2032	57	27	.	.	PUNCT
easat-2032	58	1	compared	compare	VERB
easat-2032	58	2	with	with	ADP
easat-2032	58	3	the	the	DET
easat-2032	58	4	traditional	traditional	ADJ
easat-2032	58	5	gms	gms	NOUN
easat-2032	58	6	method	method	NOUN
easat-2032	58	7	,	,	PUNCT
easat-2032	58	8	mngs	mng	NOUN
easat-2032	58	9	has	have	VERB
easat-2032	58	10	absolute	absolute	ADJ
easat-2032	58	11	advantages	advantage	NOUN
easat-2032	58	12	[	[	X
easat-2032	58	13	25	25	NUM
easat-2032	58	14	]	]	PUNCT
easat-2032	58	15	.	.	PUNCT
easat-2032	59	1	165	165	NUM
easat-2032	59	2	edelweiss	edelweiss	PROPN
easat-2032	59	3	applied	apply	VERB
easat-2032	59	4	science	science	NOUN
easat-2032	59	5	and	and	CCONJ
easat-2032	59	6	technology	technology	NOUN
easat-2032	59	7	issn	issn	PROPN
easat-2032	59	8	:	:	PUNCT
easat-2032	59	9	2576	2576	NUM
easat-2032	59	10	-	-	SYM
easat-2032	59	11	8484	8484	NUM
easat-2032	59	12	vol	vol	NOUN
easat-2032	59	13	.	.	PROPN
easat-2032	59	14	8	8	NUM
easat-2032	59	15	,	,	PUNCT
easat-2032	59	16	no	no	INTJ
easat-2032	59	17	.	.	NOUN
easat-2032	60	1	6	6	NUM
easat-2032	60	2	:	:	SYM
easat-2032	60	3	163	163	NUM
easat-2032	60	4	-	-	SYM
easat-2032	60	5	168	168	NUM
easat-2032	60	6	,	,	PUNCT
easat-2032	60	7	2024	2024	NUM
easat-2032	60	8	doi	doi	NOUN
easat-2032	60	9	:	:	PUNCT
easat-2032	60	10	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	60	11	©	©	PROPN
easat-2032	60	12	2024	2024	NUM
easat-2032	60	13	by	by	ADP
easat-2032	60	14	the	the	DET
easat-2032	60	15	author	author	NOUN
easat-2032	60	16	;	;	PUNCT
easat-2032	60	17	licensee	licensee	PROPN
easat-2032	60	18	learning	learning	NOUN
easat-2032	60	19	gate	gate	NOUN
easat-2032	60	20	3.5	3.5	NUM
easat-2032	60	21	.	.	PUNCT
easat-2032	61	1	imaging	imaging	NOUN
easat-2032	61	2	modalities	modality	NOUN
easat-2032	61	3	high	high	ADJ
easat-2032	61	4	-	-	PUNCT
easat-2032	61	5	resolution	resolution	NOUN
easat-2032	61	6	computed	compute	VERB
easat-2032	61	7	tomography	tomography	NOUN
easat-2032	61	8	(	(	PUNCT
easat-2032	61	9	hrct	hrct	PROPN
easat-2032	61	10	)	)	PUNCT
easat-2032	61	11	scans	scan	NOUN
easat-2032	61	12	play	play	VERB
easat-2032	61	13	a	a	DET
easat-2032	61	14	crucial	crucial	ADJ
easat-2032	61	15	role	role	NOUN
easat-2032	61	16	in	in	ADP
easat-2032	61	17	diagnosing	diagnose	VERB
easat-2032	61	18	pcp	pcp	X
easat-2032	61	19	immunosuppressed	immunosuppresse	VERB
easat-2032	61	20	patients	patient	NOUN
easat-2032	61	21	with	with	ADP
easat-2032	61	22	suspected	suspect	VERB
easat-2032	61	23	pneumonia	pneumonia	NOUN
easat-2032	61	24	and	and	CCONJ
easat-2032	61	25	normal	normal	ADJ
easat-2032	61	26	chest	chest	NOUN
easat-2032	61	27	radiographic	radiographic	ADJ
easat-2032	61	28	findings	finding	NOUN
easat-2032	61	29	by	by	ADP
easat-2032	61	30	revealing	reveal	VERB
easat-2032	61	31	characteristic	characteristic	ADJ
easat-2032	61	32	findings	finding	NOUN
easat-2032	61	33	such	such	ADJ
easat-2032	61	34	as	as	ADP
easat-2032	61	35	ground	ground	NOUN
easat-2032	61	36	-	-	PUNCT
easat-2032	61	37	glass	glass	NOUN
easat-2032	61	38	opacities	opacity	NOUN
easat-2032	61	39	and	and	CCONJ
easat-2032	61	40	cystic	cystic	ADJ
easat-2032	61	41	lesions	lesion	NOUN
easat-2032	61	42	,	,	PUNCT
easat-2032	61	43	nodules	nodule	NOUN
easat-2032	61	44	,	,	PUNCT
easat-2032	61	45	cysts	cyst	NOUN
easat-2032	61	46	,	,	PUNCT
easat-2032	61	47	and	and	CCONJ
easat-2032	61	48	spontaneous	spontaneous	ADJ
easat-2032	61	49	pneumothorax	pneumothorax	NOUN
easat-2032	61	50	also	also	ADV
easat-2032	61	51	can	can	AUX
easat-2032	61	52	develop	develop	VERB
easat-2032	61	53	[	[	X
easat-2032	61	54	26	26	NUM
easat-2032	61	55	]	]	PUNCT
easat-2032	61	56	.	.	PUNCT
easat-2032	62	1	3.6	3.6	NUM
easat-2032	62	2	.	.	PUNCT
easat-2032	62	3	radiomics	radiomic	NOUN
easat-2032	62	4	:	:	PUNCT
easat-2032	62	5	radiomics	radiomic	NOUN
easat-2032	62	6	exhibited	exhibit	VERB
easat-2032	62	7	promising	promise	VERB
easat-2032	62	8	diagnostic	diagnostic	ADJ
easat-2032	62	9	efficacy	efficacy	NOUN
easat-2032	62	10	in	in	ADP
easat-2032	62	11	distinguishing	distinguish	VERB
easat-2032	62	12	pcp	pcp	NOUN
easat-2032	62	13	from	from	ADP
easat-2032	62	14	various	various	ADJ
easat-2032	62	15	pneumonia	pneumonia	NOUN
easat-2032	62	16	types	type	NOUN
easat-2032	62	17	in	in	ADP
easat-2032	62	18	individuals	individual	NOUN
easat-2032	62	19	without	without	ADP
easat-2032	62	20	hiv	hiv	PROPN
easat-2032	62	21	.	.	PUNCT
easat-2032	63	1	integrating	integrate	VERB
easat-2032	63	2	radiomics	radiomic	NOUN
easat-2032	63	3	with	with	ADP
easat-2032	63	4	serum	serum	NOUN
easat-2032	63	5	β	β	NOUN
easat-2032	63	6	-	-	ADJ
easat-2032	63	7	d	d	NOUN
easat-2032	63	8	-	-	PUNCT
easat-2032	63	9	glucan	glucan	NOUN
easat-2032	63	10	presents	present	VERB
easat-2032	63	11	a	a	DET
easat-2032	63	12	prospective	prospective	ADJ
easat-2032	63	13	,	,	PUNCT
easat-2032	63	14	precise	precise	ADJ
easat-2032	63	15	,	,	PUNCT
easat-2032	63	16	and	and	CCONJ
easat-2032	63	17	non	non	ADJ
easat-2032	63	18	-	-	ADJ
easat-2032	63	19	invasive	invasive	ADJ
easat-2032	63	20	approach	approach	NOUN
easat-2032	63	21	to	to	PART
easat-2032	63	22	assess	assess	VERB
easat-2032	63	23	pcp	pcp	NOUN
easat-2032	63	24	infection	infection	NOUN
easat-2032	63	25	risk	risk	NOUN
easat-2032	63	26	among	among	ADP
easat-2032	63	27	non	non	ADJ
easat-2032	63	28	-	-	ADJ
easat-2032	63	29	hiv	hiv	ADJ
easat-2032	63	30	patients	patient	NOUN
easat-2032	63	31	displaying	display	VERB
easat-2032	63	32	pneumonia	pneumonia	NOUN
easat-2032	63	33	manifestations	manifestation	NOUN
easat-2032	63	34	on	on	ADP
easat-2032	63	35	ct	ct	PROPN
easat-2032	63	36	scans	scan	NOUN
easat-2032	63	37	[	[	X
easat-2032	63	38	27	27	NUM
easat-2032	63	39	]	]	SYM
easat-2032	63	40	.	.	PUNCT
easat-2032	64	1	3.7	3.7	NUM
easat-2032	64	2	.	.	PUNCT
easat-2032	64	3	artificial	artificial	ADJ
easat-2032	64	4	intelligence	intelligence	NOUN
easat-2032	64	5	pcp	pcp	NOUN
easat-2032	64	6	diagnostic	diagnostic	ADJ
easat-2032	64	7	model	model	NOUN
easat-2032	64	8	in	in	ADP
easat-2032	64	9	patients	patient	NOUN
easat-2032	64	10	with	with	ADP
easat-2032	64	11	severe	severe	ADJ
easat-2032	64	12	pneumonia	pneumonia	NOUN
easat-2032	64	13	using	use	VERB
easat-2032	64	14	four	four	NUM
easat-2032	64	15	easily	easily	ADV
easat-2032	64	16	available	available	ADJ
easat-2032	64	17	and	and	CCONJ
easat-2032	64	18	noninvasive	noninvasive	ADJ
easat-2032	64	19	clinical	clinical	ADJ
easat-2032	64	20	indicators	indicator	NOUN
easat-2032	64	21	.	.	PUNCT
easat-2032	65	1	with	with	ADP
easat-2032	65	2	satisfying	satisfy	VERB
easat-2032	65	3	diagnostic	diagnostic	ADJ
easat-2032	65	4	performance	performance	NOUN
easat-2032	65	5	and	and	CCONJ
easat-2032	65	6	good	good	ADJ
easat-2032	65	7	clinical	clinical	ADJ
easat-2032	65	8	practicability	practicability	NOUN
easat-2032	65	9	,	,	PUNCT
easat-2032	65	10	this	this	DET
easat-2032	65	11	model	model	NOUN
easat-2032	65	12	may	may	AUX
easat-2032	65	13	help	help	VERB
easat-2032	65	14	clinicians	clinician	NOUN
easat-2032	65	15	to	to	PART
easat-2032	65	16	make	make	VERB
easat-2032	65	17	early	early	ADJ
easat-2032	65	18	diagnosis	diagnosis	NOUN
easat-2032	65	19	of	of	ADP
easat-2032	65	20	pcp	pcp	NOUN
easat-2032	65	21	,	,	PUNCT
easat-2032	65	22	reduce	reduce	VERB
easat-2032	65	23	the	the	DET
easat-2032	65	24	delays	delay	NOUN
easat-2032	65	25	of	of	ADP
easat-2032	65	26	treatment	treatment	NOUN
easat-2032	65	27	and	and	CCONJ
easat-2032	65	28	improve	improve	VERB
easat-2032	65	29	the	the	DET
easat-2032	65	30	prognosis	prognosis	NOUN
easat-2032	65	31	among	among	ADP
easat-2032	65	32	these	these	DET
easat-2032	65	33	patients	patient	NOUN
easat-2032	66	1	[	[	X
easat-2032	66	2	28	28	NUM
easat-2032	66	3	]	]	PUNCT
easat-2032	66	4	.	.	PUNCT
easat-2032	67	1	4	4	X
easat-2032	67	2	.	.	X
easat-2032	67	3	results	result	NOUN
easat-2032	67	4	of	of	ADP
easat-2032	67	5	pcp	pcp	PROPN
easat-2032	67	6	treatment	treatment	NOUN
easat-2032	67	7	4.1	4.1	NUM
easat-2032	67	8	.	.	PUNCT
easat-2032	68	1	background	background	NOUN
easat-2032	68	2	in	in	ADP
easat-2032	68	3	general	general	ADJ
easat-2032	68	4	,	,	PUNCT
easat-2032	68	5	efforts	effort	NOUN
easat-2032	68	6	should	should	AUX
easat-2032	68	7	be	be	AUX
easat-2032	68	8	made	make	VERB
easat-2032	68	9	to	to	PART
easat-2032	68	10	confirm	confirm	VERB
easat-2032	68	11	the	the	DET
easat-2032	68	12	diagnosis	diagnosis	NOUN
easat-2032	68	13	of	of	ADP
easat-2032	68	14	pcp	pcp	NOUN
easat-2032	68	15	before	before	ADP
easat-2032	68	16	the	the	DET
easat-2032	68	17	initiation	initiation	NOUN
easat-2032	68	18	of	of	ADP
easat-2032	68	19	treatment	treatment	NOUN
easat-2032	68	20	or	or	CCONJ
easat-2032	68	21	prophylaxis	prophylaxis	NOUN
easat-2032	68	22	.	.	PUNCT
easat-2032	69	1	this	this	PRON
easat-2032	69	2	is	be	AUX
easat-2032	69	3	because	because	SCONJ
easat-2032	69	4	(	(	PUNCT
easat-2032	69	5	a	a	X
easat-2032	69	6	)	)	PUNCT
easat-2032	69	7	all	all	DET
easat-2032	69	8	drugs	drug	NOUN
easat-2032	69	9	have	have	VERB
easat-2032	69	10	some	some	DET
easat-2032	69	11	toxicity	toxicity	NOUN
easat-2032	69	12	,	,	PUNCT
easat-2032	69	13	and	and	CCONJ
easat-2032	69	14	(	(	PUNCT
easat-2032	69	15	b	b	NOUN
easat-2032	69	16	)	)	PUNCT
easat-2032	69	17	patients	patient	NOUN
easat-2032	69	18	with	with	ADP
easat-2032	69	19	pcp	pcp	PROPN
easat-2032	69	20	may	may	AUX
easat-2032	69	21	worsen	worsen	VERB
easat-2032	69	22	before	before	SCONJ
easat-2032	69	23	they	they	PRON
easat-2032	69	24	get	get	VERB
easat-2032	69	25	better	well	ADJ
easat-2032	69	26	[	[	X
easat-2032	69	27	29	29	NUM
easat-2032	69	28	]	]	PUNCT
easat-2032	69	29	.	.	PUNCT
easat-2032	70	1	4.2	4.2	NUM
easat-2032	70	2	.	.	PUNCT
easat-2032	70	3	antimicrobial	antimicrobial	ADJ
easat-2032	70	4	therapy	therapy	NOUN
easat-2032	70	5	trimethoprim	trimethoprim	NOUN
easat-2032	70	6	-	-	PUNCT
easat-2032	70	7	sulfamethoxazole	sulfamethoxazole	NOUN
easat-2032	70	8	(	(	PUNCT
easat-2032	70	9	tmp	tmp	NOUN
easat-2032	70	10	-	-	PUNCT
easat-2032	70	11	smx	smx	NOUN
easat-2032	70	12	)	)	PUNCT
easat-2032	70	13	remains	remain	VERB
easat-2032	70	14	the	the	DET
easat-2032	70	15	first	first	ADJ
easat-2032	70	16	-	-	PUNCT
easat-2032	70	17	line	line	NOUN
easat-2032	70	18	treatment	treatment	NOUN
easat-2032	70	19	for	for	ADP
easat-2032	70	20	pcp	pcp	NOUN
easat-2032	70	21	due	due	ADP
easat-2032	70	22	to	to	ADP
easat-2032	70	23	its	its	PRON
easat-2032	70	24	efficacy	efficacy	NOUN
easat-2032	70	25	and	and	CCONJ
easat-2032	70	26	cost	cost	NOUN
easat-2032	70	27	-	-	PUNCT
easat-2032	70	28	effectiveness	effectiveness	NOUN
easat-2032	70	29	.	.	PUNCT
easat-2032	71	1	however	however	ADV
easat-2032	71	2	,	,	PUNCT
easat-2032	71	3	alternative	alternative	ADJ
easat-2032	71	4	agents	agent	NOUN
easat-2032	71	5	like	like	ADP
easat-2032	71	6	pentamidine	pentamidine	NOUN
easat-2032	71	7	,	,	PUNCT
easat-2032	71	8	atovaquone	atovaquone	NOUN
easat-2032	71	9	,	,	PUNCT
easat-2032	71	10	and	and	CCONJ
easat-2032	71	11	clindamycin	clindamycin	NOUN
easat-2032	71	12	-	-	PUNCT
easat-2032	71	13	primaquine	primaquine	NOUN
easat-2032	71	14	are	be	AUX
easat-2032	71	15	reserved	reserve	VERB
easat-2032	71	16	for	for	ADP
easat-2032	71	17	patients	patient	NOUN
easat-2032	71	18	who	who	PRON
easat-2032	71	19	are	be	AUX
easat-2032	71	20	intolerant	intolerant	ADJ
easat-2032	71	21	to	to	PART
easat-2032	71	22	tmp	tmp	VERB
easat-2032	71	23	-	-	PUNCT
easat-2032	71	24	smx	smx	NOUN
easat-2032	71	25	or	or	CCONJ
easat-2032	71	26	those	those	PRON
easat-2032	71	27	with	with	ADP
easat-2032	71	28	severe	severe	ADJ
easat-2032	71	29	adverse	adverse	ADJ
easat-2032	71	30	reactions	reaction	NOUN
easat-2032	71	31	[	[	X
easat-2032	71	32	30	30	NUM
easat-2032	71	33	]	]	PUNCT
easat-2032	71	34	.	.	PUNCT
easat-2032	72	1	4.3	4.3	NUM
easat-2032	72	2	.	.	PUNCT
easat-2032	72	3	corticosteroids	corticosteroid	NOUN
easat-2032	72	4	adjunctive	adjunctive	ADJ
easat-2032	72	5	treatment	treatment	NOUN
easat-2032	72	6	(	(	PUNCT
easat-2032	72	7	cat	cat	NOUN
easat-2032	72	8	)	)	PUNCT
easat-2032	72	9	it	it	PRON
easat-2032	72	10	is	be	AUX
easat-2032	72	11	possible	possible	ADJ
easat-2032	72	12	that	that	SCONJ
easat-2032	72	13	corticosteroids	corticosteroid	NOUN
easat-2032	72	14	adjunctive	adjunctive	ADJ
easat-2032	72	15	treatment	treatment	NOUN
easat-2032	72	16	is	be	AUX
easat-2032	72	17	also	also	ADV
easat-2032	72	18	beneficial	beneficial	ADJ
easat-2032	72	19	for	for	ADP
easat-2032	72	20	hiv‐infected	hiv‐infecte	VERB
easat-2032	72	21	patients	patient	NOUN
easat-2032	72	22	with	with	ADP
easat-2032	72	23	mild	mild	ADJ
easat-2032	72	24	hypoxaemia	hypoxaemia	NOUN
easat-2032	72	25	due	due	ADP
easat-2032	72	26	to	to	ADP
easat-2032	72	27	pcp	pcp	PROPN
easat-2032	72	28	[	[	X
easat-2032	72	29	31	31	NUM
easat-2032	72	30	]	]	PUNCT
easat-2032	72	31	.	.	PUNCT
easat-2032	73	1	a	a	DET
easat-2032	73	2	meta	meta	ADJ
easat-2032	73	3	-	-	PUNCT
easat-2032	73	4	analysis	analysis	NOUN
easat-2032	73	5	by	by	ADP
easat-2032	73	6	ding	ding	NOUN
easat-2032	73	7	et	et	PROPN
easat-2032	73	8	al	al	PROPN
easat-2032	73	9	,	,	PUNCT
easat-2032	73	10	suggests	suggest	VERB
easat-2032	73	11	that	that	SCONJ
easat-2032	73	12	among	among	ADP
easat-2032	73	13	non	non	ADJ
easat-2032	73	14	-	-	ADJ
easat-2032	73	15	hiv	hiv	ADJ
easat-2032	73	16	pcp	pcp	PROPN
easat-2032	73	17	patients	patient	NOUN
easat-2032	73	18	with	with	ADP
easat-2032	73	19	respiratory	respiratory	ADJ
easat-2032	73	20	failure	failure	NOUN
easat-2032	73	21	,	,	PUNCT
easat-2032	73	22	cat	cat	NOUN
easat-2032	73	23	use	use	NOUN
easat-2032	73	24	may	may	AUX
easat-2032	73	25	be	be	AUX
easat-2032	73	26	associated	associate	VERB
easat-2032	73	27	with	with	ADP
easat-2032	73	28	better	well	ADJ
easat-2032	73	29	clinical	clinical	ADJ
easat-2032	73	30	outcomes	outcome	NOUN
easat-2032	73	31	,	,	PUNCT
easat-2032	73	32	and	and	CCONJ
easat-2032	73	33	it	it	PRON
easat-2032	73	34	may	may	AUX
easat-2032	73	35	be	be	AUX
easat-2032	73	36	associated	associate	VERB
easat-2032	73	37	with	with	ADP
easat-2032	73	38	increased	increase	VERB
easat-2032	73	39	mortality	mortality	NOUN
easat-2032	73	40	in	in	ADP
easat-2032	73	41	unselected	unselected	ADJ
easat-2032	73	42	non	non	ADJ
easat-2032	73	43	-	-	ADJ
easat-2032	73	44	hiv	hiv	ADJ
easat-2032	73	45	pcp	pcp	PROPN
easat-2032	73	46	population	population	NOUN
easat-2032	74	1	[	[	X
easat-2032	74	2	32	32	NUM
easat-2032	74	3	]	]	PUNCT
easat-2032	74	4	.	.	PUNCT
easat-2032	75	1	in	in	ADP
easat-2032	75	2	infants	infant	NOUN
easat-2032	75	3	with	with	ADP
easat-2032	75	4	a	a	DET
easat-2032	75	5	clinical	clinical	ADJ
easat-2032	75	6	diagnosis	diagnosis	NOUN
easat-2032	75	7	of	of	ADP
easat-2032	75	8	pjp	pjp	ADJ
easat-2032	75	9	,	,	PUNCT
easat-2032	75	10	early	early	ADJ
easat-2032	75	11	use	use	NOUN
easat-2032	75	12	of	of	ADP
easat-2032	75	13	steroids	steroid	NOUN
easat-2032	75	14	in	in	ADP
easat-2032	75	15	addition	addition	NOUN
easat-2032	75	16	to	to	ADP
easat-2032	75	17	conventional	conventional	ADJ
easat-2032	75	18	tmp	tmp	NOUN
easat-2032	75	19	/	/	SYM
easat-2032	75	20	smx	smx	NOUN
easat-2032	75	21	therapy	therapy	NOUN
easat-2032	75	22	significantly	significantly	ADV
easat-2032	75	23	reduced	reduce	VERB
easat-2032	75	24	mortality	mortality	NOUN
easat-2032	75	25	in	in	ADP
easat-2032	75	26	hospital	hospital	NOUN
easat-2032	75	27	and	and	CCONJ
easat-2032	75	28	6	6	NUM
easat-2032	75	29	months	month	NOUN
easat-2032	75	30	after	after	ADP
easat-2032	75	31	discharge	discharge	NOUN
easat-2032	75	32	[	[	X
easat-2032	75	33	33	33	NUM
easat-2032	75	34	]	]	PUNCT
easat-2032	75	35	.	.	PUNCT
easat-2032	76	1	4.4	4.4	NUM
easat-2032	76	2	.	.	PUNCT
easat-2032	77	1	immunomodulatory	immunomodulatory	PROPN
easat-2032	77	2	agents	agent	NOUN
easat-2032	77	3	a	a	DET
easat-2032	77	4	promising	promising	ADJ
easat-2032	77	5	avenue	avenue	NOUN
easat-2032	77	6	of	of	ADP
easat-2032	77	7	treatment	treatment	NOUN
easat-2032	77	8	is	be	AUX
easat-2032	77	9	the	the	DET
easat-2032	77	10	use	use	NOUN
easat-2032	77	11	of	of	ADP
easat-2032	77	12	combination	combination	NOUN
easat-2032	77	13	therapy	therapy	NOUN
easat-2032	77	14	to	to	PART
easat-2032	77	15	treat	treat	VERB
easat-2032	77	16	pcp	pcp	PROPN
easat-2032	77	17	.	.	PUNCT
easat-2032	78	1	it	it	PRON
easat-2032	78	2	was	be	AUX
easat-2032	78	3	recently	recently	ADV
easat-2032	78	4	shown	show	VERB
easat-2032	78	5	that	that	SCONJ
easat-2032	78	6	a	a	DET
easat-2032	78	7	cocktail	cocktail	NOUN
easat-2032	78	8	of	of	ADP
easat-2032	78	9	antibody	antibody	NOUN
easat-2032	78	10	and	and	CCONJ
easat-2032	78	11	sulfasalazine	sulfasalazine	NOUN
easat-2032	78	12	leads	lead	VERB
easat-2032	78	13	to	to	ADP
easat-2032	78	14	a	a	DET
easat-2032	78	15	dramatic	dramatic	ADJ
easat-2032	78	16	improvement	improvement	NOUN
easat-2032	78	17	in	in	ADP
easat-2032	78	18	the	the	DET
easat-2032	78	19	severity	severity	NOUN
easat-2032	78	20	of	of	ADP
easat-2032	78	21	pcp	pcp	PROPN
easat-2032	78	22	in	in	ADP
easat-2032	78	23	a	a	DET
easat-2032	78	24	mouse	mouse	NOUN
easat-2032	78	25	model	model	NOUN
easat-2032	78	26	compared	compare	VERB
easat-2032	78	27	to	to	ADP
easat-2032	78	28	single	single	ADJ
easat-2032	78	29	therapy	therapy	NOUN
easat-2032	78	30	methods	method	NOUN
easat-2032	78	31	;	;	PUNCT
easat-2032	78	32	however	however	ADV
easat-2032	78	33	,	,	PUNCT
easat-2032	78	34	the	the	DET
easat-2032	78	35	mechanism	mechanism	NOUN
easat-2032	78	36	by	by	ADP
easat-2032	78	37	which	which	PRON
easat-2032	78	38	this	this	PRON
easat-2032	78	39	occurs	occur	VERB
easat-2032	78	40	needs	need	VERB
easat-2032	78	41	further	further	ADJ
easat-2032	78	42	investigation	investigation	NOUN
easat-2032	78	43	[	[	X
easat-2032	78	44	34	34	NUM
easat-2032	78	45	]	]	PUNCT
easat-2032	78	46	.	.	PUNCT
easat-2032	79	1	emerging	emerge	VERB
easat-2032	79	2	research	research	NOUN
easat-2032	79	3	suggests	suggest	VERB
easat-2032	79	4	a	a	DET
easat-2032	79	5	potential	potential	ADJ
easat-2032	79	6	role	role	NOUN
easat-2032	79	7	for	for	ADP
easat-2032	79	8	immunomodulatory	immunomodulatory	ADJ
easat-2032	79	9	agents	agent	NOUN
easat-2032	79	10	like	like	ADP
easat-2032	79	11	monoclonal	monoclonal	NOUN
easat-2032	79	12	antibodies	antibody	NOUN
easat-2032	79	13	targeting	target	VERB
easat-2032	79	14	specific	specific	ADJ
easat-2032	79	15	cytokines	cytokine	NOUN
easat-2032	79	16	or	or	CCONJ
easat-2032	79	17	immune	immune	ADJ
easat-2032	79	18	pathways	pathway	NOUN
easat-2032	79	19	in	in	ADP
easat-2032	79	20	the	the	DET
easat-2032	79	21	management	management	NOUN
easat-2032	79	22	of	of	ADP
easat-2032	79	23	severe	severe	ADJ
easat-2032	79	24	pcp	pcp	PROPN
easat-2032	79	25	,	,	PUNCT
easat-2032	79	26	warranting	warrant	VERB
easat-2032	79	27	further	further	ADJ
easat-2032	79	28	investigation	investigation	NOUN
easat-2032	79	29	[	[	X
easat-2032	79	30	35	35	NUM
easat-2032	79	31	]	]	SYM
easat-2032	79	32	.	.	PUNCT
easat-2032	80	1	5	5	X
easat-2032	80	2	.	.	X
easat-2032	80	3	results	result	NOUN
easat-2032	80	4	of	of	ADP
easat-2032	80	5	pcp	pcp	PROPN
easat-2032	80	6	prevention	prevention	NOUN
easat-2032	80	7	5.1	5.1	NUM
easat-2032	80	8	.	.	PUNCT
easat-2032	81	1	vaccination	vaccination	NOUN
easat-2032	81	2	166	166	NUM
easat-2032	81	3	edelweiss	edelweiss	PROPN
easat-2032	81	4	applied	apply	VERB
easat-2032	81	5	science	science	NOUN
easat-2032	81	6	and	and	CCONJ
easat-2032	81	7	technology	technology	NOUN
easat-2032	81	8	issn	issn	PROPN
easat-2032	81	9	:	:	PUNCT
easat-2032	81	10	2576	2576	NUM
easat-2032	81	11	-	-	SYM
easat-2032	81	12	8484	8484	NUM
easat-2032	81	13	vol	vol	NOUN
easat-2032	81	14	.	.	PROPN
easat-2032	82	1	8	8	NUM
easat-2032	82	2	,	,	PUNCT
easat-2032	82	3	no	no	INTJ
easat-2032	82	4	.	.	NOUN
easat-2032	83	1	6	6	NUM
easat-2032	83	2	:	:	SYM
easat-2032	83	3	163	163	NUM
easat-2032	83	4	-	-	SYM
easat-2032	83	5	168	168	NUM
easat-2032	83	6	,	,	PUNCT
easat-2032	83	7	2024	2024	NUM
easat-2032	83	8	doi	doi	NOUN
easat-2032	83	9	:	:	PUNCT
easat-2032	83	10	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	83	11	©	©	PROPN
easat-2032	83	12	2024	2024	NUM
easat-2032	83	13	by	by	ADP
easat-2032	83	14	the	the	DET
easat-2032	83	15	author	author	NOUN
easat-2032	83	16	;	;	PUNCT
easat-2032	83	17	licensee	licensee	PROPN
easat-2032	83	18	learning	learning	NOUN
easat-2032	83	19	gate	gate	VERB
easat-2032	83	20	some	some	DET
easat-2032	83	21	current	current	ADJ
easat-2032	83	22	results	result	NOUN
easat-2032	83	23	are	be	AUX
easat-2032	83	24	promising	promise	VERB
easat-2032	83	25	for	for	ADP
easat-2032	83	26	utilizing	utilize	VERB
easat-2032	83	27	whole	whole	ADJ
easat-2032	83	28	organisms	organism	NOUN
easat-2032	83	29	in	in	ADP
easat-2032	83	30	developing	develop	VERB
easat-2032	83	31	a	a	DET
easat-2032	83	32	vaccine	vaccine	NOUN
easat-2032	83	33	against	against	ADP
easat-2032	83	34	pcp	pcp	PROPN
easat-2032	83	35	;	;	PUNCT
easat-2032	83	36	however	however	ADV
easat-2032	83	37	,	,	PUNCT
easat-2032	83	38	a	a	DET
easat-2032	83	39	major	major	ADJ
easat-2032	83	40	issue	issue	NOUN
easat-2032	83	41	in	in	ADP
easat-2032	83	42	this	this	DET
easat-2032	83	43	technique	technique	NOUN
easat-2032	83	44	is	be	AUX
easat-2032	83	45	the	the	DET
easat-2032	83	46	inability	inability	NOUN
easat-2032	83	47	to	to	PART
easat-2032	83	48	culture	culture	VERB
easat-2032	83	49	pneumocystis	pneumocystis	NOUN
easat-2032	83	50	in	in	ADP
easat-2032	83	51	vitro	vitro	VERB
easat-2032	83	52	,	,	PUNCT
easat-2032	83	53	limiting	limit	VERB
easat-2032	83	54	this	this	DET
easat-2032	83	55	approach	approach	NOUN
easat-2032	83	56	from	from	ADP
easat-2032	83	57	being	be	AUX
easat-2032	83	58	effective	effective	ADJ
easat-2032	83	59	on	on	ADP
easat-2032	83	60	a	a	DET
easat-2032	83	61	large	large	ADJ
easat-2032	83	62	scale	scale	NOUN
easat-2032	83	63	.	.	PUNCT
easat-2032	84	1	overall	overall	ADJ
easat-2032	84	2	,	,	PUNCT
easat-2032	84	3	while	while	SCONJ
easat-2032	84	4	immunization	immunization	NOUN
easat-2032	84	5	with	with	ADP
easat-2032	84	6	whole	whole	ADJ
easat-2032	84	7	pneumocystis	pneumocystis	NOUN
easat-2032	84	8	organisms	organism	NOUN
easat-2032	84	9	has	have	AUX
easat-2032	84	10	been	be	AUX
easat-2032	84	11	shown	show	VERB
easat-2032	84	12	to	to	PART
easat-2032	84	13	be	be	AUX
easat-2032	84	14	quite	quite	ADV
easat-2032	84	15	effective	effective	ADJ
easat-2032	84	16	in	in	ADP
easat-2032	84	17	animal	animal	NOUN
easat-2032	84	18	models	model	NOUN
easat-2032	84	19	[	[	X
easat-2032	84	20	36	36	NUM
easat-2032	84	21	,	,	PUNCT
easat-2032	84	22	37	37	NUM
easat-2032	84	23	,	,	PUNCT
easat-2032	84	24	38	38	NUM
easat-2032	84	25	]	]	PUNCT
easat-2032	84	26	.	.	PUNCT
easat-2032	85	1	the	the	DET
easat-2032	85	2	above	above	ADJ
easat-2032	85	3	limitation	limitation	NOUN
easat-2032	85	4	has	have	AUX
easat-2032	85	5	led	lead	VERB
easat-2032	85	6	to	to	ADP
easat-2032	85	7	the	the	DET
easat-2032	85	8	exploration	exploration	NOUN
easat-2032	85	9	of	of	ADP
easat-2032	85	10	subunit	subunit	NOUN
easat-2032	85	11	-	-	PUNCT
easat-2032	85	12	based	base	VERB
easat-2032	85	13	vaccines	vaccine	NOUN
easat-2032	85	14	,	,	PUNCT
easat-2032	85	15	but	but	CCONJ
easat-2032	85	16	the	the	DET
easat-2032	85	17	results	result	NOUN
easat-2032	85	18	are	be	AUX
easat-2032	85	19	not	not	PART
easat-2032	85	20	yet	yet	ADV
easat-2032	85	21	clinically	clinically	ADV
easat-2032	85	22	applied	apply	VERB
easat-2032	85	23	[	[	PUNCT
easat-2032	85	24	39	39	NUM
easat-2032	85	25	]	]	PUNCT
easat-2032	85	26	.	.	PUNCT
easat-2032	86	1	5.2	5.2	NUM
easat-2032	86	2	.	.	PUNCT
easat-2032	87	1	prophylactic	prophylactic	ADJ
easat-2032	87	2	agents	agent	NOUN
easat-2032	87	3	prophylaxis	prophylaxi	VERB
easat-2032	87	4	against	against	ADP
easat-2032	87	5	pcp	pcp	PROPN
easat-2032	87	6	is	be	AUX
easat-2032	87	7	paramount	paramount	ADJ
easat-2032	87	8	in	in	ADP
easat-2032	87	9	high	high	ADJ
easat-2032	87	10	-	-	PUNCT
easat-2032	87	11	risk	risk	NOUN
easat-2032	87	12	populations	population	NOUN
easat-2032	87	13	,	,	PUNCT
easat-2032	87	14	with	with	SCONJ
easat-2032	87	15	tmp	tmp	NOUN
easat-2032	87	16	-	-	PUNCT
easat-2032	87	17	smx	smx	NOUN
easat-2032	87	18	remaining	remain	VERB
easat-2032	87	19	the	the	DET
easat-2032	87	20	preferred	preferred	ADJ
easat-2032	87	21	agent	agent	NOUN
easat-2032	87	22	.	.	PUNCT
easat-2032	88	1	alternative	alternative	ADJ
easat-2032	88	2	agents	agent	NOUN
easat-2032	88	3	such	such	ADJ
easat-2032	88	4	as	as	ADP
easat-2032	88	5	dapsone	dapsone	PROPN
easat-2032	88	6	,	,	PUNCT
easat-2032	88	7	atovaquone	atovaquone	NOUN
easat-2032	88	8	,	,	PUNCT
easat-2032	88	9	and	and	CCONJ
easat-2032	88	10	aerosolized	aerosolize	VERB
easat-2032	88	11	pentamidine	pentamidine	PROPN
easat-2032	88	12	offer	offer	VERB
easat-2032	88	13	options	option	NOUN
easat-2032	88	14	for	for	ADP
easat-2032	88	15	tmp	tmp	NOUN
easat-2032	88	16	-	-	PUNCT
easat-2032	88	17	smx	smx	NOUN
easat-2032	88	18	intolerant	intolerant	ADJ
easat-2032	88	19	patients	patient	NOUN
easat-2032	88	20	.	.	PUNCT
easat-2032	89	1	however	however	ADV
easat-2032	89	2	,	,	PUNCT
easat-2032	89	3	some	some	DET
easat-2032	89	4	reviews	review	NOUN
easat-2032	89	5	underscore	underscore	VERB
easat-2032	89	6	the	the	DET
easat-2032	89	7	significance	significance	NOUN
easat-2032	89	8	of	of	ADP
easat-2032	89	9	evidence	evidence	NOUN
easat-2032	89	10	-	-	PUNCT
easat-2032	89	11	based	base	VERB
easat-2032	89	12	approaches	approach	NOUN
easat-2032	89	13	in	in	ADP
easat-2032	89	14	pcp	pcp	PROPN
easat-2032	89	15	prophylaxis	prophylaxis	NOUN
easat-2032	89	16	,	,	PUNCT
easat-2032	89	17	as	as	SCONJ
easat-2032	89	18	demonstrated	demonstrate	VERB
easat-2032	89	19	through	through	ADP
easat-2032	89	20	rcts	rct	NOUN
easat-2032	89	21	[	[	X
easat-2032	89	22	40	40	NUM
easat-2032	89	23	,	,	PUNCT
easat-2032	89	24	41	41	NUM
easat-2032	89	25	]	]	PUNCT
easat-2032	89	26	.	.	PUNCT
easat-2032	90	1	6	6	X
easat-2032	90	2	.	.	X
easat-2032	90	3	conclusion	conclusion	NOUN
easat-2032	90	4	despite	despite	SCONJ
easat-2032	90	5	advances	advance	NOUN
easat-2032	90	6	in	in	ADP
easat-2032	90	7	real	real	ADJ
easat-2032	90	8	-	-	PUNCT
easat-2032	90	9	time	time	NOUN
easat-2032	90	10	pcr	pcr	NOUN
easat-2032	90	11	,	,	PUNCT
easat-2032	90	12	mngs	mng	NOUN
easat-2032	90	13	,	,	PUNCT
easat-2032	90	14	imaging	imaging	NOUN
easat-2032	90	15	,	,	PUNCT
easat-2032	90	16	and	and	CCONJ
easat-2032	90	17	radiomics	radiomic	NOUN
easat-2032	90	18	technologies	technology	NOUN
easat-2032	90	19	,	,	PUNCT
easat-2032	90	20	treatment	treatment	NOUN
easat-2032	90	21	for	for	ADP
easat-2032	90	22	pcp	pcp	NOUN
easat-2032	90	23	using	use	VERB
easat-2032	90	24	tmp	tmp	NOUN
easat-2032	90	25	-	-	PUNCT
easat-2032	90	26	smx	smx	NOUN
easat-2032	90	27	,	,	PUNCT
easat-2032	90	28	dapsone	dapsone	PROPN
easat-2032	90	29	with	with	ADP
easat-2032	90	30	trimethoprim	trimethoprim	NOUN
easat-2032	90	31	,	,	PUNCT
easat-2032	90	32	clindamycin	clindamycin	NOUN
easat-2032	90	33	with	with	ADP
easat-2032	90	34	primaquine	primaquine	NOUN
easat-2032	90	35	,	,	PUNCT
easat-2032	90	36	atovaquone	atovaquone	NOUN
easat-2032	90	37	,	,	PUNCT
easat-2032	90	38	or	or	CCONJ
easat-2032	90	39	pentamidine	pentamidine	NOUN
easat-2032	90	40	has	have	AUX
easat-2032	90	41	largely	largely	ADV
easat-2032	90	42	remained	remain	VERB
easat-2032	90	43	unchanged	unchanged	ADJ
easat-2032	90	44	.	.	PUNCT
easat-2032	91	1	there	there	PRON
easat-2032	91	2	are	be	VERB
easat-2032	91	3	currently	currently	ADV
easat-2032	91	4	no	no	DET
easat-2032	91	5	vaccines	vaccine	NOUN
easat-2032	91	6	,	,	PUNCT
easat-2032	91	7	and	and	CCONJ
easat-2032	91	8	chemoprophylaxis	chemoprophylaxis	VERB
easat-2032	91	9	with	with	ADP
easat-2032	91	10	tmp	tmp	NOUN
easat-2032	91	11	-	-	PUNCT
easat-2032	91	12	smx	smx	NOUN
easat-2032	91	13	remains	remain	VERB
easat-2032	91	14	the	the	DET
easat-2032	91	15	primary	primary	ADJ
easat-2032	91	16	method	method	NOUN
easat-2032	91	17	of	of	ADP
easat-2032	91	18	prevention	prevention	NOUN
easat-2032	91	19	.	.	PUNCT
easat-2032	92	1	7	7	X
easat-2032	92	2	.	.	NOUN
easat-2032	92	3	practical	practical	ADJ
easat-2032	92	4	implications	implication	NOUN
easat-2032	92	5	•	•	ADP
easat-2032	92	6	staining	stain	VERB
easat-2032	92	7	techniques	technique	NOUN
easat-2032	92	8	and	and	CCONJ
easat-2032	92	9	microscopy	microscopy	NOUN
easat-2032	92	10	may	may	AUX
easat-2032	92	11	lead	lead	VERB
easat-2032	92	12	to	to	ADP
easat-2032	92	13	delays	delay	NOUN
easat-2032	92	14	in	in	ADP
easat-2032	92	15	treatment	treatment	NOUN
easat-2032	92	16	and	and	CCONJ
easat-2032	92	17	worse	bad	ADJ
easat-2032	92	18	prognosis	prognosis	NOUN
easat-2032	92	19	;	;	PUNCT
easat-2032	92	20	therefore	therefore	ADV
easat-2032	92	21	,	,	PUNCT
easat-2032	92	22	empiric	empiric	ADJ
easat-2032	92	23	treatment	treatment	NOUN
easat-2032	92	24	should	should	AUX
easat-2032	92	25	be	be	AUX
easat-2032	92	26	initiated	initiate	VERB
easat-2032	92	27	as	as	ADV
easat-2032	92	28	soon	soon	ADV
easat-2032	92	29	as	as	SCONJ
easat-2032	92	30	pcp	pcp	PROPN
easat-2032	92	31	is	be	AUX
easat-2032	92	32	suspected	suspect	VERB
easat-2032	92	33	.	.	PUNCT
easat-2032	93	1	•	•	NUM
easat-2032	93	2	new	new	ADJ
easat-2032	93	3	elisa	elisa	NOUN
easat-2032	93	4	techniques	technique	NOUN
easat-2032	93	5	are	be	AUX
easat-2032	93	6	inexpensive	inexpensive	ADJ
easat-2032	93	7	and	and	CCONJ
easat-2032	93	8	require	require	VERB
easat-2032	93	9	a	a	DET
easat-2032	93	10	non	non	ADJ
easat-2032	93	11	-	-	ADJ
easat-2032	93	12	invasive	invasive	ADJ
easat-2032	93	13	specimen	speciman	NOUN
easat-2032	93	14	with	with	ADP
easat-2032	93	15	improvement	improvement	NOUN
easat-2032	93	16	in	in	ADP
easat-2032	93	17	the	the	DET
easat-2032	93	18	patient	patient	NOUN
easat-2032	93	19	’s	’s	PART
easat-2032	93	20	care	care	NOUN
easat-2032	93	21	and	and	CCONJ
easat-2032	93	22	clinical	clinical	ADJ
easat-2032	93	23	management	management	NOUN
easat-2032	93	24	.	.	PUNCT
easat-2032	94	1	•	•	NUM
easat-2032	94	2	real	real	ADJ
easat-2032	94	3	-	-	PUNCT
easat-2032	94	4	time	time	NOUN
easat-2032	94	5	pcr	pcr	NOUN
easat-2032	94	6	has	have	VERB
easat-2032	94	7	a	a	DET
easat-2032	94	8	better	well	ADJ
easat-2032	94	9	specificity	specificity	NOUN
easat-2032	94	10	than	than	ADP
easat-2032	94	11	nested	nest	VERB
easat-2032	94	12	pcr	pcr	NOUN
easat-2032	94	13	and	and	CCONJ
easat-2032	94	14	is	be	AUX
easat-2032	94	15	likely	likely	ADJ
easat-2032	94	16	to	to	PART
easat-2032	94	17	generate	generate	VERB
easat-2032	94	18	fewer	few	ADJ
easat-2032	94	19	false	false	ADJ
easat-2032	94	20	positives	positive	NOUN
easat-2032	94	21	.	.	PUNCT
easat-2032	95	1	•	•	NOUN
easat-2032	95	2	the	the	DET
easat-2032	95	3	mngs	mng	NOUN
easat-2032	95	4	can	can	AUX
easat-2032	95	5	be	be	AUX
easat-2032	95	6	used	use	VERB
easat-2032	95	7	to	to	PART
easat-2032	95	8	quickly	quickly	ADV
easat-2032	95	9	and	and	CCONJ
easat-2032	95	10	accurately	accurately	ADV
easat-2032	95	11	diagnose	diagnose	VERB
easat-2032	95	12	pjp	pjp	ADV
easat-2032	95	13	,	,	PUNCT
easat-2032	95	14	but	but	CCONJ
easat-2032	95	15	a	a	DET
easat-2032	95	16	combination	combination	NOUN
easat-2032	95	17	of	of	ADP
easat-2032	95	18	clinical	clinical	ADJ
easat-2032	95	19	judgement	judgement	NOUN
easat-2032	95	20	of	of	ADP
easat-2032	95	21	symptoms	symptom	NOUN
easat-2032	95	22	,	,	PUNCT
easat-2032	95	23	laboratory	laboratory	NOUN
easat-2032	95	24	testing	testing	NOUN
easat-2032	95	25	,	,	PUNCT
easat-2032	95	26	and	and	CCONJ
easat-2032	95	27	imaging	imaging	NOUN
easat-2032	95	28	examination	examination	NOUN
easat-2032	95	29	is	be	AUX
easat-2032	95	30	required	require	VERB
easat-2032	95	31	to	to	PART
easat-2032	95	32	make	make	VERB
easat-2032	95	33	a	a	DET
easat-2032	95	34	comprehensive	comprehensive	ADJ
easat-2032	95	35	judgment	judgment	NOUN
easat-2032	95	36	along	along	ADP
easat-2032	95	37	with	with	ADP
easat-2032	95	38	mngs	mng	NOUN
easat-2032	95	39	test	test	NOUN
easat-2032	95	40	results	result	NOUN
easat-2032	95	41	.	.	PUNCT
easat-2032	96	1	•	•	NUM
easat-2032	96	2	high	high	ADJ
easat-2032	96	3	-	-	PUNCT
easat-2032	96	4	resolution	resolution	NOUN
easat-2032	96	5	ct	ct	NOUN
easat-2032	96	6	may	may	AUX
easat-2032	96	7	be	be	AUX
easat-2032	96	8	indicated	indicate	VERB
easat-2032	96	9	for	for	ADP
easat-2032	96	10	evaluation	evaluation	NOUN
easat-2032	96	11	of	of	ADP
easat-2032	96	12	immunosuppressed	immunosuppressed	ADJ
easat-2032	96	13	patients	patient	NOUN
easat-2032	96	14	with	with	ADP
easat-2032	96	15	suspected	suspect	VERB
easat-2032	96	16	pneumonia	pneumonia	NOUN
easat-2032	96	17	and	and	CCONJ
easat-2032	96	18	normal	normal	ADJ
easat-2032	96	19	chest	chest	NOUN
easat-2032	96	20	radiographic	radiographic	ADJ
easat-2032	96	21	findings	finding	NOUN
easat-2032	96	22	.	.	PUNCT
easat-2032	97	1	•	•	NOUN
easat-2032	97	2	radiomics	radiomic	NOUN
easat-2032	97	3	showed	show	VERB
easat-2032	97	4	good	good	ADJ
easat-2032	97	5	diagnostic	diagnostic	ADJ
easat-2032	97	6	performance	performance	NOUN
easat-2032	97	7	in	in	ADP
easat-2032	97	8	differentiating	differentiate	VERB
easat-2032	97	9	pcp	pcp	PROPN
easat-2032	97	10	from	from	ADP
easat-2032	97	11	other	other	ADJ
easat-2032	97	12	types	type	NOUN
easat-2032	97	13	of	of	ADP
easat-2032	97	14	pneumonia	pneumonia	NOUN
easat-2032	97	15	in	in	ADP
easat-2032	97	16	non	non	ADJ
easat-2032	97	17	-	-	ADJ
easat-2032	97	18	hiv	hiv	ADJ
easat-2032	97	19	patients	patient	NOUN
easat-2032	97	20	.	.	PUNCT
easat-2032	98	1	•	•	NUM
easat-2032	98	2	trimethoprim	trimethoprim	ADJ
easat-2032	98	3	/	/	SYM
easat-2032	98	4	sulfamethoxazole	sulfamethoxazole	NOUN
easat-2032	98	5	for	for	ADP
easat-2032	98	6	21	21	NUM
easat-2032	98	7	days	day	NOUN
easat-2032	98	8	is	be	AUX
easat-2032	98	9	the	the	DET
easat-2032	98	10	treatment	treatment	NOUN
easat-2032	98	11	of	of	ADP
easat-2032	98	12	choice	choice	NOUN
easat-2032	98	13	in	in	ADP
easat-2032	98	14	adults	adult	NOUN
easat-2032	98	15	and	and	CCONJ
easat-2032	98	16	children	child	NOUN
easat-2032	98	17	.	.	PUNCT
easat-2032	99	1	alternative	alternative	ADJ
easat-2032	99	2	treatment	treatment	NOUN
easat-2032	99	3	regimens	regimen	NOUN
easat-2032	99	4	include	include	VERB
easat-2032	99	5	dapsone	dapsone	PROPN
easat-2032	99	6	with	with	ADP
easat-2032	99	7	trimethoprim	trimethoprim	NOUN
easat-2032	99	8	,	,	PUNCT
easat-2032	99	9	clindamycin	clindamycin	NOUN
easat-2032	99	10	with	with	ADP
easat-2032	99	11	primaquine	primaquine	NOUN
easat-2032	99	12	,	,	PUNCT
easat-2032	99	13	atovaquone	atovaquone	NOUN
easat-2032	99	14	,	,	PUNCT
easat-2032	99	15	or	or	CCONJ
easat-2032	99	16	pentamidine	pentamidine	VERB
easat-2032	99	17	.	.	PUNCT
easat-2032	100	1	•	•	NUM
easat-2032	100	2	patients	patient	NOUN
easat-2032	100	3	with	with	ADP
easat-2032	100	4	moderate	moderate	ADJ
easat-2032	100	5	to	to	ADP
easat-2032	100	6	severe	severe	ADJ
easat-2032	100	7	disease	disease	NOUN
easat-2032	100	8	should	should	AUX
easat-2032	100	9	receive	receive	VERB
easat-2032	100	10	cat	cat	NOUN
easat-2032	100	11	.	.	PUNCT
easat-2032	101	1	the	the	DET
easat-2032	101	2	use	use	NOUN
easat-2032	101	3	cat	cat	NOUN
easat-2032	101	4	is	be	AUX
easat-2032	101	5	beneficial	beneficial	ADJ
easat-2032	101	6	for	for	ADP
easat-2032	101	7	patients	patient	NOUN
easat-2032	101	8	with	with	ADP
easat-2032	101	9	hiv	hiv	PROPN
easat-2032	101	10	pcp	pcp	PROPN
easat-2032	101	11	patients	patient	NOUN
easat-2032	101	12	and	and	CCONJ
easat-2032	101	13	non	non	ADJ
easat-2032	101	14	-	-	ADJ
easat-2032	101	15	hiv	hiv	ADJ
easat-2032	101	16	pcp	pcp	PROPN
easat-2032	101	17	patients	patient	NOUN
easat-2032	101	18	without	without	ADP
easat-2032	101	19	hypoxemia	hypoxemia	PROPN
easat-2032	101	20	.	.	PUNCT
easat-2032	102	1	cat	cat	NOUN
easat-2032	102	2	use	use	NOUN
easat-2032	102	3	should	should	AUX
easat-2032	102	4	be	be	AUX
easat-2032	102	5	withheld	withhold	VERB
easat-2032	102	6	in	in	ADP
easat-2032	102	7	non	non	ADJ
easat-2032	102	8	-	-	ADJ
easat-2032	102	9	hiv	hiv	ADJ
easat-2032	102	10	pcp	pcp	PROPN
easat-2032	102	11	patients	patient	NOUN
easat-2032	102	12	without	without	ADP
easat-2032	102	13	hypoxemia	hypoxemia	PROPN
easat-2032	102	14	.	.	PUNCT
easat-2032	103	1	•	•	INTJ
easat-2032	103	2	there	there	PRON
easat-2032	103	3	are	be	VERB
easat-2032	103	4	no	no	DET
easat-2032	103	5	vaccines	vaccine	NOUN
easat-2032	103	6	in	in	ADP
easat-2032	103	7	clinical	clinical	ADJ
easat-2032	103	8	trials	trial	NOUN
easat-2032	103	9	for	for	ADP
easat-2032	103	10	the	the	DET
easat-2032	103	11	prevention	prevention	NOUN
easat-2032	103	12	of	of	ADP
easat-2032	103	13	pcp	pcp	PROPN
easat-2032	103	14	,	,	PUNCT
easat-2032	103	15	and	and	CCONJ
easat-2032	103	16	significant	significant	ADJ
easat-2032	103	17	obstacles	obstacle	NOUN
easat-2032	103	18	exist	exist	VERB
easat-2032	103	19	that	that	PRON
easat-2032	103	20	have	have	AUX
easat-2032	103	21	slowed	slow	VERB
easat-2032	103	22	development	development	NOUN
easat-2032	103	23	,	,	PUNCT
easat-2032	103	24	including	include	VERB
easat-2032	103	25	host	host	NOUN
easat-2032	103	26	range	range	NOUN
easat-2032	103	27	specificity	specificity	NOUN
easat-2032	103	28	,	,	PUNCT
easat-2032	103	29	and	and	CCONJ
easat-2032	103	30	the	the	DET
easat-2032	103	31	inability	inability	NOUN
easat-2032	103	32	to	to	PART
easat-2032	103	33	culture	culture	VERB
easat-2032	103	34	pneumocystis	pneumocystis	PROPN
easat-2032	103	35	spp	spp	NOUN
easat-2032	103	36	.	.	PUNCT
easat-2032	104	1	therefore	therefore	ADV
easat-2032	104	2	,	,	PUNCT
easat-2032	104	3	chemoprophylaxis	chemoprophylaxis	ADJ
easat-2032	104	4	against	against	ADP
easat-2032	104	5	pcp	pcp	PROPN
easat-2032	104	6	is	be	AUX
easat-2032	104	7	paramount	paramount	ADJ
easat-2032	104	8	in	in	ADP
easat-2032	104	9	high	high	ADJ
easat-2032	104	10	-	-	PUNCT
easat-2032	104	11	risk	risk	NOUN
easat-2032	104	12	populations	population	NOUN
easat-2032	104	13	,	,	PUNCT
easat-2032	104	14	with	with	SCONJ
easat-2032	104	15	tmp	tmp	NOUN
easat-2032	104	16	-	-	PUNCT
easat-2032	104	17	smx	smx	NOUN
easat-2032	104	18	remaining	remain	VERB
easat-2032	104	19	the	the	DET
easat-2032	104	20	preferred	preferred	ADJ
easat-2032	104	21	agent	agent	NOUN
easat-2032	104	22	.	.	PUNCT
easat-2032	105	1	8	8	X
easat-2032	105	2	.	.	PUNCT
easat-2032	105	3	recommendations	recommendation	NOUN
easat-2032	105	4	•	•	VERB
easat-2032	105	5	future	future	ADJ
easat-2032	105	6	research	research	NOUN
easat-2032	105	7	to	to	PART
easat-2032	105	8	address	address	VERB
easat-2032	105	9	antimicrobial	antimicrobial	ADJ
easat-2032	105	10	resistance	resistance	NOUN
easat-2032	105	11	,	,	PUNCT
easat-2032	105	12	understand	understand	VERB
easat-2032	105	13	host	host	NOUN
easat-2032	105	14	immune	immune	ADJ
easat-2032	105	15	responses	response	NOUN
easat-2032	105	16	.	.	PUNCT
easat-2032	106	1	•	•	NUM
easat-2032	106	2	emerging	emerge	VERB
easat-2032	106	3	monoclonal	monoclonal	NOUN
easat-2032	106	4	antibodies	antibody	NOUN
easat-2032	106	5	are	be	AUX
easat-2032	106	6	promising	promise	VERB
easat-2032	106	7	but	but	CCONJ
easat-2032	106	8	need	need	VERB
easat-2032	106	9	further	further	ADJ
easat-2032	106	10	studies	study	NOUN
easat-2032	106	11	and	and	CCONJ
easat-2032	106	12	trials	trial	NOUN
easat-2032	106	13	in	in	ADP
easat-2032	106	14	human	human	NOUN
easat-2032	106	15	.	.	PUNCT
easat-2032	107	1	167	167	NUM
easat-2032	107	2	edelweiss	edelweiss	PROPN
easat-2032	107	3	applied	apply	VERB
easat-2032	107	4	science	science	NOUN
easat-2032	107	5	and	and	CCONJ
easat-2032	107	6	technology	technology	NOUN
easat-2032	107	7	issn	issn	PROPN
easat-2032	107	8	:	:	PUNCT
easat-2032	107	9	2576	2576	NUM
easat-2032	107	10	-	-	SYM
easat-2032	107	11	8484	8484	NUM
easat-2032	107	12	vol	vol	NOUN
easat-2032	107	13	.	.	PROPN
easat-2032	107	14	8	8	NUM
easat-2032	107	15	,	,	PUNCT
easat-2032	107	16	no	no	INTJ
easat-2032	107	17	.	.	NOUN
easat-2032	108	1	6	6	NUM
easat-2032	108	2	:	:	SYM
easat-2032	108	3	163	163	NUM
easat-2032	108	4	-	-	SYM
easat-2032	108	5	168	168	NUM
easat-2032	108	6	,	,	PUNCT
easat-2032	108	7	2024	2024	NUM
easat-2032	108	8	doi	doi	NOUN
easat-2032	108	9	:	:	PUNCT
easat-2032	108	10	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	108	11	©	©	PROPN
easat-2032	108	12	2024	2024	NUM
easat-2032	108	13	by	by	ADP
easat-2032	108	14	the	the	DET
easat-2032	108	15	author	author	NOUN
easat-2032	108	16	;	;	PUNCT
easat-2032	109	1	licensee	licensee	PROPN
easat-2032	109	2	learning	learn	VERB
easat-2032	109	3	gate	gate	NOUN
easat-2032	109	4	acknowledgments	acknowledgment	NOUN
easat-2032	109	5	:	:	PUNCT
easat-2032	109	6	the	the	DET
easat-2032	109	7	author	author	NOUN
easat-2032	109	8	would	would	AUX
easat-2032	109	9	like	like	VERB
easat-2032	109	10	to	to	PART
easat-2032	109	11	thank	thank	VERB
easat-2032	109	12	the	the	DET
easat-2032	109	13	national	national	PROPN
easat-2032	109	14	university	university	PROPN
easat-2032	109	15	of	of	ADP
easat-2032	109	16	science	science	NOUN
easat-2032	109	17	and	and	CCONJ
easat-2032	109	18	technology	technology	NOUN
easat-2032	109	19	in	in	ADP
easat-2032	109	20	oman	oman	NOUN
easat-2032	109	21	for	for	ADP
easat-2032	109	22	providing	provide	VERB
easat-2032	109	23	access	access	NOUN
easat-2032	109	24	to	to	ADP
easat-2032	109	25	some	some	PRON
easat-2032	109	26	of	of	ADP
easat-2032	109	27	the	the	DET
easat-2032	109	28	articles	article	NOUN
easat-2032	109	29	in	in	ADP
easat-2032	109	30	review	review	NOUN
easat-2032	109	31	.	.	PUNCT
easat-2032	110	1	copyright	copyright	NOUN
easat-2032	110	2	:	:	PUNCT
easat-2032	110	3	©	©	PROPN
easat-2032	110	4	2024	2024	NUM
easat-2032	110	5	by	by	ADP
easat-2032	110	6	the	the	DET
easat-2032	110	7	authors	author	NOUN
easat-2032	110	8	.	.	PUNCT
easat-2032	111	1	this	this	DET
easat-2032	111	2	article	article	NOUN
easat-2032	111	3	is	be	AUX
easat-2032	111	4	an	an	DET
easat-2032	111	5	open	open	ADJ
easat-2032	111	6	access	access	NOUN
easat-2032	111	7	article	article	NOUN
easat-2032	111	8	distributed	distribute	VERB
easat-2032	111	9	under	under	ADP
easat-2032	111	10	the	the	DET
easat-2032	111	11	terms	term	NOUN
easat-2032	111	12	and	and	CCONJ
easat-2032	111	13	conditionsof	conditionsof	VERB
easat-2032	111	14	the	the	DET
easat-2032	111	15	creative	creative	ADJ
easat-2032	111	16	commons	common	NOUN
easat-2032	111	17	attribution	attribution	NOUN
easat-2032	111	18	(	(	PUNCT
easat-2032	111	19	cc	cc	NOUN
easat-2032	111	20	by	by	ADP
easat-2032	111	21	)	)	PUNCT
easat-2032	111	22	license	license	NOUN
easat-2032	111	23	(	(	PUNCT
easat-2032	111	24	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-2032	111	25	)	)	PUNCT
easat-2032	111	26	.	.	PUNCT
easat-2032	112	1	references	reference	NOUN
easat-2032	112	2	[	[	X
easat-2032	112	3	1	1	NUM
easat-2032	112	4	]	]	PUNCT
easat-2032	112	5	a.-d	a.-d	PROPN
easat-2032	112	6	.	.	PUNCT
easat-2032	113	1	c.	c.	PROPN
easat-2032	113	2	martinez	martinez	PROPN
easat-2032	113	3	,	,	PUNCT
easat-2032	113	4	a.	a.	PROPN
easat-2032	113	5	el	el	PROPN
easat-2032	113	6	,	,	PUNCT
easat-2032	113	7	m.	m.	NOUN
easat-2032	113	8	pottier	pottier	NOUN
easat-2032	113	9	,	,	PUNCT
easat-2032	113	10	and	and	CCONJ
easat-2032	113	11	m.	m.	NOUN
easat-2032	113	12	gantois	gantois	NOUN
easat-2032	113	13	,	,	PUNCT
easat-2032	113	14	“	"	PUNCT
easat-2032	113	15	dei	dei	NOUN
easat-2032	113	16	-	-	PUNCT
easat-2032	113	17	cas	cas	PROPN
easat-2032	113	18	e.	e.	PROPN
easat-2032	113	19	the	the	DET
easat-2032	113	20	pneumocystis	pneumocystis	PROPN
easat-2032	113	21	life	life	NOUN
easat-2032	113	22	cycle	cycle	NOUN
easat-2032	113	23	,	,	PUNCT
easat-2032	113	24	”	"	PUNCT
easat-2032	113	25	mem	mem	X
easat-2032	113	26	inst	inst	PROPN
easat-2032	113	27	oswaldo	oswaldo	PROPN
easat-2032	113	28	cruz	cruz	PROPN
easat-2032	113	29	,	,	PUNCT
easat-2032	113	30	vol	vol	NOUN
easat-2032	113	31	.	.	PROPN
easat-2032	114	1	104	104	NUM
easat-2032	114	2	,	,	PUNCT
easat-2032	114	3	no	no	INTJ
easat-2032	114	4	.	.	NOUN
easat-2032	114	5	3	3	NUM
easat-2032	114	6	,	,	PUNCT
easat-2032	114	7	pp	pp	ADJ
easat-2032	114	8	.	.	PUNCT
easat-2032	115	1	419–426	419–426	NUM
easat-2032	115	2	,	,	PUNCT
easat-2032	115	3	2009	2009	NUM
easat-2032	115	4	.	.	PUNCT
easat-2032	116	1	[	[	X
easat-2032	116	2	2	2	NUM
easat-2032	116	3	]	]	PUNCT
easat-2032	116	4	m.	m.	NOUN
easat-2032	116	5	s.	s.	PROPN
easat-2032	116	6	gottlieb	gottlieb	PROPN
easat-2032	116	7	,	,	PUNCT
easat-2032	116	8	“	"	PUNCT
easat-2032	116	9	pneumocystis	pneumocystis	ADJ
easat-2032	116	10	pneumonia	pneumonia	NOUN
easat-2032	116	11	--	--	PUNCT
easat-2032	116	12	los	los	PROPN
easat-2032	116	13	angeles	angeles	PROPN
easat-2032	116	14	.	.	PUNCT
easat-2032	117	1	1981	1981	NUM
easat-2032	117	2	,	,	PUNCT
easat-2032	117	3	”	"	PUNCT
easat-2032	117	4	am	am	NOUN
easat-2032	117	5	.	.	PUNCT
easat-2032	118	1	j.	j.	PROPN
easat-2032	118	2	public	public	PROPN
easat-2032	118	3	health	health	PROPN
easat-2032	118	4	,	,	PUNCT
easat-2032	118	5	vol	vol	NOUN
easat-2032	118	6	.	.	PROPN
easat-2032	118	7	96	96	NUM
easat-2032	118	8	,	,	PUNCT
easat-2032	118	9	no	no	INTJ
easat-2032	118	10	.	.	NOUN
easat-2032	118	11	6	6	NUM
easat-2032	118	12	,	,	PUNCT
easat-2032	118	13	pp	pp	ADJ
easat-2032	118	14	.	.	PUNCT
easat-2032	119	1	980–1	980–1	NOUN
easat-2032	119	2	;	;	PUNCT
easat-2032	119	3	discussion	discussion	NOUN
easat-2032	119	4	982	982	NUM
easat-2032	119	5	-	-	SYM
easat-2032	119	6	3	3	NUM
easat-2032	119	7	,	,	PUNCT
easat-2032	119	8	2006	2006	NUM
easat-2032	119	9	.	.	PUNCT
easat-2032	120	1	[	[	X
easat-2032	120	2	3	3	X
easat-2032	120	3	]	]	PUNCT
easat-2032	120	4	k.	k.	PROPN
easat-2032	120	5	a.	a.	PROPN
easat-2032	120	6	sepkowitz	sepkowitz	PROPN
easat-2032	120	7	,	,	PUNCT
easat-2032	120	8	“	"	PUNCT
easat-2032	120	9	opportunistic	opportunistic	ADJ
easat-2032	120	10	infections	infection	NOUN
easat-2032	120	11	in	in	ADP
easat-2032	120	12	patients	patient	NOUN
easat-2032	120	13	with	with	ADP
easat-2032	120	14	and	and	CCONJ
easat-2032	120	15	patients	patient	NOUN
easat-2032	120	16	without	without	ADP
easat-2032	120	17	acquired	acquire	VERB
easat-2032	120	18	immunodeficiency	immunodeficiency	NOUN
easat-2032	120	19	syndrome	syndrome	NOUN
easat-2032	120	20	,	,	PUNCT
easat-2032	120	21	”	"	PUNCT
easat-2032	120	22	clin	clin	PROPN
easat-2032	120	23	.	.	PUNCT
easat-2032	121	1	infect	infect	VERB
easat-2032	121	2	.	.	PUNCT
easat-2032	122	1	dis	dis	PROPN
easat-2032	122	2	.	.	PUNCT
easat-2032	122	3	,	,	PUNCT
easat-2032	122	4	vol	vol	NOUN
easat-2032	122	5	.	.	PROPN
easat-2032	123	1	34	34	NUM
easat-2032	123	2	,	,	PUNCT
easat-2032	123	3	no	no	INTJ
easat-2032	123	4	.	.	NOUN
easat-2032	123	5	8	8	NUM
easat-2032	123	6	,	,	PUNCT
easat-2032	123	7	pp	pp	ADJ
easat-2032	123	8	.	.	PUNCT
easat-2032	124	1	1098–1107	1098–1107	NUM
easat-2032	124	2	,	,	PUNCT
easat-2032	124	3	2002	2002	NUM
easat-2032	124	4	.	.	PUNCT
easat-2032	125	1	[	[	X
easat-2032	125	2	4	4	NUM
easat-2032	125	3	]	]	X
easat-2032	125	4	elvin	elvin	PROPN
easat-2032	125	5	,	,	PUNCT
easat-2032	125	6	c.	c.	PROPN
easat-2032	125	7	lidman	lidman	PROPN
easat-2032	125	8	,	,	PUNCT
easat-2032	125	9	e.	e.	PROPN
easat-2032	125	10	tynell	tynell	PROPN
easat-2032	125	11	,	,	PUNCT
easat-2032	125	12	e.	e.	PROPN
easat-2032	125	13	linder	linder	PROPN
easat-2032	125	14	,	,	PUNCT
easat-2032	125	15	and	and	CCONJ
easat-2032	125	16	a.	a.	NOUN
easat-2032	125	17	björkman	björkman	NOUN
easat-2032	125	18	,	,	PUNCT
easat-2032	125	19	“	"	PUNCT
easat-2032	125	20	natural	natural	ADJ
easat-2032	125	21	history	history	NOUN
easat-2032	125	22	of	of	ADP
easat-2032	125	23	asymptomatic	asymptomatic	ADJ
easat-2032	125	24	and	and	CCONJ
easat-2032	125	25	symptomatic	symptomatic	ADJ
easat-2032	125	26	pneumocystis	pneumocystis	NOUN
easat-2032	125	27	carinii	carinii	ADJ
easat-2032	125	28	infection	infection	NOUN
easat-2032	125	29	in	in	ADP
easat-2032	125	30	hiv	hiv	PROPN
easat-2032	125	31	infected	infect	VERB
easat-2032	125	32	patients	patient	NOUN
easat-2032	125	33	,	,	PUNCT
easat-2032	125	34	”	"	PUNCT
easat-2032	125	35	scand	scand	PROPN
easat-2032	125	36	.	.	PUNCT
easat-2032	126	1	j.	j.	PROPN
easat-2032	126	2	infect	infect	PROPN
easat-2032	126	3	.	.	PUNCT
easat-2032	127	1	dis	dis	PROPN
easat-2032	127	2	.	.	PUNCT
easat-2032	127	3	,	,	PUNCT
easat-2032	127	4	vol	vol	NOUN
easat-2032	127	5	.	.	PROPN
easat-2032	128	1	26	26	NUM
easat-2032	128	2	,	,	PUNCT
easat-2032	128	3	no	no	INTJ
easat-2032	128	4	.	.	NOUN
easat-2032	128	5	6	6	NUM
easat-2032	128	6	,	,	PUNCT
easat-2032	128	7	pp	pp	ADJ
easat-2032	128	8	.	.	PUNCT
easat-2032	129	1	643–651	643–651	NUM
easat-2032	129	2	,	,	PUNCT
easat-2032	129	3	1994	1994	NUM
easat-2032	129	4	.	.	PUNCT
easat-2032	130	1	[	[	X
easat-2032	130	2	5	5	NUM
easat-2032	130	3	]	]	PUNCT
easat-2032	130	4	a.	a.	NOUN
easat-2032	130	5	morris	morris	PROPN
easat-2032	130	6	and	and	CCONJ
easat-2032	130	7	k.	k.	PROPN
easat-2032	130	8	a.	a.	PROPN
easat-2032	130	9	norris	norris	PROPN
easat-2032	130	10	,	,	PUNCT
easat-2032	130	11	“	"	PUNCT
easat-2032	130	12	colonization	colonization	NOUN
easat-2032	130	13	by	by	ADP
easat-2032	130	14	pneumocystis	pneumocystis	ADJ
easat-2032	130	15	jirovecii	jirovecii	NOUN
easat-2032	130	16	and	and	CCONJ
easat-2032	130	17	its	its	PRON
easat-2032	130	18	role	role	NOUN
easat-2032	130	19	in	in	ADP
easat-2032	130	20	disease	disease	NOUN
easat-2032	130	21	,	,	PUNCT
easat-2032	130	22	”	"	PUNCT
easat-2032	130	23	clin	clin	PROPN
easat-2032	130	24	.	.	PUNCT
easat-2032	131	1	microbiol	microbiol	PROPN
easat-2032	131	2	.	.	PUNCT
easat-2032	132	1	rev	rev	PROPN
easat-2032	132	2	.	.	PROPN
easat-2032	132	3	,	,	PUNCT
easat-2032	132	4	vol	vol	NOUN
easat-2032	132	5	.	.	PROPN
easat-2032	132	6	25	25	NUM
easat-2032	132	7	,	,	PUNCT
easat-2032	132	8	no	no	INTJ
easat-2032	132	9	.	.	NOUN
easat-2032	132	10	2	2	NUM
easat-2032	132	11	,	,	PUNCT
easat-2032	132	12	pp	pp	ADJ
easat-2032	132	13	.	.	PUNCT
easat-2032	133	1	297–317	297–317	NUM
easat-2032	133	2	,	,	PUNCT
easat-2032	133	3	2012	2012	NUM
easat-2032	133	4	.	.	PUNCT
easat-2032	134	1	[	[	X
easat-2032	134	2	6	6	NUM
easat-2032	134	3	]	]	PUNCT
easat-2032	134	4	s.	s.	PROPN
easat-2032	134	5	e.	e.	PROPN
easat-2032	134	6	sulieman	sulieman	PROPN
easat-2032	134	7	,	,	PUNCT
easat-2032	134	8	t.	t.	PROPN
easat-2032	134	9	a.	a.	NOUN
easat-2032	134	10	metjian	metjian	PROPN
easat-2032	134	11	,	,	PUNCT
easat-2032	134	12	t.	t.	PROPN
easat-2032	134	13	e.	e.	PROPN
easat-2032	134	14	zaoutis	zaoutis	PROPN
easat-2032	134	15	,	,	PUNCT
easat-2032	134	16	and	and	CCONJ
easat-2032	134	17	b.	b.	PROPN
easat-2032	134	18	t.	t.	PROPN
easat-2032	134	19	fisher	fisher	PROPN
easat-2032	134	20	,	,	PUNCT
easat-2032	134	21	“	"	PUNCT
easat-2032	134	22	pneumocystis	pneumocystis	ADJ
easat-2032	134	23	pneumonia	pneumonia	NOUN
easat-2032	134	24	:	:	PUNCT
easat-2032	134	25	epidemiology	epidemiology	NOUN
easat-2032	134	26	and	and	CCONJ
easat-2032	134	27	options	option	NOUN
easat-2032	134	28	for	for	ADP
easat-2032	134	29	prophylaxis	prophylaxis	NOUN
easat-2032	134	30	in	in	ADP
easat-2032	134	31	non	non	ADJ
easat-2032	134	32	-	-	ADJ
easat-2032	134	33	hiv	hiv	ADJ
easat-2032	134	34	immunocompromised	immunocompromise	VERB
easat-2032	134	35	pediatric	pediatric	ADJ
easat-2032	134	36	patients	patient	NOUN
easat-2032	134	37	,	,	PUNCT
easat-2032	134	38	”	"	PUNCT
easat-2032	134	39	curr	curr	X
easat-2032	134	40	.	.	PUNCT
easat-2032	134	41	fungal	fungal	PROPN
easat-2032	134	42	infect	infect	NOUN
easat-2032	134	43	.	.	PUNCT
easat-2032	135	1	rep	rep	PROPN
easat-2032	135	2	.	.	PROPN
easat-2032	135	3	,	,	PUNCT
easat-2032	135	4	vol	vol	NOUN
easat-2032	135	5	.	.	PROPN
easat-2032	135	6	8	8	NUM
easat-2032	135	7	,	,	PUNCT
easat-2032	135	8	no	no	INTJ
easat-2032	135	9	.	.	NOUN
easat-2032	135	10	1	1	NUM
easat-2032	135	11	,	,	PUNCT
easat-2032	135	12	pp	pp	ADJ
easat-2032	135	13	.	.	PUNCT
easat-2032	136	1	45–55	45–55	NUM
easat-2032	136	2	,	,	PUNCT
easat-2032	136	3	2014	2014	NUM
easat-2032	136	4	.	.	PUNCT
easat-2032	137	1	[	[	X
easat-2032	137	2	7	7	X
easat-2032	137	3	]	]	X
easat-2032	137	4	m.	m.	NOUN
easat-2032	137	5	bateman	bateman	PROPN
easat-2032	137	6	,	,	PUNCT
easat-2032	137	7	r.	r.	PROPN
easat-2032	137	8	oladele	oladele	PROPN
easat-2032	137	9	,	,	PUNCT
easat-2032	137	10	and	and	CCONJ
easat-2032	137	11	j.	j.	PROPN
easat-2032	137	12	k.	k.	PROPN
easat-2032	137	13	kolls	kolls	PROPN
easat-2032	137	14	,	,	PUNCT
easat-2032	137	15	“	"	PUNCT
easat-2032	137	16	diagnosing	diagnose	VERB
easat-2032	137	17	pneumocystis	pneumocystis	ADJ
easat-2032	137	18	jirovecii	jirovecii	ADJ
easat-2032	137	19	pneumonia	pneumonia	NOUN
easat-2032	137	20	:	:	PUNCT
easat-2032	137	21	a	a	DET
easat-2032	137	22	review	review	NOUN
easat-2032	137	23	of	of	ADP
easat-2032	137	24	current	current	ADJ
easat-2032	137	25	methods	method	NOUN
easat-2032	137	26	and	and	CCONJ
easat-2032	137	27	novel	novel	ADJ
easat-2032	137	28	approaches	approach	NOUN
easat-2032	137	29	,	,	PUNCT
easat-2032	137	30	”	"	PUNCT
easat-2032	137	31	med	me	VERB
easat-2032	137	32	.	.	PUNCT
easat-2032	138	1	mycol	mycol	PROPN
easat-2032	138	2	.	.	PUNCT
easat-2032	138	3	,	,	PUNCT
easat-2032	138	4	vol	vol	NOUN
easat-2032	138	5	.	.	PROPN
easat-2032	139	1	58	58	NUM
easat-2032	139	2	,	,	PUNCT
easat-2032	139	3	no	no	INTJ
easat-2032	139	4	.	.	NOUN
easat-2032	139	5	8	8	NUM
easat-2032	139	6	,	,	PUNCT
easat-2032	139	7	pp	pp	ADJ
easat-2032	139	8	.	.	PUNCT
easat-2032	140	1	1015–1028	1015–1028	NUM
easat-2032	140	2	,	,	PUNCT
easat-2032	140	3	2020	2020	NUM
easat-2032	140	4	.	.	PUNCT
easat-2032	141	1	[	[	X
easat-2032	141	2	8	8	NUM
easat-2032	141	3	]	]	PUNCT
easat-2032	141	4	m.	m.	NOUN
easat-2032	141	5	g.	g.	PROPN
easat-2032	141	6	j.	j.	PROPN
easat-2032	141	7	de	de	PROPN
easat-2032	141	8	boer	boer	PROPN
easat-2032	141	9	et	et	PROPN
easat-2032	141	10	al	al	PROPN
easat-2032	141	11	.	.	PROPN
easat-2032	141	12	,	,	PUNCT
easat-2032	141	13	“	"	PUNCT
easat-2032	141	14	an	an	DET
easat-2032	141	15	outbreak	outbreak	NOUN
easat-2032	141	16	of	of	ADP
easat-2032	141	17	pneumocystis	pneumocystis	ADJ
easat-2032	141	18	jiroveci	jiroveci	PROPN
easat-2032	141	19	pneumonia	pneumonia	NOUN
easat-2032	141	20	with	with	ADP
easat-2032	141	21	1	1	NUM
easat-2032	141	22	predominant	predominant	ADJ
easat-2032	141	23	genotype	genotype	NOUN
easat-2032	141	24	among	among	ADP
easat-2032	141	25	renal	renal	ADJ
easat-2032	141	26	transplant	transplant	NOUN
easat-2032	141	27	recipients	recipient	NOUN
easat-2032	141	28	:	:	PUNCT
easat-2032	141	29	interhuman	interhuman	NOUN
easat-2032	141	30	transmission	transmission	NOUN
easat-2032	141	31	or	or	CCONJ
easat-2032	141	32	a	a	DET
easat-2032	141	33	common	common	ADJ
easat-2032	141	34	environmental	environmental	ADJ
easat-2032	141	35	source	source	NOUN
easat-2032	141	36	?	?	PUNCT
easat-2032	141	37	,	,	PUNCT
easat-2032	141	38	”	"	PUNCT
easat-2032	141	39	clin	clin	PROPN
easat-2032	141	40	.	.	PUNCT
easat-2032	142	1	infect	infect	VERB
easat-2032	142	2	.	.	PUNCT
easat-2032	143	1	dis	dis	PROPN
easat-2032	143	2	.	.	PUNCT
easat-2032	143	3	,	,	PUNCT
easat-2032	143	4	vol	vol	NOUN
easat-2032	143	5	.	.	PROPN
easat-2032	144	1	44	44	NUM
easat-2032	144	2	,	,	PUNCT
easat-2032	144	3	no	no	INTJ
easat-2032	144	4	.	.	NOUN
easat-2032	144	5	9	9	NUM
easat-2032	144	6	,	,	PUNCT
easat-2032	144	7	pp	pp	ADJ
easat-2032	144	8	.	.	PUNCT
easat-2032	145	1	1143–1149	1143–1149	NUM
easat-2032	145	2	,	,	PUNCT
easat-2032	145	3	2007	2007	NUM
easat-2032	145	4	.	.	PUNCT
easat-2032	146	1	[	[	X
easat-2032	146	2	9	9	NUM
easat-2032	146	3	]	]	PUNCT
easat-2032	146	4	k.	k.	PROPN
easat-2032	146	5	sanno	sanno	PROPN
easat-2032	146	6	et	et	PROPN
easat-2032	146	7	al	al	PROPN
easat-2032	146	8	.	.	PROPN
easat-2032	146	9	,	,	PUNCT
easat-2032	146	10	“	"	PUNCT
easat-2032	146	11	pneumocystis	pneumocystis	ADJ
easat-2032	146	12	pneumonia	pneumonia	NOUN
easat-2032	146	13	in	in	ADP
easat-2032	146	14	a	a	DET
easat-2032	146	15	patient	patient	NOUN
easat-2032	146	16	with	with	ADP
easat-2032	146	17	type	type	NOUN
easat-2032	146	18	2	2	NUM
easat-2032	146	19	diabetes	diabetes	NOUN
easat-2032	146	20	mellitus	mellitus	NOUN
easat-2032	146	21	,	,	PUNCT
easat-2032	146	22	”	"	PUNCT
easat-2032	146	23	intern	intern	NOUN
easat-2032	146	24	.	.	PUNCT
easat-2032	147	1	med	med	PROPN
easat-2032	147	2	.	.	PROPN
easat-2032	147	3	,	,	PUNCT
easat-2032	147	4	vol	vol	NOUN
easat-2032	147	5	.	.	PROPN
easat-2032	148	1	46	46	NUM
easat-2032	148	2	,	,	PUNCT
easat-2032	148	3	no	no	INTJ
easat-2032	148	4	.	.	NOUN
easat-2032	148	5	14	14	NUM
easat-2032	148	6	,	,	PUNCT
easat-2032	148	7	pp	pp	ADJ
easat-2032	148	8	.	.	PUNCT
easat-2032	149	1	1131–1133	1131–1133	NUM
easat-2032	149	2	,	,	PUNCT
easat-2032	149	3	2007	2007	NUM
easat-2032	149	4	.	.	PUNCT
easat-2032	150	1	[	[	X
easat-2032	150	2	10	10	NUM
easat-2032	150	3	]	]	X
easat-2032	150	4	b.	b.	PROPN
easat-2032	150	5	m.	m.	PROPN
easat-2032	150	6	morrow	morrow	PROPN
easat-2032	150	7	,	,	PUNCT
easat-2032	150	8	c.	c.	PROPN
easat-2032	150	9	m.	m.	PROPN
easat-2032	150	10	samuel	samuel	PROPN
easat-2032	150	11	,	,	PUNCT
easat-2032	150	12	m.	m.	NOUN
easat-2032	150	13	zampoli	zampoli	PROPN
easat-2032	150	14	,	,	PUNCT
easat-2032	150	15	a.	a.	NOUN
easat-2032	150	16	whitelaw	whitelaw	PROPN
easat-2032	150	17	,	,	PUNCT
easat-2032	150	18	and	and	CCONJ
easat-2032	150	19	h.	h.	PROPN
easat-2032	150	20	j.	j.	PROPN
easat-2032	150	21	zar	zar	PROPN
easat-2032	150	22	,	,	PUNCT
easat-2032	150	23	“	"	PUNCT
easat-2032	150	24	pneumocystis	pneumocystis	ADJ
easat-2032	150	25	pneumonia	pneumonia	NOUN
easat-2032	150	26	in	in	ADP
easat-2032	150	27	south	south	ADJ
easat-2032	150	28	african	african	ADJ
easat-2032	150	29	children	child	NOUN
easat-2032	150	30	diagnosed	diagnose	VERB
easat-2032	150	31	by	by	ADP
easat-2032	150	32	molecular	molecular	ADJ
easat-2032	150	33	methods	method	NOUN
easat-2032	150	34	,	,	PUNCT
easat-2032	150	35	”	"	PUNCT
easat-2032	150	36	bmc	bmc	NOUN
easat-2032	150	37	res	re	NOUN
easat-2032	150	38	.	.	PUNCT
easat-2032	151	1	notes	note	NOUN
easat-2032	151	2	,	,	PUNCT
easat-2032	151	3	vol	vol	NOUN
easat-2032	151	4	.	.	PROPN
easat-2032	151	5	7	7	NUM
easat-2032	151	6	,	,	PUNCT
easat-2032	151	7	no	no	INTJ
easat-2032	151	8	.	.	NOUN
easat-2032	151	9	1	1	NUM
easat-2032	151	10	,	,	PUNCT
easat-2032	151	11	p.	p.	NOUN
easat-2032	151	12	26	26	NUM
easat-2032	151	13	,	,	PUNCT
easat-2032	151	14	2014	2014	NUM
easat-2032	151	15	.	.	PUNCT
easat-2032	152	1	[	[	X
easat-2032	152	2	11	11	NUM
easat-2032	152	3	]	]	PUNCT
easat-2032	152	4	j.	j.	PROPN
easat-2032	152	5	a.	a.	PROPN
easat-2032	152	6	kovacs	kovacs	PROPN
easat-2032	152	7	and	and	CCONJ
easat-2032	152	8	h.	h.	PROPN
easat-2032	152	9	masur	masur	PROPN
easat-2032	152	10	,	,	PUNCT
easat-2032	152	11	“	"	PUNCT
easat-2032	152	12	evolving	evolve	VERB
easat-2032	152	13	health	health	NOUN
easat-2032	152	14	effects	effect	NOUN
easat-2032	152	15	of	of	ADP
easat-2032	152	16	pneumocystis	pneumocystis	NOUN
easat-2032	152	17	:	:	PUNCT
easat-2032	152	18	one	one	NUM
easat-2032	152	19	hundred	hundred	NUM
easat-2032	152	20	years	year	NOUN
easat-2032	152	21	of	of	ADP
easat-2032	152	22	progress	progress	NOUN
easat-2032	152	23	in	in	ADP
easat-2032	152	24	diagnosis	diagnosis	NOUN
easat-2032	152	25	and	and	CCONJ
easat-2032	152	26	treatment	treatment	NOUN
easat-2032	152	27	:	:	PUNCT
easat-2032	152	28	one	one	NUM
easat-2032	152	29	hundred	hundred	NUM
easat-2032	152	30	years	year	NOUN
easat-2032	152	31	of	of	ADP
easat-2032	152	32	progress	progress	NOUN
easat-2032	152	33	in	in	ADP
easat-2032	152	34	diagnosis	diagnosis	NOUN
easat-2032	152	35	and	and	CCONJ
easat-2032	152	36	treatment	treatment	NOUN
easat-2032	152	37	,	,	PUNCT
easat-2032	152	38	”	"	PUNCT
easat-2032	152	39	jama	jama	NOUN
easat-2032	152	40	:	:	PUNCT
easat-2032	152	41	the	the	DET
easat-2032	152	42	journal	journal	NOUN
easat-2032	152	43	of	of	ADP
easat-2032	152	44	the	the	DET
easat-2032	152	45	american	american	PROPN
easat-2032	152	46	medical	medical	PROPN
easat-2032	152	47	association	association	PROPN
easat-2032	152	48	,	,	PUNCT
easat-2032	152	49	vol	vol	NOUN
easat-2032	152	50	.	.	PROPN
easat-2032	152	51	301	301	NUM
easat-2032	152	52	,	,	PUNCT
easat-2032	152	53	no	no	INTJ
easat-2032	152	54	.	.	NOUN
easat-2032	152	55	24	24	NUM
easat-2032	152	56	,	,	PUNCT
easat-2032	152	57	pp	pp	ADJ
easat-2032	152	58	.	.	PUNCT
easat-2032	153	1	2578–2585	2578–2585	NUM
easat-2032	153	2	,	,	PUNCT
easat-2032	153	3	2009	2009	NUM
easat-2032	153	4	.	.	PUNCT
easat-2032	154	1	[	[	X
easat-2032	154	2	12	12	NUM
easat-2032	154	3	]	]	PUNCT
easat-2032	154	4	c.-j	c.-j	PROPN
easat-2032	154	5	.	.	PUNCT
easat-2032	155	1	liu	liu	PROPN
easat-2032	155	2	,	,	PUNCT
easat-2032	155	3	t.-f	t.-f	PROPN
easat-2032	155	4	.	.	PUNCT
easat-2032	156	1	lee	lee	PROPN
easat-2032	156	2	,	,	PUNCT
easat-2032	156	3	s.-y	s.-y	NOUN
easat-2032	156	4	.	.	PUNCT
easat-2032	157	1	ruan	ruan	NOUN
easat-2032	157	2	,	,	PUNCT
easat-2032	157	3	c.-j	c.-j	PROPN
easat-2032	157	4	.	.	PUNCT
easat-2032	158	1	yu	yu	PROPN
easat-2032	158	2	,	,	PUNCT
easat-2032	158	3	j.-y	j.-y	PROPN
easat-2032	158	4	.	.	PUNCT
easat-2032	158	5	chien	chien	PROPN
easat-2032	158	6	,	,	PUNCT
easat-2032	158	7	and	and	CCONJ
easat-2032	158	8	p.-r	p.-r	PROPN
easat-2032	158	9	.	.	PUNCT
easat-2032	159	1	hsueh	hsueh	PROPN
easat-2032	159	2	,	,	PUNCT
easat-2032	159	3	“	"	PUNCT
easat-2032	159	4	clinical	clinical	ADJ
easat-2032	159	5	characteristics	characteristic	NOUN
easat-2032	159	6	,	,	PUNCT
easat-2032	159	7	treatment	treatment	NOUN
easat-2032	159	8	outcomes	outcome	NOUN
easat-2032	159	9	,	,	PUNCT
easat-2032	159	10	and	and	CCONJ
easat-2032	159	11	prognostic	prognostic	ADJ
easat-2032	159	12	factors	factor	NOUN
easat-2032	159	13	of	of	ADP
easat-2032	159	14	pneumocystis	pneumocystis	ADJ
easat-2032	159	15	pneumonia	pneumonia	NOUN
easat-2032	159	16	in	in	ADP
easat-2032	159	17	non	non	ADJ
easat-2032	159	18	-	-	ADJ
easat-2032	159	19	hiv	hiv	ADJ
easat-2032	159	20	-	-	PUNCT
easat-2032	159	21	infected	infect	VERB
easat-2032	159	22	patients	patient	NOUN
easat-2032	159	23	,	,	PUNCT
easat-2032	159	24	”	"	PUNCT
easat-2032	159	25	infect	infect	VERB
easat-2032	159	26	.	.	PUNCT
easat-2032	160	1	drug	drug	NOUN
easat-2032	160	2	resist	resist	NOUN
easat-2032	160	3	.	.	PUNCT
easat-2032	161	1	,	,	PUNCT
easat-2032	161	2	vol	vol	NOUN
easat-2032	161	3	.	.	PROPN
easat-2032	162	1	12	12	NUM
easat-2032	162	2	,	,	PUNCT
easat-2032	162	3	pp	pp	ADJ
easat-2032	162	4	.	.	PUNCT
easat-2032	163	1	1457–1467	1457–1467	NUM
easat-2032	163	2	,	,	PUNCT
easat-2032	163	3	2019	2019	NUM
easat-2032	163	4	.	.	PUNCT
easat-2032	164	1	[	[	X
easat-2032	164	2	13	13	NUM
easat-2032	164	3	]	]	PUNCT
easat-2032	164	4	s.	s.	PROPN
easat-2032	164	5	ewig	ewig	PROPN
easat-2032	164	6	et	et	PROPN
easat-2032	164	7	al	al	PROPN
easat-2032	164	8	.	.	PROPN
easat-2032	164	9	,	,	PUNCT
easat-2032	164	10	“	"	PUNCT
easat-2032	164	11	clinical	clinical	ADJ
easat-2032	164	12	characteristics	characteristic	NOUN
easat-2032	164	13	and	and	CCONJ
easat-2032	164	14	outcome	outcome	NOUN
easat-2032	164	15	of	of	ADP
easat-2032	164	16	pneumocystis	pneumocystis	ADJ
easat-2032	164	17	carinii	carinii	ADJ
easat-2032	164	18	pneumonia	pneumonia	NOUN
easat-2032	164	19	in	in	ADP
easat-2032	164	20	hiv	hiv	PROPN
easat-2032	164	21	-	-	PUNCT
easat-2032	164	22	infected	infect	VERB
easat-2032	164	23	and	and	CCONJ
easat-2032	164	24	otherwise	otherwise	ADV
easat-2032	164	25	immunosuppressed	immunosuppressed	ADJ
easat-2032	164	26	patients	patient	NOUN
easat-2032	164	27	,	,	PUNCT
easat-2032	164	28	”	"	PUNCT
easat-2032	164	29	eur	eur	PROPN
easat-2032	164	30	.	.	PUNCT
easat-2032	164	31	respir	respir	PROPN
easat-2032	164	32	.	.	PUNCT
easat-2032	165	1	j.	j.	PROPN
easat-2032	165	2	,	,	PUNCT
easat-2032	165	3	vol	vol	NOUN
easat-2032	165	4	.	.	PROPN
easat-2032	165	5	8	8	NUM
easat-2032	165	6	,	,	PUNCT
easat-2032	165	7	no	no	INTJ
easat-2032	165	8	.	.	NOUN
easat-2032	165	9	9	9	NUM
easat-2032	165	10	,	,	PUNCT
easat-2032	165	11	pp	pp	ADJ
easat-2032	165	12	.	.	PUNCT
easat-2032	165	13	1548–1553	1548–1553	NUM
easat-2032	165	14	,	,	PUNCT
easat-2032	165	15	1995	1995	NUM
easat-2032	165	16	.	.	PUNCT
easat-2032	166	1	[	[	X
easat-2032	166	2	14	14	NUM
easat-2032	166	3	]	]	PUNCT
easat-2032	166	4	a.	a.	NOUN
easat-2032	166	5	morris	morris	PROPN
easat-2032	166	6	et	et	PROPN
easat-2032	166	7	al	al	PROPN
easat-2032	166	8	.	.	PROPN
easat-2032	166	9	,	,	PUNCT
easat-2032	166	10	“	"	PUNCT
easat-2032	166	11	current	current	ADJ
easat-2032	166	12	epidemiology	epidemiology	NOUN
easat-2032	166	13	of	of	ADP
easat-2032	166	14	pneumocystis	pneumocystis	ADJ
easat-2032	166	15	pneumonia	pneumonia	NOUN
easat-2032	166	16	,	,	PUNCT
easat-2032	166	17	”	"	PUNCT
easat-2032	166	18	emerg	emerg	PROPN
easat-2032	166	19	.	.	PUNCT
easat-2032	167	1	infect	infect	PROPN
easat-2032	167	2	.	.	PUNCT
easat-2032	168	1	dis	dis	PROPN
easat-2032	168	2	.	.	PUNCT
easat-2032	168	3	,	,	PUNCT
easat-2032	168	4	vol	vol	NOUN
easat-2032	168	5	.	.	PROPN
easat-2032	169	1	10	10	NUM
easat-2032	169	2	,	,	PUNCT
easat-2032	169	3	no	no	INTJ
easat-2032	169	4	.	.	NOUN
easat-2032	169	5	10	10	NUM
easat-2032	169	6	,	,	PUNCT
easat-2032	169	7	pp	pp	ADJ
easat-2032	169	8	.	.	PUNCT
easat-2032	170	1	1713	1713	NUM
easat-2032	170	2	–	–	PUNCT
easat-2032	170	3	1720	1720	NUM
easat-2032	170	4	,	,	PUNCT
easat-2032	170	5	2004	2004	NUM
easat-2032	170	6	.	.	PUNCT
easat-2032	171	1	[	[	X
easat-2032	171	2	15	15	NUM
easat-2032	171	3	]	]	X
easat-2032	171	4	e.	e.	PROPN
easat-2032	171	5	dei	dei	PROPN
easat-2032	171	6	-	-	PUNCT
easat-2032	171	7	cas	cas	PROPN
easat-2032	171	8	,	,	PUNCT
easat-2032	171	9	“	"	PUNCT
easat-2032	171	10	pneumocystis	pneumocystis	ADJ
easat-2032	171	11	infections	infection	NOUN
easat-2032	171	12	:	:	PUNCT
easat-2032	171	13	the	the	DET
easat-2032	171	14	iceberg	iceberg	NOUN
easat-2032	171	15	?	?	PUNCT
easat-2032	172	1	medical	medical	ADJ
easat-2032	172	2	mycology	mycology	NOUN
easat-2032	172	3	:	:	PUNCT
easat-2032	172	4	official	official	ADJ
easat-2032	172	5	publication	publication	NOUN
easat-2032	172	6	of	of	ADP
easat-2032	172	7	the	the	DET
easat-2032	172	8	international	international	ADJ
easat-2032	172	9	society	society	NOUN
easat-2032	172	10	for	for	ADP
easat-2032	172	11	,	,	PUNCT
easat-2032	172	12	”	"	PUNCT
easat-2032	172	13	human	human	ADJ
easat-2032	172	14	and	and	CCONJ
easat-2032	172	15	animal	animal	NOUN
easat-2032	172	16	mycology	mycology	NOUN
easat-2032	172	17	,	,	PUNCT
easat-2032	172	18	vol	vol	NOUN
easat-2032	172	19	.	.	PROPN
easat-2032	173	1	38	38	NUM
easat-2032	173	2	,	,	PUNCT
easat-2032	173	3	pp	pp	ADJ
easat-2032	173	4	.	.	PUNCT
easat-2032	174	1	23–32	23–32	NUM
easat-2032	174	2	,	,	PUNCT
easat-2032	174	3	2000	2000	NUM
easat-2032	174	4	.	.	PUNCT
easat-2032	175	1	[	[	X
easat-2032	175	2	16	16	NUM
easat-2032	175	3	]	]	X
easat-2032	175	4	f.	f.	PROPN
easat-2032	175	5	j.	j.	PROPN
easat-2032	175	6	medrano	medrano	PROPN
easat-2032	175	7	et	et	PROPN
easat-2032	175	8	al	al	PROPN
easat-2032	175	9	.	.	PROPN
easat-2032	175	10	,	,	PUNCT
easat-2032	175	11	“	"	PUNCT
easat-2032	175	12	pneumocystis	pneumocystis	ADJ
easat-2032	175	13	jirovecii	jirovecii	NOUN
easat-2032	175	14	in	in	ADP
easat-2032	175	15	general	general	ADJ
easat-2032	175	16	population	population	NOUN
easat-2032	175	17	,	,	PUNCT
easat-2032	175	18	”	"	PUNCT
easat-2032	175	19	emerg	emerg	PROPN
easat-2032	175	20	.	.	PUNCT
easat-2032	176	1	infect	infect	PROPN
easat-2032	176	2	.	.	PUNCT
easat-2032	177	1	dis	dis	PROPN
easat-2032	177	2	.	.	PUNCT
easat-2032	177	3	,	,	PUNCT
easat-2032	177	4	vol	vol	NOUN
easat-2032	177	5	.	.	PROPN
easat-2032	178	1	11	11	NUM
easat-2032	178	2	,	,	PUNCT
easat-2032	178	3	no	no	INTJ
easat-2032	178	4	.	.	NOUN
easat-2032	178	5	2	2	NUM
easat-2032	178	6	,	,	PUNCT
easat-2032	178	7	pp	pp	ADJ
easat-2032	178	8	.	.	PUNCT
easat-2032	179	1	245–250	245–250	NUM
easat-2032	179	2	,	,	PUNCT
easat-2032	179	3	2005	2005	NUM
easat-2032	179	4	.	.	PUNCT
easat-2032	180	1	[	[	X
easat-2032	180	2	17	17	NUM
easat-2032	180	3	]	]	PUNCT
easat-2032	180	4	s.	s.	PROPN
easat-2032	180	5	mori	mori	PROPN
easat-2032	180	6	,	,	PUNCT
easat-2032	180	7	i.	i.	PROPN
easat-2032	180	8	cho	cho	PROPN
easat-2032	180	9	,	,	PUNCT
easat-2032	180	10	and	and	CCONJ
easat-2032	180	11	m.	m.	PROPN
easat-2032	180	12	sugimoto	sugimoto	PROPN
easat-2032	180	13	,	,	PUNCT
easat-2032	180	14	“	"	PUNCT
easat-2032	180	15	a	a	DET
easat-2032	180	16	cluster	cluster	NOUN
easat-2032	180	17	of	of	ADP
easat-2032	180	18	pneumocystis	pneumocystis	ADJ
easat-2032	180	19	jirovecii	jirovecii	ADJ
easat-2032	180	20	infection	infection	NOUN
easat-2032	180	21	among	among	ADP
easat-2032	180	22	outpatients	outpatient	NOUN
easat-2032	180	23	with	with	ADP
easat-2032	180	24	rheumatoid	rheumatoid	NOUN
easat-2032	180	25	arthritis	arthritis	NOUN
easat-2032	180	26	,	,	PUNCT
easat-2032	180	27	”	"	PUNCT
easat-2032	180	28	j.	j.	PROPN
easat-2032	180	29	rheumatol	rheumatol	PROPN
easat-2032	180	30	.	.	PUNCT
easat-2032	180	31	,	,	PUNCT
easat-2032	180	32	vol	vol	NOUN
easat-2032	180	33	.	.	PROPN
easat-2032	180	34	37	37	NUM
easat-2032	180	35	,	,	PUNCT
easat-2032	180	36	no	no	INTJ
easat-2032	180	37	.	.	NOUN
easat-2032	180	38	7	7	NUM
easat-2032	180	39	,	,	PUNCT
easat-2032	180	40	pp	pp	ADJ
easat-2032	180	41	.	.	PUNCT
easat-2032	180	42	1547–1548	1547–1548	NUM
easat-2032	180	43	,	,	PUNCT
easat-2032	180	44	2010	2010	NUM
easat-2032	180	45	.	.	PUNCT
easat-2032	181	1	[	[	X
easat-2032	181	2	18	18	NUM
easat-2032	181	3	]	]	X
easat-2032	181	4	r.	r.	PROPN
easat-2032	181	5	chew	chew	VERB
easat-2032	181	6	et	et	PROPN
easat-2032	181	7	al	al	PROPN
easat-2032	181	8	.	.	PROPN
easat-2032	181	9	,	,	PUNCT
easat-2032	181	10	“	"	PUNCT
easat-2032	181	11	comparing	compare	VERB
easat-2032	181	12	polymerase	polymerase	NOUN
easat-2032	181	13	chain	chain	NOUN
easat-2032	181	14	reaction	reaction	NOUN
easat-2032	181	15	testing	testing	NOUN
easat-2032	181	16	of	of	ADP
easat-2032	181	17	nasopharyngeal	nasopharyngeal	ADJ
easat-2032	181	18	swab	swab	NOUN
easat-2032	181	19	and	and	CCONJ
easat-2032	181	20	lower	low	ADJ
easat-2032	181	21	respiratory	respiratory	ADJ
easat-2032	181	22	tract	tract	NOUN
easat-2032	181	23	specimens	specimen	NOUN
easat-2032	181	24	for	for	ADP
easat-2032	181	25	the	the	DET
easat-2032	181	26	diagnosis	diagnosis	NOUN
easat-2032	181	27	of	of	ADP
easat-2032	181	28	pneumocystis	pneumocystis	ADJ
easat-2032	181	29	jirovecii	jirovecii	NOUN
easat-2032	181	30	pneumonia	pneumonia	NOUN
easat-2032	181	31	,	,	PUNCT
easat-2032	181	32	”	"	PUNCT
easat-2032	181	33	open	open	ADJ
easat-2032	181	34	forum	forum	NOUN
easat-2032	181	35	infect	infect	VERB
easat-2032	181	36	.	.	PUNCT
easat-2032	182	1	dis	dis	PROPN
easat-2032	182	2	.	.	PUNCT
easat-2032	182	3	,	,	PUNCT
easat-2032	182	4	vol	vol	NOUN
easat-2032	182	5	.	.	PROPN
easat-2032	183	1	11	11	NUM
easat-2032	183	2	,	,	PUNCT
easat-2032	183	3	no	no	INTJ
easat-2032	183	4	.	.	NOUN
easat-2032	183	5	3	3	NUM
easat-2032	183	6	,	,	PUNCT
easat-2032	183	7	p.	p.	NOUN
easat-2032	183	8	ofae071	ofae071	PROPN
easat-2032	183	9	,	,	PUNCT
easat-2032	183	10	2024	2024	NUM
easat-2032	183	11	.	.	PUNCT
easat-2032	184	1	[	[	X
easat-2032	184	2	19	19	NUM
easat-2032	184	3	]	]	PUNCT
easat-2032	184	4	l.	l.	PROPN
easat-2032	184	5	huang	huang	PROPN
easat-2032	184	6	et	et	PROPN
easat-2032	184	7	al	al	PROPN
easat-2032	184	8	.	.	PROPN
easat-2032	184	9	,	,	PUNCT
easat-2032	184	10	“	"	PUNCT
easat-2032	184	11	dihydropteroate	dihydropteroate	VERB
easat-2032	184	12	synthase	synthase	NOUN
easat-2032	184	13	gene	gene	NOUN
easat-2032	184	14	mutations	mutation	NOUN
easat-2032	184	15	in	in	ADP
easat-2032	184	16	pneumocystis	pneumocystis	NOUN
easat-2032	184	17	and	and	CCONJ
easat-2032	184	18	sulfa	sulfa	NOUN
easat-2032	184	19	resistance	resistance	NOUN
easat-2032	184	20	,	,	PUNCT
easat-2032	184	21	”	"	PUNCT
easat-2032	184	22	emerg	emerg	PROPN
easat-2032	184	23	.	.	PUNCT
easat-2032	185	1	infect	infect	PROPN
easat-2032	185	2	.	.	PUNCT
easat-2032	186	1	dis	dis	PROPN
easat-2032	186	2	.	.	PUNCT
easat-2032	186	3	,	,	PUNCT
easat-2032	186	4	vol	vol	NOUN
easat-2032	186	5	.	.	PROPN
easat-2032	187	1	10	10	NUM
easat-2032	187	2	,	,	PUNCT
easat-2032	187	3	no	no	INTJ
easat-2032	187	4	.	.	NOUN
easat-2032	187	5	10	10	NUM
easat-2032	187	6	,	,	PUNCT
easat-2032	187	7	pp	pp	ADJ
easat-2032	187	8	.	.	PUNCT
easat-2032	188	1	1721–1728	1721–1728	NUM
easat-2032	188	2	,	,	PUNCT
easat-2032	188	3	2004	2004	NUM
easat-2032	188	4	.	.	PUNCT
easat-2032	189	1	[	[	X
easat-2032	189	2	20	20	NUM
easat-2032	189	3	]	]	PUNCT
easat-2032	189	4	a.	a.	NOUN
easat-2032	189	5	engelmaier	engelmaier	NOUN
easat-2032	189	6	,	,	PUNCT
easat-2032	189	7	h.	h.	PROPN
easat-2032	189	8	a.	a.	PROPN
easat-2032	189	9	butterweck	butterweck	PROPN
easat-2032	189	10	,	,	PUNCT
easat-2032	189	11	and	and	CCONJ
easat-2032	189	12	a.	a.	PROPN
easat-2032	189	13	weber	weber	PROPN
easat-2032	189	14	,	,	PUNCT
easat-2032	189	15	“	"	PUNCT
easat-2032	189	16	stability	stability	NOUN
easat-2032	189	17	assessment	assessment	NOUN
easat-2032	189	18	of	of	ADP
easat-2032	189	19	anti	anti	ADJ
easat-2032	189	20	-	-	ADJ
easat-2032	189	21	bacterial	bacterial	ADJ
easat-2032	189	22	antibodies	antibody	NOUN
easat-2032	189	23	in	in	ADP
easat-2032	189	24	immunoglobulin	immunoglobulin	NOUN
easat-2032	189	25	g	g	NOUN
easat-2032	189	26	-	-	PUNCT
easat-2032	189	27	depleted	deplete	VERB
easat-2032	189	28	serum	serum	NOUN
easat-2032	189	29	with	with	ADP
easat-2032	189	30	validated	validated	ADJ
easat-2032	189	31	immunoassays	immunoassay	NOUN
easat-2032	189	32	,	,	PUNCT
easat-2032	189	33	”	"	PUNCT
easat-2032	189	34	immunotherapy	immunotherapy	NOUN
easat-2032	189	35	,	,	PUNCT
easat-2032	189	36	vol	vol	NOUN
easat-2032	189	37	.	.	PROPN
easat-2032	189	38	15	15	NUM
easat-2032	189	39	,	,	PUNCT
easat-2032	189	40	no	no	INTJ
easat-2032	189	41	.	.	NOUN
easat-2032	189	42	17	17	NUM
easat-2032	189	43	,	,	PUNCT
easat-2032	189	44	pp	pp	ADJ
easat-2032	189	45	.	.	PUNCT
easat-2032	189	46	1459–1476	1459–1476	NUM
easat-2032	189	47	,	,	PUNCT
easat-2032	189	48	2023	2023	NUM
easat-2032	189	49	.	.	PUNCT
easat-2032	190	1	[	[	X
easat-2032	190	2	21	21	NUM
easat-2032	190	3	]	]	PUNCT
easat-2032	190	4	a.	a.	PROPN
easat-2032	190	5	l.	l.	PROPN
easat-2032	190	6	tomás	tomás	PROPN
easat-2032	190	7	,	,	PUNCT
easat-2032	190	8	f.	f.	PROPN
easat-2032	190	9	cardoso	cardoso	PROPN
easat-2032	190	10	,	,	PUNCT
easat-2032	190	11	f.	f.	PROPN
easat-2032	190	12	esteves	esteves	PROPN
easat-2032	190	13	,	,	PUNCT
easat-2032	190	14	and	and	CCONJ
easat-2032	190	15	o.	o.	PROPN
easat-2032	190	16	matos	matos	PROPN
easat-2032	190	17	,	,	PUNCT
easat-2032	190	18	“	"	PUNCT
easat-2032	190	19	serological	serological	ADJ
easat-2032	190	20	diagnosis	diagnosis	NOUN
easat-2032	190	21	of	of	ADP
easat-2032	190	22	pneumocystosis	pneumocystosis	NOUN
easat-2032	190	23	:	:	PUNCT
easat-2032	190	24	production	production	NOUN
easat-2032	190	25	of	of	ADP
easat-2032	190	26	a	a	DET
easat-2032	190	27	synthetic	synthetic	ADJ
easat-2032	190	28	recombinant	recombinant	ADJ
easat-2032	190	29	antigen	antigen	NOUN
easat-2032	190	30	for	for	ADP
easat-2032	190	31	immunodetection	immunodetection	NOUN
easat-2032	190	32	of	of	ADP
easat-2032	190	33	pneumocystis	pneumocystis	ADJ
easat-2032	190	34	jirovecii	jirovecii	NOUN
easat-2032	190	35	,	,	PUNCT
easat-2032	190	36	”	"	PUNCT
easat-2032	190	37	sci	sci	PROPN
easat-2032	190	38	.	.	PROPN
easat-2032	190	39	rep	rep	PROPN
easat-2032	190	40	.	.	PROPN
easat-2032	190	41	,	,	PUNCT
easat-2032	190	42	vol	vol	NOUN
easat-2032	190	43	.	.	PROPN
easat-2032	190	44	6	6	NUM
easat-2032	190	45	,	,	PUNCT
easat-2032	190	46	p.	p.	NOUN
easat-2032	190	47	36287	36287	NUM
easat-2032	190	48	,	,	PUNCT
easat-2032	190	49	2016	2016	NUM
easat-2032	190	50	.	.	PUNCT
easat-2032	191	1	[	[	X
easat-2032	191	2	22	22	NUM
easat-2032	191	3	]	]	PUNCT
easat-2032	191	4	k.	k.	PROPN
easat-2032	191	5	r.	r.	PROPN
easat-2032	191	6	daly	daly	PROPN
easat-2032	191	7	,	,	PUNCT
easat-2032	191	8	j.	j.	PROPN
easat-2032	191	9	koch	koch	PROPN
easat-2032	191	10	,	,	PUNCT
easat-2032	191	11	l.	l.	PROPN
easat-2032	191	12	levin	levin	PROPN
easat-2032	191	13	,	,	PUNCT
easat-2032	191	14	and	and	CCONJ
easat-2032	191	15	p.	p.	PROPN
easat-2032	191	16	d.	d.	PROPN
easat-2032	191	17	walzer	walzer	PROPN
easat-2032	191	18	,	,	PUNCT
easat-2032	191	19	“	"	PUNCT
easat-2032	191	20	enzyme	enzyme	NOUN
easat-2032	191	21	-	-	PUNCT
easat-2032	191	22	linked	link	VERB
easat-2032	191	23	immunosorbent	immunosorbent	ADJ
easat-2032	191	24	assay	assay	NOUN
easat-2032	191	25	and	and	CCONJ
easat-2032	191	26	serologic	serologic	VERB
easat-2032	191	27	responses	response	NOUN
easat-2032	191	28	to	to	ADP
easat-2032	191	29	pneumocystis	pneumocystis	PROPN
easat-2032	191	30	jiroveci	jiroveci	NOUN
easat-2032	191	31	,	,	PUNCT
easat-2032	191	32	”	"	PUNCT
easat-2032	191	33	emerg	emerg	PROPN
easat-2032	191	34	.	.	PUNCT
easat-2032	192	1	infect	infect	PROPN
easat-2032	192	2	.	.	PUNCT
easat-2032	193	1	dis	dis	PROPN
easat-2032	193	2	.	.	PUNCT
easat-2032	193	3	,	,	PUNCT
easat-2032	193	4	vol	vol	NOUN
easat-2032	193	5	.	.	PROPN
easat-2032	194	1	10	10	NUM
easat-2032	194	2	,	,	PUNCT
easat-2032	194	3	no	no	INTJ
easat-2032	194	4	.	.	NOUN
easat-2032	194	5	5	5	NUM
easat-2032	194	6	,	,	PUNCT
easat-2032	194	7	pp	pp	ADJ
easat-2032	194	8	.	.	PUNCT
easat-2032	195	1	848–854	848–854	NUM
easat-2032	195	2	,	,	PUNCT
easat-2032	195	3	2004	2004	NUM
easat-2032	195	4	.	.	PUNCT
easat-2032	196	1	[	[	X
easat-2032	196	2	23	23	NUM
easat-2032	196	3	]	]	PUNCT
easat-2032	196	4	m.	m.	NOUN
easat-2032	196	5	parian	parian	NOUN
easat-2032	196	6	,	,	PUNCT
easat-2032	196	7	a.	a.	NOUN
easat-2032	196	8	fata	fata	PROPN
easat-2032	196	9	,	,	PUNCT
easat-2032	196	10	m.	m.	NOUN
easat-2032	196	11	j.	j.	PROPN
easat-2032	196	12	najafzadeh	najafzadeh	PROPN
easat-2032	196	13	,	,	PUNCT
easat-2032	196	14	and	and	CCONJ
easat-2032	196	15	f.	f.	PROPN
easat-2032	196	16	rezaeitalab	rezaeitalab	PROPN
easat-2032	196	17	,	,	PUNCT
easat-2032	196	18	“	"	PUNCT
easat-2032	196	19	molecular	molecular	ADJ
easat-2032	196	20	detection	detection	NOUN
easat-2032	196	21	of	of	ADP
easat-2032	196	22	pneumocystis	pneumocystis	ADJ
easat-2032	196	23	jirovecii	jirovecii	NOUN
easat-2032	196	24	using	use	VERB
easat-2032	196	25	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
easat-2032	196	26	168	168	NUM
easat-2032	196	27	edelweiss	edelweiss	PROPN
easat-2032	196	28	applied	apply	VERB
easat-2032	196	29	science	science	NOUN
easat-2032	196	30	and	and	CCONJ
easat-2032	196	31	technology	technology	NOUN
easat-2032	196	32	issn	issn	PROPN
easat-2032	196	33	:	:	PUNCT
easat-2032	196	34	2576	2576	NUM
easat-2032	196	35	-	-	SYM
easat-2032	196	36	8484	8484	NUM
easat-2032	196	37	vol	vol	NOUN
easat-2032	196	38	.	.	PROPN
easat-2032	196	39	8	8	NUM
easat-2032	196	40	,	,	PUNCT
easat-2032	196	41	no	no	INTJ
easat-2032	196	42	.	.	NOUN
easat-2032	196	43	6	6	NUM
easat-2032	196	44	:	:	SYM
easat-2032	196	45	163	163	NUM
easat-2032	196	46	-	-	SYM
easat-2032	196	47	168	168	NUM
easat-2032	196	48	,	,	PUNCT
easat-2032	196	49	2024	2024	NUM
easat-2032	196	50	doi	doi	NOUN
easat-2032	196	51	:	:	PUNCT
easat-2032	196	52	10.55214/25768484.v8i6.2032	10.55214/25768484.v8i6.2032	NUM
easat-2032	196	53	©	©	PROPN
easat-2032	196	54	2024	2024	NUM
easat-2032	196	55	by	by	ADP
easat-2032	196	56	the	the	DET
easat-2032	196	57	author	author	NOUN
easat-2032	196	58	;	;	PUNCT
easat-2032	196	59	licensee	licensee	PROPN
easat-2032	196	60	learning	learning	NOUN
easat-2032	196	61	gate	gate	NOUN
easat-2032	196	62	polymerase	polymerase	NOUN
easat-2032	196	63	chain	chain	NOUN
easat-2032	196	64	reaction	reaction	NOUN
easat-2032	196	65	in	in	ADP
easat-2032	196	66	immunocompromised	immunocompromise	VERB
easat-2032	196	67	patients	patient	NOUN
easat-2032	196	68	with	with	ADP
easat-2032	196	69	pulmonary	pulmonary	ADJ
easat-2032	196	70	disorders	disorder	NOUN
easat-2032	196	71	in	in	ADP
easat-2032	196	72	northeast	northeast	ADV
easat-2032	196	73	of	of	ADP
easat-2032	196	74	iran	iran	PROPN
easat-2032	196	75	,	,	PUNCT
easat-2032	196	76	”	"	PUNCT
easat-2032	196	77	curr	curr	X
easat-2032	196	78	.	.	PUNCT
easat-2032	196	79	med	med	PROPN
easat-2032	196	80	.	.	PUNCT
easat-2032	197	1	mycol	mycol	PROPN
easat-2032	197	2	.	.	PUNCT
easat-2032	197	3	,	,	PUNCT
easat-2032	197	4	vol	vol	NOUN
easat-2032	197	5	.	.	PROPN
easat-2032	197	6	1	1	NUM
easat-2032	197	7	,	,	PUNCT
easat-2032	197	8	no	no	INTJ
easat-2032	197	9	.	.	NOUN
easat-2032	197	10	2	2	NUM
easat-2032	197	11	,	,	PUNCT
easat-2032	197	12	pp	pp	ADJ
easat-2032	197	13	.	.	PUNCT
easat-2032	198	1	13–18	13–18	NUM
easat-2032	198	2	,	,	PUNCT
easat-2032	198	3	2015	2015	NUM
easat-2032	198	4	.	.	PUNCT
easat-2032	199	1	[	[	X
easat-2032	199	2	24	24	NUM
easat-2032	199	3	]	]	PUNCT
easat-2032	199	4	m.	m.	NOUN
easat-2032	199	5	j.	j.	PROPN
easat-2032	199	6	alvarez	alvarez	PROPN
easat-2032	199	7	-	-	PUNCT
easat-2032	199	8	martínez	martínez	PROPN
easat-2032	199	9	et	et	PROPN
easat-2032	199	10	al	al	PROPN
easat-2032	199	11	.	.	PROPN
easat-2032	199	12	,	,	PUNCT
easat-2032	199	13	“	"	PUNCT
easat-2032	199	14	sensitivity	sensitivity	NOUN
easat-2032	199	15	and	and	CCONJ
easat-2032	199	16	specificity	specificity	NOUN
easat-2032	199	17	of	of	ADP
easat-2032	199	18	nested	nested	ADJ
easat-2032	199	19	and	and	CCONJ
easat-2032	199	20	real	real	ADJ
easat-2032	199	21	-	-	PUNCT
easat-2032	199	22	time	time	NOUN
easat-2032	199	23	pcr	pcr	NOUN
easat-2032	199	24	for	for	ADP
easat-2032	199	25	the	the	DET
easat-2032	199	26	detection	detection	NOUN
easat-2032	199	27	of	of	ADP
easat-2032	199	28	pneumocystis	pneumocystis	ADJ
easat-2032	199	29	jiroveci	jiroveci	PROPN
easat-2032	199	30	in	in	ADP
easat-2032	199	31	clinical	clinical	ADJ
easat-2032	199	32	specimens	specimen	NOUN
easat-2032	199	33	,	,	PUNCT
easat-2032	199	34	”	"	PUNCT
easat-2032	199	35	diagn	diagn	NOUN
easat-2032	199	36	.	.	PUNCT
easat-2032	200	1	microbiol	microbiol	PROPN
easat-2032	200	2	.	.	PUNCT
easat-2032	201	1	infect	infect	VERB
easat-2032	201	2	.	.	PUNCT
easat-2032	202	1	dis	dis	PROPN
easat-2032	202	2	.	.	PUNCT
easat-2032	202	3	,	,	PUNCT
easat-2032	202	4	vol	vol	NOUN
easat-2032	202	5	.	.	PROPN
easat-2032	203	1	56	56	NUM
easat-2032	203	2	,	,	PUNCT
easat-2032	203	3	no	no	INTJ
easat-2032	203	4	.	.	NOUN
easat-2032	203	5	2	2	NUM
easat-2032	203	6	,	,	PUNCT
easat-2032	203	7	pp	pp	ADJ
easat-2032	203	8	.	.	PUNCT
easat-2032	204	1	153–160	153–160	NUM
easat-2032	204	2	,	,	PUNCT
easat-2032	204	3	2006	2006	NUM
easat-2032	204	4	.	.	PUNCT
easat-2032	205	1	[	[	X
easat-2032	205	2	25	25	NUM
easat-2032	205	3	]	]	PUNCT
easat-2032	205	4	x.	x.	NOUN
easat-2032	205	5	lu	lu	PROPN
easat-2032	205	6	,	,	PUNCT
easat-2032	205	7	j.	j.	PROPN
easat-2032	205	8	zhang	zhang	PROPN
easat-2032	205	9	,	,	PUNCT
easat-2032	205	10	w.	w.	PROPN
easat-2032	205	11	ma	ma	PROPN
easat-2032	205	12	,	,	PUNCT
easat-2032	205	13	l.	l.	PROPN
easat-2032	205	14	xing	xing	PROPN
easat-2032	205	15	,	,	PUNCT
easat-2032	205	16	h.	h.	PROPN
easat-2032	205	17	ning	ning	PROPN
easat-2032	205	18	,	,	PUNCT
easat-2032	205	19	and	and	CCONJ
easat-2032	205	20	m.	m.	NOUN
easat-2032	205	21	yao	yao	PROPN
easat-2032	205	22	,	,	PUNCT
easat-2032	205	23	“	"	PUNCT
easat-2032	205	24	pneumocystis	pneumocystis	ADJ
easat-2032	205	25	jirovecii	jirovecii	ADJ
easat-2032	205	26	pneumonia	pneumonia	NOUN
easat-2032	205	27	diagnosis	diagnosis	NOUN
easat-2032	205	28	via	via	ADP
easat-2032	205	29	metagenomic	metagenomic	ADJ
easat-2032	205	30	next	next	ADJ
easat-2032	205	31	-	-	PUNCT
easat-2032	205	32	generation	generation	NOUN
easat-2032	205	33	sequencing	sequencing	NOUN
easat-2032	205	34	,	,	PUNCT
easat-2032	205	35	”	"	PUNCT
easat-2032	205	36	front	front	NOUN
easat-2032	205	37	.	.	PUNCT
easat-2032	206	1	med	med	PROPN
easat-2032	206	2	.	.	PUNCT
easat-2032	207	1	(	(	PUNCT
easat-2032	207	2	lausanne	lausanne	PROPN
easat-2032	207	3	)	)	PUNCT
easat-2032	207	4	,	,	PUNCT
easat-2032	207	5	vol	vol	NOUN
easat-2032	207	6	.	.	PROPN
easat-2032	207	7	9	9	NUM
easat-2032	207	8	,	,	PUNCT
easat-2032	207	9	p.	p.	NOUN
easat-2032	207	10	812005	812005	NUM
easat-2032	207	11	,	,	PUNCT
easat-2032	207	12	2022	2022	NUM
easat-2032	207	13	.	.	PUNCT
easat-2032	208	1	[	[	X
easat-2032	208	2	26	26	NUM
easat-2032	208	3	]	]	PUNCT
easat-2032	208	4	j.	j.	PROPN
easat-2032	208	5	p.	p.	PROPN
easat-2032	208	6	kanne	kanne	PROPN
easat-2032	208	7	,	,	PUNCT
easat-2032	208	8	d.	d.	PROPN
easat-2032	208	9	r.	r.	PROPN
easat-2032	208	10	yandow	yandow	PROPN
easat-2032	208	11	,	,	PUNCT
easat-2032	208	12	and	and	CCONJ
easat-2032	208	13	c.	c.	PROPN
easat-2032	208	14	a.	a.	PROPN
easat-2032	208	15	meyer	meyer	PROPN
easat-2032	208	16	,	,	PUNCT
easat-2032	208	17	“	"	PUNCT
easat-2032	208	18	pneumocystis	pneumocystis	ADJ
easat-2032	208	19	jiroveci	jiroveci	PROPN
easat-2032	208	20	pneumonia	pneumonia	NOUN
easat-2032	208	21	:	:	PUNCT
easat-2032	208	22	high	high	ADJ
easat-2032	208	23	-	-	PUNCT
easat-2032	208	24	resolution	resolution	NOUN
easat-2032	208	25	ct	ct	PROPN
easat-2032	208	26	findings	finding	NOUN
easat-2032	208	27	in	in	ADP
easat-2032	208	28	patients	patient	NOUN
easat-2032	208	29	with	with	ADP
easat-2032	208	30	and	and	CCONJ
easat-2032	208	31	without	without	ADP
easat-2032	208	32	hiv	hiv	PROPN
easat-2032	208	33	infection	infection	NOUN
easat-2032	208	34	,	,	PUNCT
easat-2032	208	35	”	"	PUNCT
easat-2032	208	36	ajr	ajr	PROPN
easat-2032	208	37	am	be	AUX
easat-2032	208	38	.	.	PUNCT
easat-2032	209	1	j.	j.	PROPN
easat-2032	209	2	roentgenol	roentgenol	PROPN
easat-2032	209	3	.	.	PUNCT
easat-2032	209	4	,	,	PUNCT
easat-2032	209	5	vol	vol	NOUN
easat-2032	209	6	.	.	PROPN
easat-2032	209	7	198	198	NUM
easat-2032	209	8	,	,	PUNCT
easat-2032	209	9	no	no	INTJ
easat-2032	209	10	.	.	NOUN
easat-2032	209	11	6	6	NUM
easat-2032	209	12	,	,	PUNCT
easat-2032	209	13	pp	pp	ADJ
easat-2032	209	14	.	.	PUNCT
easat-2032	210	1	w555	w555	NUM
easat-2032	210	2	-	-	PUNCT
easat-2032	210	3	61	61	NUM
easat-2032	210	4	,	,	PUNCT
easat-2032	210	5	2012	2012	NUM
easat-2032	210	6	.	.	PUNCT
easat-2032	211	1	[	[	X
easat-2032	211	2	27	27	NUM
easat-2032	211	3	]	]	X
easat-2032	211	4	h.	h.	PROPN
easat-2032	211	5	yu	yu	PROPN
easat-2032	211	6	et	et	PROPN
easat-2032	211	7	al	al	PROPN
easat-2032	211	8	.	.	PROPN
easat-2032	211	9	,	,	PUNCT
easat-2032	211	10	“	"	PUNCT
easat-2032	211	11	computed	compute	VERB
easat-2032	211	12	tomography	tomography	NOUN
easat-2032	211	13	-	-	PUNCT
easat-2032	211	14	based	base	VERB
easat-2032	211	15	radiomics	radiomic	NOUN
easat-2032	211	16	improves	improve	VERB
easat-2032	211	17	non	non	ADJ
easat-2032	211	18	-	-	ADJ
easat-2032	211	19	invasive	invasive	ADJ
easat-2032	211	20	diagnosis	diagnosis	NOUN
easat-2032	211	21	of	of	ADP
easat-2032	211	22	pneumocystis	pneumocystis	ADJ
easat-2032	211	23	jirovecii	jirovecii	ADJ
easat-2032	211	24	pneumonia	pneumonia	NOUN
easat-2032	211	25	in	in	ADP
easat-2032	211	26	non	non	ADJ
easat-2032	211	27	-	-	ADJ
easat-2032	211	28	hiv	hiv	ADJ
easat-2032	211	29	patients	patient	NOUN
easat-2032	211	30	:	:	PUNCT
easat-2032	211	31	a	a	DET
easat-2032	211	32	retrospective	retrospective	ADJ
easat-2032	211	33	study	study	NOUN
easat-2032	211	34	,	,	PUNCT
easat-2032	211	35	”	"	PUNCT
easat-2032	211	36	bmc	bmc	NOUN
easat-2032	211	37	pulm	pulm	NOUN
easat-2032	211	38	.	.	PUNCT
easat-2032	212	1	med	med	PROPN
easat-2032	212	2	.	.	PROPN
easat-2032	212	3	,	,	PUNCT
easat-2032	212	4	vol	vol	NOUN
easat-2032	212	5	.	.	PROPN
easat-2032	213	1	24	24	NUM
easat-2032	213	2	,	,	PUNCT
easat-2032	213	3	no	no	INTJ
easat-2032	213	4	.	.	NOUN
easat-2032	213	5	1	1	NUM
easat-2032	213	6	,	,	PUNCT
easat-2032	213	7	p.	p.	NOUN
easat-2032	213	8	11	11	NUM
easat-2032	213	9	,	,	PUNCT
easat-2032	213	10	2024	2024	NUM
easat-2032	213	11	.	.	PUNCT
easat-2032	214	1	[	[	X
easat-2032	214	2	28	28	NUM
easat-2032	214	3	]	]	X
easat-2032	214	4	x.	x.	NOUN
easat-2032	214	5	li	li	PROPN
easat-2032	214	6	,	,	PUNCT
easat-2032	214	7	x.	x.	PROPN
easat-2032	214	8	xiong	xiong	PROPN
easat-2032	214	9	,	,	PUNCT
easat-2032	214	10	z.	z.	PROPN
easat-2032	214	11	liang	liang	PROPN
easat-2032	214	12	,	,	PUNCT
easat-2032	214	13	and	and	CCONJ
easat-2032	214	14	y.	y.	PROPN
easat-2032	214	15	tang	tang	PROPN
easat-2032	214	16	,	,	PUNCT
easat-2032	214	17	“	"	PUNCT
easat-2032	214	18	a	a	DET
easat-2032	214	19	machine	machine	NOUN
easat-2032	214	20	learning	learn	VERB
easat-2032	214	21	diagnostic	diagnostic	ADJ
easat-2032	214	22	model	model	NOUN
easat-2032	214	23	for	for	ADP
easat-2032	214	24	pneumocystis	pneumocystis	ADJ
easat-2032	214	25	jirovecii	jirovecii	ADJ
easat-2032	214	26	pneumonia	pneumonia	NOUN
easat-2032	214	27	in	in	ADP
easat-2032	214	28	patients	patient	NOUN
easat-2032	214	29	with	with	ADP
easat-2032	214	30	severe	severe	ADJ
easat-2032	214	31	pneumonia	pneumonia	NOUN
easat-2032	214	32	,	,	PUNCT
easat-2032	214	33	”	"	PUNCT
easat-2032	214	34	intern	intern	NOUN
easat-2032	214	35	.	.	PUNCT
easat-2032	215	1	emerg	emerg	PROPN
easat-2032	215	2	.	.	PUNCT
easat-2032	216	1	med	med	PROPN
easat-2032	216	2	.	.	PROPN
easat-2032	216	3	,	,	PUNCT
easat-2032	216	4	vol	vol	NOUN
easat-2032	216	5	.	.	PROPN
easat-2032	216	6	18	18	NUM
easat-2032	216	7	,	,	PUNCT
easat-2032	216	8	no	no	INTJ
easat-2032	216	9	.	.	NOUN
easat-2032	216	10	6	6	NUM
easat-2032	216	11	,	,	PUNCT
easat-2032	216	12	pp	pp	ADJ
easat-2032	216	13	.	.	PUNCT
easat-2032	217	1	1741–1749	1741–1749	NUM
easat-2032	217	2	,	,	PUNCT
easat-2032	217	3	2023	2023	NUM
easat-2032	217	4	.	.	PUNCT
easat-2032	218	1	[	[	X
easat-2032	218	2	29	29	NUM
easat-2032	218	3	]	]	X
easat-2032	218	4	e.	e.	PROPN
easat-2032	218	5	g.	g.	PROPN
easat-2032	218	6	mcdonald	mcdonald	PROPN
easat-2032	218	7	et	et	PROPN
easat-2032	218	8	al	al	PROPN
easat-2032	218	9	.	.	PROPN
easat-2032	218	10	,	,	PUNCT
easat-2032	218	11	“	"	PUNCT
easat-2032	218	12	pneumocystis	pneumocystis	ADJ
easat-2032	218	13	jirovecii	jirovecii	ADJ
easat-2032	218	14	pneumonia	pneumonia	NOUN
easat-2032	218	15	in	in	ADP
easat-2032	218	16	people	people	NOUN
easat-2032	218	17	living	live	VERB
easat-2032	218	18	with	with	ADP
easat-2032	218	19	hiv	hiv	PROPN
easat-2032	218	20	:	:	PUNCT
easat-2032	218	21	a	a	DET
easat-2032	218	22	review	review	NOUN
easat-2032	218	23	,	,	PUNCT
easat-2032	218	24	”	"	PUNCT
easat-2032	218	25	clin	clin	PROPN
easat-2032	218	26	.	.	PUNCT
easat-2032	219	1	microbiol	microbiol	PROPN
easat-2032	219	2	.	.	PUNCT
easat-2032	220	1	rev	rev	PROPN
easat-2032	220	2	.	.	PROPN
easat-2032	220	3	,	,	PUNCT
easat-2032	220	4	vol	vol	NOUN
easat-2032	220	5	.	.	PROPN
easat-2032	221	1	37	37	NUM
easat-2032	221	2	,	,	PUNCT
easat-2032	221	3	no	no	INTJ
easat-2032	221	4	.	.	NOUN
easat-2032	221	5	1	1	NUM
easat-2032	221	6	,	,	PUNCT
easat-2032	221	7	p.	p.	NOUN
easat-2032	221	8	e0010122	e0010122	PROPN
easat-2032	221	9	,	,	PUNCT
easat-2032	221	10	2024	2024	NUM
easat-2032	221	11	.	.	PUNCT
easat-2032	222	1	[	[	X
easat-2032	222	2	30	30	NUM
easat-2032	222	3	]	]	PUNCT
easat-2032	222	4	a.	a.	NOUN
easat-2032	222	5	h.	h.	PROPN
easat-2032	222	6	limper	limper	PROPN
easat-2032	222	7	et	et	PROPN
easat-2032	222	8	al	al	PROPN
easat-2032	222	9	.	.	PROPN
easat-2032	222	10	,	,	PUNCT
easat-2032	222	11	“	"	PUNCT
easat-2032	222	12	an	an	DET
easat-2032	222	13	official	official	ADJ
easat-2032	222	14	american	american	ADJ
easat-2032	222	15	thoracic	thoracic	NOUN
easat-2032	222	16	society	society	PROPN
easat-2032	222	17	statement	statement	NOUN
easat-2032	222	18	:	:	PUNCT
easat-2032	222	19	treatment	treatment	NOUN
easat-2032	222	20	of	of	ADP
easat-2032	222	21	fungal	fungal	ADJ
easat-2032	222	22	infections	infection	NOUN
easat-2032	222	23	in	in	ADP
easat-2032	222	24	adult	adult	NOUN
easat-2032	222	25	pulmonary	pulmonary	NOUN
easat-2032	222	26	and	and	CCONJ
easat-2032	222	27	critical	critical	ADJ
easat-2032	222	28	care	care	NOUN
easat-2032	222	29	patients	patient	NOUN
easat-2032	222	30	,	,	PUNCT
easat-2032	222	31	”	"	PUNCT
easat-2032	222	32	am	be	AUX
easat-2032	222	33	.	.	PUNCT
easat-2032	223	1	j.	j.	PROPN
easat-2032	223	2	respir	respir	PROPN
easat-2032	223	3	.	.	PUNCT
easat-2032	224	1	crit	crit	PROPN
easat-2032	224	2	.	.	PUNCT
easat-2032	225	1	care	care	PROPN
easat-2032	225	2	med	med	PROPN
easat-2032	225	3	.	.	PROPN
easat-2032	225	4	,	,	PUNCT
easat-2032	225	5	vol	vol	NOUN
easat-2032	225	6	.	.	PROPN
easat-2032	226	1	183	183	NUM
easat-2032	226	2	,	,	PUNCT
easat-2032	226	3	no	no	INTJ
easat-2032	226	4	.	.	NOUN
easat-2032	226	5	1	1	NUM
easat-2032	226	6	,	,	PUNCT
easat-2032	226	7	pp	pp	ADJ
easat-2032	226	8	.	.	PUNCT
easat-2032	227	1	96–128	96–128	NUM
easat-2032	227	2	,	,	PUNCT
easat-2032	227	3	2011	2011	NUM
easat-2032	227	4	.	.	PUNCT
easat-2032	228	1	[	[	X
easat-2032	228	2	31	31	NUM
easat-2032	228	3	]	]	PUNCT
easat-2032	228	4	h.	h.	PROPN
easat-2032	228	5	ewald	ewald	PROPN
easat-2032	228	6	,	,	PUNCT
easat-2032	228	7	h.	h.	PROPN
easat-2032	228	8	raatz	raatz	PROPN
easat-2032	228	9	,	,	PUNCT
easat-2032	228	10	r.	r.	PROPN
easat-2032	228	11	boscacci	boscacci	PROPN
easat-2032	228	12	,	,	PUNCT
easat-2032	228	13	h.	h.	PROPN
easat-2032	228	14	furrer	furrer	PROPN
easat-2032	228	15	,	,	PUNCT
easat-2032	228	16	h.	h.	PROPN
easat-2032	228	17	c.	c.	PROPN
easat-2032	228	18	bucher	bucher	PROPN
easat-2032	228	19	,	,	PUNCT
easat-2032	228	20	and	and	CCONJ
easat-2032	228	21	m.	m.	PROPN
easat-2032	228	22	briel	briel	PROPN
easat-2032	228	23	,	,	PUNCT
easat-2032	228	24	adjunctive	adjunctive	ADJ
easat-2032	228	25	corticosteroids	corticosteroid	NOUN
easat-2032	228	26	for	for	ADP
easat-2032	228	27	pneumocystis	pneumocystis	ADJ
easat-2032	228	28	jiroveci	jiroveci	PROPN
easat-2032	228	29	pneumonia	pneumonia	NOUN
easat-2032	228	30	in	in	ADP
easat-2032	228	31	patients	patient	NOUN
easat-2032	228	32	with	with	ADP
easat-2032	228	33	hiv	hiv	PROPN
easat-2032	228	34	infection	infection	NOUN
easat-2032	228	35	.	.	PUNCT
easat-2032	229	1	the	the	DET
easat-2032	229	2	cochrane	cochrane	PROPN
easat-2032	229	3	database	database	NOUN
easat-2032	229	4	of	of	ADP
easat-2032	229	5	systematic	systematic	ADJ
easat-2032	229	6	reviews	review	NOUN
easat-2032	229	7	.	.	PUNCT
easat-2032	229	8	2015	2015	NUM
easat-2032	229	9	.	.	PUNCT
easat-2032	230	1	[	[	X
easat-2032	230	2	32	32	NUM
easat-2032	230	3	]	]	PUNCT
easat-2032	230	4	l.	l.	PROPN
easat-2032	230	5	ding	ding	PROPN
easat-2032	230	6	,	,	PUNCT
easat-2032	230	7	h.	h.	PROPN
easat-2032	230	8	huang	huang	PROPN
easat-2032	230	9	,	,	PUNCT
easat-2032	230	10	h.	h.	PROPN
easat-2032	230	11	wang	wang	PROPN
easat-2032	230	12	,	,	PUNCT
easat-2032	230	13	and	and	CCONJ
easat-2032	230	14	h.	h.	PROPN
easat-2032	230	15	he	he	PRON
easat-2032	230	16	,	,	PUNCT
easat-2032	230	17	“	"	PUNCT
easat-2032	230	18	adjunctive	adjunctive	ADJ
easat-2032	230	19	corticosteroids	corticosteroid	NOUN
easat-2032	230	20	may	may	AUX
easat-2032	230	21	be	be	AUX
easat-2032	230	22	associated	associate	VERB
easat-2032	230	23	with	with	ADP
easat-2032	230	24	better	well	ADJ
easat-2032	230	25	outcome	outcome	NOUN
easat-2032	230	26	for	for	ADP
easat-2032	230	27	nonhiv	nonhiv	PROPN
easat-2032	230	28	pneumocystis	pneumocystis	ADJ
easat-2032	230	29	pneumonia	pneumonia	NOUN
easat-2032	230	30	with	with	ADP
easat-2032	230	31	respiratory	respiratory	ADJ
easat-2032	230	32	failure	failure	NOUN
easat-2032	230	33	:	:	PUNCT
easat-2032	230	34	a	a	DET
easat-2032	230	35	systemic	systemic	ADJ
easat-2032	230	36	review	review	NOUN
easat-2032	230	37	and	and	CCONJ
easat-2032	230	38	meta	meta	NOUN
easat-2032	230	39	-	-	PUNCT
easat-2032	230	40	analysis	analysis	NOUN
easat-2032	230	41	of	of	ADP
easat-2032	230	42	observational	observational	ADJ
easat-2032	230	43	studies	study	NOUN
easat-2032	230	44	,	,	PUNCT
easat-2032	230	45	”	"	PUNCT
easat-2032	230	46	ann	ann	PROPN
easat-2032	230	47	.	.	PUNCT
easat-2032	230	48	intensive	intensive	ADJ
easat-2032	230	49	care	care	NOUN
easat-2032	230	50	,	,	PUNCT
easat-2032	230	51	vol	vol	NOUN
easat-2032	230	52	.	.	PROPN
easat-2032	231	1	10	10	NUM
easat-2032	231	2	,	,	PUNCT
easat-2032	231	3	no	no	INTJ
easat-2032	231	4	.	.	NOUN
easat-2032	231	5	1	1	NUM
easat-2032	231	6	,	,	PUNCT
easat-2032	231	7	p.	p.	NOUN
easat-2032	231	8	34	34	NUM
easat-2032	231	9	,	,	PUNCT
easat-2032	231	10	2020	2020	NUM
easat-2032	231	11	.	.	PUNCT
easat-2032	232	1	[	[	X
easat-2032	232	2	33	33	NUM
easat-2032	232	3	]	]	PUNCT
easat-2032	232	4	l.	l.	PROPN
easat-2032	232	5	newberry	newberry	PROPN
easat-2032	232	6	,	,	PUNCT
easat-2032	232	7	b.	b.	PROPN
easat-2032	232	8	ohare	ohare	PROPN
easat-2032	232	9	,	,	PUNCT
easat-2032	232	10	n.	n.	PROPN
easat-2032	232	11	kennedy	kennedy	PROPN
easat-2032	232	12	,	,	PUNCT
easat-2032	232	13	a.	a.	NOUN
easat-2032	232	14	selman	selman	PROPN
easat-2032	232	15	,	,	PUNCT
easat-2032	232	16	s.	s.	PROPN
easat-2032	232	17	omar	omar	PROPN
easat-2032	232	18	,	,	PUNCT
easat-2032	232	19	and	and	CCONJ
easat-2032	232	20	p.	p.	PROPN
easat-2032	232	21	dawson	dawson	PROPN
easat-2032	232	22	,	,	PUNCT
easat-2032	232	23	“	"	PUNCT
easat-2032	232	24	early	early	ADJ
easat-2032	232	25	use	use	NOUN
easat-2032	232	26	of	of	ADP
easat-2032	232	27	corticosteroids	corticosteroid	NOUN
easat-2032	232	28	in	in	ADP
easat-2032	232	29	infants	infant	NOUN
easat-2032	232	30	with	with	ADP
easat-2032	232	31	a	a	DET
easat-2032	232	32	clinical	clinical	ADJ
easat-2032	232	33	diagnosis	diagnosis	NOUN
easat-2032	232	34	of	of	ADP
easat-2032	232	35	pneumocystis	pneumocystis	ADJ
easat-2032	232	36	jiroveci	jiroveci	PROPN
easat-2032	232	37	pneumonia	pneumonia	NOUN
easat-2032	232	38	in	in	ADP
easat-2032	232	39	malawi	malawi	PROPN
easat-2032	232	40	:	:	PUNCT
easat-2032	232	41	a	a	DET
easat-2032	232	42	double	double	ADJ
easat-2032	232	43	-	-	PUNCT
easat-2032	232	44	blind	blind	ADJ
easat-2032	232	45	,	,	PUNCT
easat-2032	232	46	randomized	randomize	VERB
easat-2032	232	47	clinical	clinical	ADJ
easat-2032	232	48	trial	trial	NOUN
easat-2032	232	49	,	,	PUNCT
easat-2032	232	50	”	"	PUNCT
easat-2032	232	51	paediatrics	paediatric	NOUN
easat-2032	232	52	and	and	CCONJ
easat-2032	232	53	international	international	ADJ
easat-2032	232	54	child	child	NOUN
easat-2032	232	55	health	health	NOUN
easat-2032	232	56	,	,	PUNCT
easat-2032	232	57	vol	vol	NOUN
easat-2032	232	58	.	.	PROPN
easat-2032	232	59	37	37	NUM
easat-2032	232	60	,	,	PUNCT
easat-2032	232	61	pp	pp	ADJ
easat-2032	232	62	.	.	PUNCT
easat-2032	233	1	121–128	121–128	NUM
easat-2032	233	2	,	,	PUNCT
easat-2032	233	3	2017	2017	NUM
easat-2032	233	4	.	.	PUNCT
easat-2032	234	1	[	[	X
easat-2032	234	2	34	34	NUM
easat-2032	234	3	]	]	PUNCT
easat-2032	234	4	z.	z.	PROPN
easat-2032	234	5	hoy	hoy	PROPN
easat-2032	234	6	et	et	PROPN
easat-2032	234	7	al	al	PROPN
easat-2032	234	8	.	.	PROPN
easat-2032	234	9	,	,	PUNCT
easat-2032	234	10	“	"	PUNCT
easat-2032	234	11	combination	combination	NOUN
easat-2032	234	12	immunotherapy	immunotherapy	NOUN
easat-2032	234	13	with	with	ADP
easat-2032	234	14	passive	passive	ADJ
easat-2032	234	15	antibody	antibody	NOUN
easat-2032	234	16	and	and	CCONJ
easat-2032	234	17	sulfasalazine	sulfasalazine	NOUN
easat-2032	234	18	accelerates	accelerate	VERB
easat-2032	234	19	fungal	fungal	ADJ
easat-2032	234	20	clearance	clearance	NOUN
easat-2032	234	21	and	and	CCONJ
easat-2032	234	22	promotes	promote	VERB
easat-2032	234	23	the	the	DET
easat-2032	234	24	resolution	resolution	NOUN
easat-2032	234	25	of	of	ADP
easat-2032	234	26	pneumocystis	pneumocystis	NOUN
easat-2032	234	27	-	-	PUNCT
easat-2032	234	28	associated	associate	VERB
easat-2032	234	29	immunopathogenesis	immunopathogenesis	NOUN
easat-2032	234	30	,	,	PUNCT
easat-2032	234	31	”	"	PUNCT
easat-2032	234	32	infect	infect	NOUN
easat-2032	234	33	.	.	PUNCT
easat-2032	235	1	immun	immun	PROPN
easat-2032	235	2	.	.	PROPN
easat-2032	235	3	,	,	PUNCT
easat-2032	235	4	vol	vol	NOUN
easat-2032	235	5	.	.	PROPN
easat-2032	235	6	88	88	NUM
easat-2032	235	7	,	,	PUNCT
easat-2032	235	8	no	no	INTJ
easat-2032	235	9	.	.	NOUN
easat-2032	235	10	2	2	NUM
easat-2032	235	11	,	,	PUNCT
easat-2032	235	12	2020	2020	NUM
easat-2032	235	13	.	.	PUNCT
easat-2032	236	1	[	[	X
easat-2032	236	2	35	35	NUM
easat-2032	236	3	]	]	PUNCT
easat-2032	236	4	a.	a.	PROPN
easat-2032	236	5	d.	d.	PROPN
easat-2032	236	6	gingerich	gingerich	PROPN
easat-2032	236	7	,	,	PUNCT
easat-2032	236	8	k.	k.	PROPN
easat-2032	236	9	a.	a.	PROPN
easat-2032	236	10	norris	norris	PROPN
easat-2032	236	11	,	,	PUNCT
easat-2032	236	12	and	and	CCONJ
easat-2032	236	13	j.	j.	PROPN
easat-2032	236	14	j.	j.	PROPN
easat-2032	236	15	mousa	mousa	PROPN
easat-2032	236	16	,	,	PUNCT
easat-2032	236	17	“	"	PUNCT
easat-2032	236	18	pneumocystis	pneumocystis	ADJ
easat-2032	236	19	pneumonia	pneumonia	NOUN
easat-2032	236	20	:	:	PUNCT
easat-2032	236	21	immunity	immunity	NOUN
easat-2032	236	22	,	,	PUNCT
easat-2032	236	23	vaccines	vaccine	NOUN
easat-2032	236	24	,	,	PUNCT
easat-2032	236	25	and	and	CCONJ
easat-2032	236	26	treatments	treatment	NOUN
easat-2032	236	27	,	,	PUNCT
easat-2032	236	28	”	"	PUNCT
easat-2032	236	29	pathogens	pathogen	NOUN
easat-2032	236	30	,	,	PUNCT
easat-2032	236	31	vol	vol	NOUN
easat-2032	236	32	.	.	PROPN
easat-2032	236	33	10	10	NUM
easat-2032	236	34	,	,	PUNCT
easat-2032	236	35	no	no	INTJ
easat-2032	236	36	.	.	NOUN
easat-2032	236	37	2	2	NUM
easat-2032	236	38	,	,	PUNCT
easat-2032	236	39	p.	p.	NOUN
easat-2032	236	40	236	236	NUM
easat-2032	236	41	,	,	PUNCT
easat-2032	236	42	2021	2021	NUM
easat-2032	236	43	.	.	PUNCT
easat-2032	237	1	[	[	X
easat-2032	237	2	36	36	NUM
easat-2032	237	3	]	]	PUNCT
easat-2032	237	4	a.	a.	NOUN
easat-2032	237	5	g.	g.	PROPN
easat-2032	237	6	harmsen	harmsen	PROPN
easat-2032	237	7	,	,	PUNCT
easat-2032	237	8	w.	w.	PROPN
easat-2032	237	9	chen	chen	PROPN
easat-2032	237	10	,	,	PUNCT
easat-2032	237	11	and	and	CCONJ
easat-2032	237	12	f.	f.	PROPN
easat-2032	237	13	gigliotti	gigliotti	PROPN
easat-2032	237	14	,	,	PUNCT
easat-2032	237	15	“	"	PUNCT
easat-2032	237	16	active	active	ADJ
easat-2032	237	17	immunity	immunity	NOUN
easat-2032	237	18	to	to	ADP
easat-2032	237	19	pneumocystis	pneumocystis	ADJ
easat-2032	237	20	carinii	carinii	ADJ
easat-2032	237	21	reinfection	reinfection	NOUN
easat-2032	237	22	in	in	ADP
easat-2032	237	23	t	t	NOUN
easat-2032	237	24	-	-	PUNCT
easat-2032	237	25	cell	cell	NOUN
easat-2032	237	26	-	-	PUNCT
easat-2032	237	27	depleted	deplete	VERB
easat-2032	237	28	mice	mouse	NOUN
easat-2032	237	29	,	,	PUNCT
easat-2032	237	30	”	"	PUNCT
easat-2032	237	31	infect	infect	VERB
easat-2032	237	32	.	.	PUNCT
easat-2032	238	1	immun	immun	PROPN
easat-2032	238	2	.	.	PROPN
easat-2032	238	3	,	,	PUNCT
easat-2032	238	4	vol	vol	NOUN
easat-2032	238	5	.	.	PROPN
easat-2032	238	6	63	63	NUM
easat-2032	238	7	,	,	PUNCT
easat-2032	238	8	no	no	INTJ
easat-2032	238	9	.	.	NOUN
easat-2032	238	10	7	7	NUM
easat-2032	238	11	,	,	PUNCT
easat-2032	238	12	pp	pp	ADJ
easat-2032	238	13	.	.	PUNCT
easat-2032	239	1	2391–2395	2391–2395	NUM
easat-2032	239	2	,	,	PUNCT
easat-2032	239	3	1995	1995	NUM
easat-2032	239	4	.	.	PUNCT
easat-2032	240	1	[	[	X
easat-2032	240	2	37	37	NUM
easat-2032	240	3	]	]	PUNCT
easat-2032	240	4	j.	j.	PROPN
easat-2032	240	5	m.	m.	PROPN
easat-2032	240	6	pascale	pascale	PROPN
easat-2032	240	7	et	et	PROPN
easat-2032	240	8	al	al	PROPN
easat-2032	240	9	.	.	PROPN
easat-2032	240	10	,	,	PUNCT
easat-2032	240	11	“	"	PUNCT
easat-2032	240	12	intranasal	intranasal	ADJ
easat-2032	240	13	immunization	immunization	NOUN
easat-2032	240	14	confers	confer	NOUN
easat-2032	240	15	protection	protection	NOUN
easat-2032	240	16	against	against	ADP
easat-2032	240	17	murine	murine	ADJ
easat-2032	240	18	pneumocystis	pneumocystis	ADJ
easat-2032	240	19	carinii	carinii	ADJ
easat-2032	240	20	lung	lung	NOUN
easat-2032	240	21	infection	infection	NOUN
easat-2032	240	22	,	,	PUNCT
easat-2032	240	23	”	"	PUNCT
easat-2032	240	24	infect	infect	VERB
easat-2032	240	25	.	.	PUNCT
easat-2032	241	1	immun	immun	PROPN
easat-2032	241	2	.	.	PROPN
easat-2032	241	3	,	,	PUNCT
easat-2032	241	4	vol	vol	NOUN
easat-2032	241	5	.	.	PROPN
easat-2032	241	6	67	67	NUM
easat-2032	241	7	,	,	PUNCT
easat-2032	241	8	no	no	INTJ
easat-2032	241	9	.	.	NOUN
easat-2032	241	10	2	2	NUM
easat-2032	241	11	,	,	PUNCT
easat-2032	241	12	pp	pp	ADJ
easat-2032	241	13	.	.	PUNCT
easat-2032	242	1	805–809	805–809	NUM
easat-2032	242	2	,	,	PUNCT
easat-2032	242	3	1999	1999	NUM
easat-2032	242	4	.	.	PUNCT
easat-2032	243	1	[	[	X
easat-2032	243	2	38	38	NUM
easat-2032	243	3	]	]	PUNCT
easat-2032	243	4	b.	b.	PROPN
easat-2032	243	5	a.	a.	NOUN
easat-2032	243	6	garvy	garvy	PROPN
easat-2032	243	7	,	,	PUNCT
easat-2032	243	8	j.	j.	PROPN
easat-2032	243	9	a.	a.	PROPN
easat-2032	243	10	wiley	wiley	PROPN
easat-2032	243	11	,	,	PUNCT
easat-2032	243	12	f.	f.	PROPN
easat-2032	243	13	gigliotti	gigliotti	PROPN
easat-2032	243	14	,	,	PUNCT
easat-2032	243	15	and	and	CCONJ
easat-2032	243	16	a.	a.	PROPN
easat-2032	243	17	g.	g.	PROPN
easat-2032	243	18	harmsen	harmsen	PROPN
easat-2032	243	19	,	,	PUNCT
easat-2032	243	20	“	"	PUNCT
easat-2032	243	21	protection	protection	NOUN
easat-2032	243	22	against	against	ADP
easat-2032	243	23	pneumocystis	pneumocystis	ADJ
easat-2032	243	24	carinii	carinii	ADJ
easat-2032	243	25	pneumonia	pneumonia	NOUN
easat-2032	243	26	by	by	ADP
easat-2032	243	27	antibodies	antibody	NOUN
easat-2032	243	28	generated	generate	VERB
easat-2032	243	29	from	from	ADP
easat-2032	243	30	either	either	CCONJ
easat-2032	243	31	t	t	PROPN
easat-2032	243	32	helper	helper	NOUN
easat-2032	243	33	1	1	NUM
easat-2032	243	34	or	or	CCONJ
easat-2032	243	35	t	t	PROPN
easat-2032	243	36	helper	helper	NOUN
easat-2032	243	37	2	2	NUM
easat-2032	243	38	responses	response	NOUN
easat-2032	243	39	,	,	PUNCT
easat-2032	243	40	”	"	PUNCT
easat-2032	243	41	infect	infect	NOUN
easat-2032	243	42	.	.	PUNCT
easat-2032	244	1	immun	immun	PROPN
easat-2032	244	2	.	.	PROPN
easat-2032	244	3	,	,	PUNCT
easat-2032	244	4	vol	vol	NOUN
easat-2032	244	5	.	.	PROPN
easat-2032	244	6	65	65	NUM
easat-2032	244	7	,	,	PUNCT
easat-2032	244	8	no	no	INTJ
easat-2032	244	9	.	.	NOUN
easat-2032	244	10	12	12	NUM
easat-2032	244	11	,	,	PUNCT
easat-2032	244	12	pp	pp	ADJ
easat-2032	244	13	.	.	PUNCT
easat-2032	245	1	5052–5056	5052–5056	NUM
easat-2032	245	2	,	,	PUNCT
easat-2032	245	3	1997	1997	NUM
easat-2032	245	4	.	.	PUNCT
easat-2032	246	1	[	[	X
easat-2032	246	2	39	39	NUM
easat-2032	246	3	]	]	PUNCT
easat-2032	246	4	f.	f.	PROPN
easat-2032	246	5	gigliotti	gigliotti	PROPN
easat-2032	246	6	,	,	PUNCT
easat-2032	246	7	j.	j.	PROPN
easat-2032	246	8	a.	a.	PROPN
easat-2032	246	9	wiley	wiley	PROPN
easat-2032	246	10	,	,	PUNCT
easat-2032	246	11	and	and	CCONJ
easat-2032	246	12	a.	a.	PROPN
easat-2032	246	13	g.	g.	PROPN
easat-2032	246	14	harmsen	harmsen	PROPN
easat-2032	246	15	,	,	PUNCT
easat-2032	246	16	“	"	PUNCT
easat-2032	246	17	immunization	immunization	NOUN
easat-2032	246	18	with	with	ADP
easat-2032	246	19	pneumocystis	pneumocystis	ADJ
easat-2032	246	20	carinii	carinii	ADJ
easat-2032	246	21	gpa	gpa	PROPN
easat-2032	246	22	is	be	AUX
easat-2032	246	23	immunogenic	immunogenic	ADJ
easat-2032	246	24	but	but	CCONJ
easat-2032	246	25	not	not	PART
easat-2032	246	26	protective	protective	ADJ
easat-2032	246	27	in	in	ADP
easat-2032	246	28	a	a	DET
easat-2032	246	29	mouse	mouse	NOUN
easat-2032	246	30	model	model	NOUN
easat-2032	246	31	of	of	ADP
easat-2032	246	32	p.	p.	NOUN
easat-2032	246	33	carinii	carinii	ADJ
easat-2032	246	34	pneumonia	pneumonia	NOUN
easat-2032	246	35	,	,	PUNCT
easat-2032	246	36	”	"	PUNCT
easat-2032	246	37	infect	infect	VERB
easat-2032	246	38	.	.	PUNCT
easat-2032	247	1	immun	immun	PROPN
easat-2032	247	2	.	.	PROPN
easat-2032	247	3	,	,	PUNCT
easat-2032	247	4	vol	vol	NOUN
easat-2032	247	5	.	.	PROPN
easat-2032	248	1	66	66	NUM
easat-2032	248	2	,	,	PUNCT
easat-2032	248	3	no	no	INTJ
easat-2032	248	4	.	.	NOUN
easat-2032	248	5	7	7	NUM
easat-2032	248	6	,	,	PUNCT
easat-2032	248	7	pp	pp	ADJ
easat-2032	248	8	.	.	PUNCT
easat-2032	249	1	3179–3182	3179–3182	NUM
easat-2032	249	2	,	,	PUNCT
easat-2032	249	3	1998	1998	NUM
easat-2032	249	4	.	.	PUNCT
easat-2032	250	1	[	[	X
easat-2032	250	2	40	40	NUM
easat-2032	250	3	]	]	PUNCT
easat-2032	250	4	w.	w.	PROPN
easat-2032	250	5	t.	t.	PROPN
easat-2032	250	6	hughes	hughes	PROPN
easat-2032	250	7	,	,	PUNCT
easat-2032	250	8	g.	g.	PROPN
easat-2032	250	9	k.	k.	PROPN
easat-2032	250	10	rivera	rivera	PROPN
easat-2032	250	11	,	,	PUNCT
easat-2032	250	12	m.	m.	PROPN
easat-2032	250	13	j.	j.	PROPN
easat-2032	250	14	schell	schell	PROPN
easat-2032	250	15	,	,	PUNCT
easat-2032	250	16	d.	d.	PROPN
easat-2032	250	17	thornton	thornton	PROPN
easat-2032	250	18	,	,	PUNCT
easat-2032	250	19	and	and	CCONJ
easat-2032	250	20	l.	l.	PROPN
easat-2032	250	21	lott	lott	PROPN
easat-2032	250	22	,	,	PUNCT
easat-2032	250	23	“	"	PUNCT
easat-2032	250	24	successful	successful	ADJ
easat-2032	250	25	intermittent	intermittent	ADJ
easat-2032	250	26	chemoprophylaxis	chemoprophylaxis	NOUN
easat-2032	250	27	for	for	ADP
easat-2032	250	28	pneumocystis	pneumocystis	ADJ
easat-2032	250	29	carinii	carinii	NOUN
easat-2032	250	30	pneumonitis	pneumonitis	NOUN
easat-2032	250	31	,	,	PUNCT
easat-2032	250	32	”	"	PUNCT
easat-2032	250	33	n.	n.	PROPN
easat-2032	250	34	engl	engl	PROPN
easat-2032	250	35	.	.	PUNCT
easat-2032	251	1	j.	j.	PROPN
easat-2032	251	2	med	med	PROPN
easat-2032	251	3	.	.	PROPN
easat-2032	251	4	,	,	PUNCT
easat-2032	251	5	vol	vol	NOUN
easat-2032	251	6	.	.	PROPN
easat-2032	252	1	316	316	NUM
easat-2032	252	2	,	,	PUNCT
easat-2032	252	3	no	no	INTJ
easat-2032	252	4	.	.	NOUN
easat-2032	252	5	26	26	NUM
easat-2032	252	6	,	,	PUNCT
easat-2032	252	7	pp	pp	ADJ
easat-2032	252	8	.	.	PUNCT
easat-2032	252	9	1627–1632	1627–1632	NUM
easat-2032	252	10	,	,	PUNCT
easat-2032	252	11	1987	1987	NUM
easat-2032	252	12	.	.	PUNCT
easat-2032	253	1	[	[	X
easat-2032	253	2	41	41	NUM
easat-2032	253	3	]	]	X
easat-2032	253	4	h.	h.	PROPN
easat-2032	253	5	furrer	furrer	PROPN
easat-2032	253	6	et	et	PROPN
easat-2032	253	7	al	al	PROPN
easat-2032	253	8	.	.	PROPN
easat-2032	253	9	,	,	PUNCT
easat-2032	253	10	“	"	PUNCT
easat-2032	253	11	discontinuation	discontinuation	NOUN
easat-2032	253	12	of	of	ADP
easat-2032	253	13	primary	primary	ADJ
easat-2032	253	14	prophylaxis	prophylaxis	NOUN
easat-2032	253	15	against	against	ADP
easat-2032	253	16	pneumocystis	pneumocystis	ADJ
easat-2032	253	17	carinii	carinii	ADJ
easat-2032	253	18	pneumonia	pneumonia	NOUN
easat-2032	253	19	in	in	ADP
easat-2032	253	20	hiv-1	hiv-1	ADV
easat-2032	253	21	-	-	PUNCT
easat-2032	253	22	infected	infect	VERB
easat-2032	253	23	adults	adult	NOUN
easat-2032	253	24	treated	treat	VERB
easat-2032	253	25	with	with	ADP
easat-2032	253	26	combination	combination	NOUN
easat-2032	253	27	antiretroviral	antiretroviral	ADJ
easat-2032	253	28	therapy	therapy	NOUN
easat-2032	253	29	.	.	PUNCT
easat-2032	254	1	swiss	swiss	ADJ
easat-2032	254	2	hiv	hiv	PROPN
easat-2032	254	3	cohort	cohort	PROPN
easat-2032	254	4	study	study	NOUN
easat-2032	254	5	,	,	PUNCT
easat-2032	254	6	”	"	PUNCT
easat-2032	254	7	n.	n.	PROPN
easat-2032	254	8	engl	engl	PROPN
easat-2032	254	9	.	.	PUNCT
easat-2032	255	1	j.	j.	PROPN
easat-2032	255	2	med	med	PROPN
easat-2032	255	3	.	.	PROPN
easat-2032	255	4	,	,	PUNCT
easat-2032	255	5	vol	vol	NOUN
easat-2032	255	6	.	.	PROPN
easat-2032	255	7	340	340	NUM
easat-2032	255	8	,	,	PUNCT
easat-2032	255	9	no	no	INTJ
easat-2032	255	10	.	.	NOUN
easat-2032	255	11	17	17	NUM
easat-2032	255	12	,	,	PUNCT
easat-2032	255	13	pp	pp	ADJ
easat-2032	255	14	.	.	PUNCT
easat-2032	255	15	1301–1306	1301–1306	NUM
easat-2032	255	16	,	,	PUNCT
easat-2032	255	17	1999	1999	NUM
easat-2032	255	18	.	.	PUNCT